0001142750-19-000021.txt : 20190503 0001142750-19-000021.hdr.sgml : 20190503 20190503163356 ACCESSION NUMBER: 0001142750-19-000021 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 71 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190503 DATE AS OF CHANGE: 20190503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMN HEALTHCARE SERVICES INC CENTRAL INDEX KEY: 0001142750 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] IRS NUMBER: 061500476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-16753 FILM NUMBER: 19796706 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8668718519 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92130 10-Q 1 amn-20190331x10q.htm 10-Q Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
FORM 10-Q
____________________
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2019
 
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from                       to                     
Commission File No.: 001-16753

amnlogoa01a01a01a18.jpg
AMN HEALTHCARE SERVICES, INC.
(Exact Name of Registrant as Specified in Its Charter)

Delaware
 
06-1500476
(State or Other Jurisdiction of
Incorporation or Organization)
 
(I.R.S. Employer
Identification No.)
 
 
12400 High Bluff Drive, Suite 100
San Diego, California
 
92130
(Address of Principal Executive Offices)
 
(Zip Code)

Registrant’s Telephone Number, Including Area Code: (866) 871-8519
____________________

Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Trading Symbol
Name of each exchange on which registered
Common Stock, $0.01 par value
AMN
New York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  x No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer   x
 
Accelerated filer   o
 
Non-accelerated filer  o
Smaller reporting company o
 
Emerging growth company o
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act).  Yes   o  No  x
As of May 1, 2019, there were 46,619,697 shares of common stock, $0.01 par value, outstanding.
 



TABLE OF CONTENTS
 
Item
 
Page
 
 
 
 
PART I - FINANCIAL INFORMATION
 
 
 
 
1.
 
 
 
 
 
2.
3.
4.
 
 
 
 
PART II - OTHER INFORMATION
 
 
 
 
 
 
 
1.
1A.
2.
3.
4.
5.
6.
 




PART I - FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

AMN HEALTHCARE SERVICES, INC.
 
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited and in thousands, except par value)
 
March 31, 2019
 
December 31, 2018
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
19,116

 
$
13,856

Accounts receivable, net of allowances of $11,716 and $10,560 at March 31, 2019 and December 31, 2018, respectively
365,231

 
365,871

Accounts receivable, subcontractor
55,607

 
50,143

Prepaid expenses
17,724

 
12,409

Other current assets
31,209

 
39,887

Total current assets
488,887

 
482,166

Restricted cash, cash equivalents and investments
61,279

 
59,331

Fixed assets, net of accumulated depreciation of $119,489 and $114,413 at March 31, 2019 and December 31, 2018, respectively
93,625

 
90,419

Operating lease right-of-use assets
97,055

 

Other assets
105,590

 
96,152

Goodwill
464,923

 
438,506

Intangible assets, net of accumulated amortization of $121,575 and $114,924 at March 31, 2019 and December 31, 2018, respectively
326,466

 
326,147

Total assets
$
1,637,825

 
$
1,492,721

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Accounts payable and accrued expenses
$
153,566

 
$
149,603

Accrued compensation and benefits
135,792

 
135,059

Current portion of operating lease liabilities
12,341

 

Deferred revenue
11,459

 
12,365

Other current liabilities
20,112

 
10,243

Total current liabilities
333,270

 
307,270

 
 
 
 
Revolving credit facility
150,000

 
120,000

Notes payable, less unamortized fees
320,798

 
320,607

Deferred income taxes, net
20,079

 
27,326

Operating lease liabilities
99,946

 

Other long-term liabilities
63,746

 
78,528

Total liabilities
987,839

 
853,731

Commitments and contingencies


 


Stockholders’ equity:
 
 
 
Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at March 31, 2019 and December 31, 2018

 

Common stock, $0.01 par value; 200,000 shares authorized; 49,122 issued and 46,578 outstanding at March 31, 2019 and 48,809 issued and 46,643 outstanding at December 31, 2018
491

 
488

Additional paid-in capital
447,632

 
452,730

Treasury stock, at cost (2,544 and 2,166 shares at March 31, 2019 and December 31, 2018, respectively)
(118,368
)
 
(100,438
)
Retained earnings
320,181

 
286,059

Accumulated other comprehensive income
50

 
151

Total stockholders’ equity
649,986

 
638,990

Total liabilities and stockholders’ equity
$
1,637,825

 
$
1,492,721


See accompanying notes to unaudited condensed consolidated financial statements.

1


AMN HEALTHCARE SERVICES, INC.
 
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited and in thousands, except per share amounts)
 
 
Three Months Ended March 31,
 
2019
 
2018
Revenue
$
532,441

 
$
522,489

Cost of revenue
355,682

 
354,665

Gross profit
176,759

 
167,824

Operating expenses:
 
 
 
Selling, general and administrative
119,997

 
104,737

Depreciation and amortization
11,710

 
7,886

Total operating expenses
131,707

 
112,623

Income from operations
45,052

 
55,201

Interest expense, net, and other
5,673

 
5,335

Income before income taxes
39,379

 
49,866

Income tax expense
5,257

 
7,185

Net income
$
34,122

 
$
42,681

 
 
 
 
Other comprehensive loss:
 
 
 
Foreign currency translation and other
(101
)
 
(19
)
Other comprehensive loss
(101
)
 
(19
)
 
 
 
 
Comprehensive income
$
34,021

 
$
42,662

 
 
 
 
Net income per common share:
 
 
 
Basic
$
0.73

 
$
0.89

Diluted
$
0.71

 
$
0.87

Weighted average common shares outstanding:
 
 
 
Basic
46,784

 
47,733

Diluted
47,772

 
49,116

 
 
 
 
 
See accompanying notes to unaudited condensed consolidated financial statements.


2


AMN HEALTHCARE SERVICES, INC.
 
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited and in thousands)
 
Common Stock
 
Additional
Paid-in
Capital
 
Treasury Stock
 
Retained Earnings
 
Accumulated Other Comprehensive Loss
 
Total
 
Shares
 
Amount
 
Shares
 
Amount
 
Balance, December 31, 2017
48,411

 
$
484

 
$
453,351

 
(930
)
 
$
(33,425
)
 
$
142,229

 
$
(112
)
 
$
562,527

Equity awards vested and exercised, net of shares withheld for payroll taxes
349

 
4

 
(10,930
)
 

 

 

 

 
(10,926
)
Cumulative-effect adjustment from adoption of the new revenue recognition standard

 

 

 

 

 
2,089

 

 
2,089

Share-based compensation

 

 
2,864

 

 

 

 

 
2,864

Comprehensive income (loss)

 

 

 

 

 
42,681

 
(19
)
 
42,662

Balance, March 31, 2018
48,760

 
$
488

 
$
445,285

 
(930
)
 
$
(33,425
)
 
$
186,999

 
$
(131
)
 
$
599,216


 
Common Stock
 
Additional
Paid-in
Capital
 
Treasury Stock
 
Retained Earnings
 
Accumulated Other Comprehensive Income
 
Total
 
Shares
 
Amount
 
Shares
 
Amount
 
Balance, December 31, 2018
48,809

 
$
488

 
$
452,730

 
(2,166
)
 
$
(100,438
)
 
$
286,059

 
$
151

 
$
638,990

Repurchase of common stock into treasury

 

 

 
(378
)
 
(17,930
)
 

 

 
(17,930
)
Equity awards vested and exercised, net of shares withheld for payroll taxes
313

 
3

 
(10,284
)
 

 

 

 

 
(10,281
)
Share-based compensation

 

 
5,186

 

 

 

 

 
5,186

Comprehensive income (loss)

 

 

 

 

 
34,122

 
(101
)
 
34,021

Balance, March 31, 2019
49,122

 
$
491

 
$
447,632

 
(2,544
)
 
$
(118,368
)
 
$
320,181

 
$
50

 
$
649,986


See accompanying notes to unaudited condensed consolidated financial statements.


3


AMN HEALTHCARE SERVICES, INC.
 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited and in thousands)
 
Three Months Ended March 31,
 
2019
 
2018
Cash flows from operating activities:
 
 
 
Net income
$
34,122

 
$
42,681

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation and amortization
11,710

 
7,886

Non-cash interest expense and other
543

 
600

Write-off of fees on the prior credit facilities

 
574

Change in fair value of contingent consideration
(700
)
 

Increase in allowances for doubtful accounts and sales credits
2,608

 
2,257

Provision for deferred income taxes
(9,036
)
 
(5,113
)
Share-based compensation
5,186

 
2,864

Loss on disposal or sale of fixed assets
4

 
5

Amortization of discount on investments
(120
)
 
(15
)
Non-cash lease expense
(92
)
 

Changes in assets and liabilities, net of effects from acquisitions:
 
 
 
Accounts receivable
(1,500
)
 
9,154

Accounts receivable, subcontractor
(5,465
)
 
1,985

Income taxes receivable
799

 
9,881

Prepaid expenses
(5,387
)
 
(2,375
)
Other current assets
(1,783
)
 
2,825

Other assets
(6,202
)
 
(89
)
Accounts payable and accrued expenses
2,949

 
(7,816
)
Accrued compensation and benefits
330

 
(4,007
)
Other liabilities
9,630

 
(1,498
)
Deferred revenue
(1,418
)
 
(52
)
Restricted investments balance
36

 
(12
)
Net cash provided by operating activities
36,214

 
59,735

 
 
 
 
Cash flows from investing activities:
 
 
 
Purchase and development of fixed assets
(7,388
)
 
(5,703
)
Purchase of investments
(7,362
)
 
(2,086
)
Proceeds from maturity of investments
11,700

 
2,900

Payments to fund deferred compensation plan
(3,583
)
 
(4,724
)
Cash paid for acquisitions, net of cash received
(29,525
)
 

Cash paid for other intangibles
(90
)
 

Net cash used in investing activities
(36,248
)
 
(9,613
)

4


 
Three Months Ended March 31,
 
2019
 
2018
Cash flows from financing activities:
 
 
 
Proceeds from revolving credit facility
30,000

 

Repurchase of common stock
(17,930
)
 

Payment of financing costs

 
(2,331
)
Earn-out payments for prior acquisitions

 
(1,713
)
Cash paid for shares withheld for taxes
(10,280
)
 
(10,926
)
Net cash provided by (used in) financing activities
1,790

 
(14,970
)
Effect of exchange rate changes on cash
(101
)
 
(19
)
Net increase in cash, cash equivalents and restricted cash
1,655

 
35,133

Cash, cash equivalents and restricted cash at beginning of period
84,324

 
98,894

Cash, cash equivalents and restricted cash at end of period
$
85,979

 
$
134,027

 
 
 
 
Supplemental disclosures of cash flow information:
 
 
 
Cash paid for amounts included in the measurement of operating lease liabilities
$
4,338

 
$

Cash paid for interest (net of $102 and $104 capitalized for the three months ended March 31, 2019 and 2018, respectively)
$
1,524

 
$
201

Cash paid for income taxes
$
4,192

 
$
2,731

Acquisitions:
 
 
 
Fair value of tangible assets acquired in acquisitions, net of cash received
$
1,041

 
$

Goodwill
26,494

 

Intangible assets
6,880

 

Liabilities assumed
(3,390
)
 

Earn-out liabilities
(1,500
)
 

Net cash paid for acquisitions
$
29,525

 
$

Supplemental disclosures of non-cash investing and financing activities:
 
 
 
Purchase of fixed assets recorded in accounts payable and accrued expenses
$
2,566

 
$
2,860

See accompanying notes to unaudited condensed consolidated financial statements.
AMN HEALTHCARE SERVICES, INC.
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share amounts)
 
1. BASIS OF PRESENTATION
The condensed consolidated balance sheets and related condensed consolidated statements of comprehensive income and cash flows contained in this Quarterly Report on Form 10-Q (this “Quarterly Report”), which are unaudited, include the accounts of AMN Healthcare Services, Inc. and its wholly-owned subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted of all normal recurring items. The results of operations for the interim period are not necessarily indicative of the results to be expected for any other interim period or for the entire fiscal year or for any future period.
The unaudited condensed consolidated financial statements do not include all information and notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”). Please refer to the Company’s audited consolidated financial statements and the related notes for the fiscal year ended December 31, 2018, contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018, filed with the Securities and Exchange Commission on February 21, 2019 (“2018 Annual Report”).
The preparation of financial statements in conformity with U.S. GAAP requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, earn-out liabilities, and income taxes. Actual results could differ from those estimates under different assumptions or conditions.
Recently Adopted Accounting Pronouncements
In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-02, “Leases.” This standard requires organizations that lease assets to recognize the assets and liabilities created by those leases. The standard also will require disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. A modified retrospective transition approach is required, applying the standard to all leases existing at the date of initial application. In addition, the FASB has also issued several amendments to the standard, which clarify certain aspects of the guidance, including an optional transition method for adoption of this standard, which allows organizations to initially apply the new requirements at the effective date, recognize a cumulative effect adjustment to the opening balance of retained earnings, and continue to apply the legacy guidance in Accounting Standards Codification (“ASC”) 840, Leases, including its disclosure requirements, in the comparative periods presented. The new standard provides a number of optional practical expedients in transition. The Company elected the ‘package of practical expedients’, which permits organizations not to reassess under the new standard prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect to use the hindsight practical expedient to determine the lease term or evaluate impairment for existing leases.
The Company adopted ASU 2016-02 effective January 1, 2019, using the optional transition method described above. The Company recognized the cumulative effect of adopting this guidance as an adjustment as of the effective date, primarily related to the recognition of lease liabilities of $114,807 and corresponding right-of-use assets of $99,525 for existing operating leases. The Company also derecognized existing deferred rent liabilities of $15,302. These adjustments had no effect on opening retained earnings and prior periods were not retrospectively adjusted and continue to be reported in accordance with ASC 840. The new standard also provides practical expedients for an organization’s ongoing accounting. The Company elected the short-term lease recognition exemption and the practical expedient to not separate lease and non-lease components for all leases that qualify. The Company does not expect the adoption of this standard to impact its results of operations.

There was no other material impact to the Company’s condensed consolidated financial statements as a result of adopting this updated standard.
Cash, cash equivalents and restricted cash
The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions and highly liquid

5


investments. Restricted cash and cash equivalents primarily represent cash and money market funds on deposit with financial institutions and investments represents commercial paper that serves as collateral for the Company’s outstanding letters of credit and captive insurance subsidiary claim payments. See Note (6), “New Credit Agreement” and Note (7), “Fair Value Measurement” for additional information.
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying condensed consolidated balance sheets and related notes to the amounts presented in the accompanying condensed consolidated statements of cash flows.
 
March 31, 2019
 
December 31, 2018
Cash and cash equivalents
$
19,116

 
$
13,856

Restricted cash and cash equivalents (included in other current assets)
16,522

 
26,329

Restricted cash, cash equivalents and investments
61,279

 
59,331

Total cash, cash equivalents and restricted cash and investments
96,917

 
99,516

Less restricted investments
(10,938
)
 
(15,192
)
Total cash, cash equivalents and restricted cash
$
85,979

 
$
84,324


2. ACQUISITIONS
As set forth below, the Company completed three acquisitions from January 1, 2018 through March 31, 2019. The Company accounted for each acquisition using the acquisition method of accounting. Accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. Since the applicable date of acquisition, the Company has revised the allocation of the purchase price to the tangible and intangible assets acquired and liabilities assumed based on analysis of information that has been made available through March 31, 2019. The allocation will continue to be updated through the measurement period, if necessary. For each acquisition, the Company did not incur any material acquisition-related costs.
Silversheet Acquisition
On January 30, 2019, the Company completed its acquisition of Silversheet, Inc. (“Silversheet”) which provides innovative software and services to reduce the complexities and challenges of the credentialing process for clinicians and healthcare organizations. The initial purchase price of $31,676 included (1) $30,176 cash consideration paid upon acquisition, funded primarily through borrowings under the Company’s $400,000 secured revolving credit facility (the “Senior Credit Facility”), provided for under a credit agreement (the “New Credit Agreement”), dated as of February 9, 2018, by and among the Company and several lenders, and (2) a contingent earn-out payment of up to $25,000 with an estimated fair value of $1,500 as of the acquisition date. The contingent earn-out payment is based on (A) up to $6,000 based on the operating results of Silversheet for the twelve months ending December 31, 2019, and (B) up to $19,000 based on the operating results of Silversheet for the twelve months ending December 31, 2020. The results of Silversheet have been included in the Company’s other workforce solutions segment since the date of acquisition. The New Credit Agreement is more fully described in Note (6), “New Credit Agreement.”
The preliminary allocation of the $31,676 purchase price consisted of (1) $1,692 of fair value of tangible assets acquired, which included $651 cash received, (2) $3,390 of liabilities assumed, (3) $6,880 of identified intangible assets, and (4) $26,494 of goodwill, none of which is deductible for tax purposes. The fair value of intangible assets primarily includes $5,300 of developed technology and $1,500 of trademarks with a weighted average useful life of approximately eight years.
MedPartners Acquisition
On April 9, 2018, the Company completed its acquisition of MedPartners HIM (“MedPartners”), which provides case management, clinical documentation improvement, medical coding and registry services to hospitals and physician medical groups nationwide. The initial purchase price of $200,711 included (1) $196,533 cash consideration paid upon acquisition, funded primarily through borrowings under the Senior Credit Facility, and (2) a contingent earn-out payment of up to $20,000 with an estimated fair value of $4,400 as of the acquisition date. The contingent earn-out payment is based on (A) up to $10,000 based on the operating results of MedPartners for the twelve months ending December 31, 2018, which resulted in no earn-out payment, and (B) up to $10,000 based on the operating results of MedPartners for the six months ending June 30, 2019. The results of MedPartners have been included in the Company’s other workforce solutions segment since the date of acquisition. During the third quarter of 2018, $222 was returned to the Company for the final working capital settlement.

6


The preliminary allocation of the $200,711 purchase price consisted of (1) $28,510 of fair value of tangible assets acquired, which included $8,403 cash received, (2) $11,848 of liabilities assumed, (3) $103,000 of identified intangible assets, and (4) $81,049 of goodwill, all of which is deductible for tax purposes. The intangible assets acquired have a weighted average useful life of approximately sixteen years. The following table summarizes the fair value and useful life of each intangible asset acquired:
 
 
 
Fair Value
 
Useful Life
 
 
 
 
 
(in years)
Identifiable intangible assets
 
 
 
 
 
Tradenames and Trademarks
 
$
46,000

 
20
 
Customer Relationships
 
57,000

 
12
 
 
 
$
103,000

 
 
Phillips DiPisa and Leaders For Today Acquisition
On April 6, 2018, the Company completed its acquisition of two related entities, Phillips DiPisa and Leaders For Today (“PDA and LFT”), which offer a range of leadership staffing and permanent placement solutions for the healthcare industry. The initial purchase price of $35,503 included (1) $30,268 cash consideration paid upon acquisition, funded through cash on hand, and (2) a contingent earn-out payment of up to $7,000 with an estimated fair value of $5,700 as of the acquisition date. The contingent earn-out payment is based on the operating results of PDA and LFT for the twelve months ending December 31, 2018, which resulted in the full earn-out payment made in April 2019. The results of PDA and LFT have been included in the Company’s other workforce solutions segment since the date of acquisition. During the third quarter of 2018, $465 was returned to the Company for the final working capital settlement.
The preliminary allocation of the $35,503 purchase price consisted of (1) $4,373 of fair value of tangible assets acquired, which included $351 cash received, (2) $4,764 of liabilities assumed, (3) $19,110 of identified intangible assets, and (4) $16,784 of goodwill, all of which is deductible for tax purposes. The fair value of intangible assets includes $5,400 of trademarks, $8,000 of customer relationships and $5,710 of staffing databases with a weighted average useful life of approximately twelve years.

3. REVENUE RECOGNITION
Revenue primarily consists of fees earned from the temporary and permanent placement of healthcare professionals and executives as well as from the Company’s SaaS-based technology, including its vendor management systems and its scheduling software. Revenue is recognized when control of these services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. Revenue from temporary staffing services is recognized as the services are rendered by clinical and non-clinical healthcare professionals. Under the Company’s managed services program arrangements, the Company manages all or a part of a customer’s supplemental workforce needs utilizing its own network of healthcare professionals along with those of third-party subcontractors. Revenue and the related direct costs under MSP arrangements are recorded in accordance with the accounting guidance on reporting revenue gross as a principal versus net as an agent. When the Company uses subcontractors and acts as an agent, revenue is recorded net of the related subcontractor’s expense. Revenue from executive search, physician permanent placement, and recruitment process outsourcing services is recognized as the services are rendered. The Company’s SaaS-based revenue is recognized ratably over the applicable arrangement’s service period.
The Company’s customers are primarily billed as services are rendered. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended March 31, 2019, the amount recognized as revenue that was previously deferred was not material.
The Company has elected to apply the following practical expedients and optional exemptions related to contract costs and revenue recognition:
Recognize incremental costs of obtaining a contract with amortization periods of one year or less as expense when incurred. These costs are recorded within selling, general and administrative expenses.
Recognize revenue in the amount of consideration to which the Company has a right to invoice the customer if that amount corresponds directly with the value to the customer of the Company’s services completed to date.
Exemptions from disclosing the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, (ii) contracts for which revenue is recognized in the amount of consideration to which the Company has a right to invoice for services performed and (iii) contracts for which variable consideration is allocated entirely to a wholly unsatisfied performance obligation or to a wholly unsatisfied promise to transfer a distinct service that forms part of a single performance obligation.
See Note (5), “Segment Information” for additional information.

4. NET INCOME PER COMMON SHARE
Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. The following table sets forth the computation of basic and diluted net income per common share for the three and three months ended March 31, 2019 and 2018, respectively:
 
Three Months Ended March 31,
 
2019
 
2018
Net income
$
34,122

 
$
42,681

 
 
 
 
Net income per common share - basic
$
0.73

 
$
0.89

Net income per common share - diluted
$
0.71

 
$
0.87

 
 
 
 
Weighted average common shares outstanding - basic
46,784

 
47,733

Plus dilutive effect of potential common shares
988

 
1,383

Weighted average common shares outstanding - diluted
47,772

 
49,116

Share-based awards to purchase 66 and 9 shares of common stock were not included in the above calculation of diluted net income per common share for the three months ended March 31, 2019 and 2018, respectively, because the effect of these instruments was anti-dilutive.

5. SEGMENT INFORMATION
The Company has three reportable segments: nurse and allied solutions, locum tenens solutions, and other workforce solutions.
The Company’s chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation, interest expense, net, and other, and unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.

The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes:

7


 
Three Months Ended March 31,
 
2019

2018
Revenue
 
 
 
Nurse and allied solutions
$
337,029

 
$
338,179

Locum tenens solutions
80,490

 
103,117

Other workforce solutions
114,922

 
81,193

 
$
532,441

 
$
522,489

Segment operating income
 
 
 
Nurse and allied solutions
$
47,922

 
$
51,805

Locum tenens solutions
5,701

 
9,958

Other workforce solutions
26,188

 
19,851

 
79,811

 
81,614

Unallocated corporate overhead
17,863

 
15,663

Depreciation and amortization
11,710

 
7,886

Share-based compensation
5,186

 
2,864

Interest expense, net, and other
5,673

 
5,335

Income before income taxes
$
39,379

 
$
49,866

The Company offers a comprehensive managed services program, in which the Company manages all or a portion of a client’s contingent staffing needs. This service includes both the placement of the Company’s own healthcare professionals and the utilization of other staffing agencies to fulfill the client’s staffing needs. See additional information in Note (3), “Revenue Recognition.” For the three months ended March 31, 2019 and 2018, revenue under the Company’s managed services program arrangements comprised approximately 67% and 63% for nurse and allied solutions revenue, 24% and 14% for locum tenens solutions revenue and 7% and 9% for other workforce solutions revenue, respectively.
The following table summarizes the activity related to the carrying value of goodwill by reportable segment:
 
Nurse and Allied Solutions
 
Locum Tenens Solutions
 
Other Workforce Solutions
 
Total
Balance, January 1, 2019
$
103,107

 
$
19,743

 
$
315,656

 
$
438,506

Goodwill adjustment for MedPartners acquisition

 

 
(64
)
 
(64
)
Goodwill adjustment for PDA and LFT acquisition

 

 
(13
)
 
(13
)
Goodwill from Silversheet acquisition

 

 
26,494

 
26,494

Balance, March 31, 2019
$
103,107

 
$
19,743

 
$
342,073

 
$
464,923

Accumulated impairment loss as of December 31, 2018 and March 31, 2019
$
154,444

 
$
53,940

 
$
6,555

 
$
214,939


6. NEW CREDIT AGREEMENT

On February 9, 2018, the Company entered into the New Credit Agreement with several lenders to provide for the $400,000 Senior Credit Facility to replace its then-existing credit facilities. The Senior Credit Facility includes a $50,000 sublimit for the issuance of letters of credit and a $50,000 sublimit for swingline loans. The obligations of the Company under the New Credit Agreement and the Senior Credit Facility are secured by substantially all of the assets of the Company. Borrowings under the Senior Credit Facility bear interest at floating rates, at the Company’s option, based upon either LIBOR plus a spread of 1.00% to 2.00% or a base rate plus a spread of 0.00% to 1.00%. The applicable spread is determined quarterly based upon the Company’s consolidated net leverage ratio. The Senior Credit Facility is available for working capital, capital expenditures, permitted acquisitions and general corporate purposes. The maturity date of the Senior Credit Facility is February 9, 2023.

In connection with obtaining the New Credit Agreement, the Company incurred $2,331 in fees paid to lenders and other third parties, which were capitalized and are amortized to interest expense over the term of the New Credit Facility. In addition, the Company wrote off $574 of unamortized financing fees during 2018 relating to the prior credit facilities.

7. FAIR VALUE MEASUREMENT

8


 
The Company’s valuation techniques and inputs used to measure fair value and the definition of the three levels (Level 1, Level 2, and Level 3) of the fair value hierarchy are disclosed in Part II, Item 8, “Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note 3—Fair Value Measurement” of the 2018 Annual Report. The Company has not changed the valuation techniques or inputs it uses for its fair value measurement during the three months ended March 31, 2019.
Assets and Liabilities Measured on a Recurring Basis
The Company’s restricted cash equivalents that serve as collateral for the Company’s outstanding letters of credit
typically consist of money market funds that are measured at fair value based on quoted prices, which are Level 1 inputs.
The Company’s restricted cash equivalents and investments that serve as collateral for the Company’s captive insurance company primarily consist of commercial paper that is measured at observable market prices for identical securities that are traded in less active markets, which are Level 2 inputs. Of the $61,786 commercial paper issued and outstanding as of March 31, 2019, $10,938 had original maturities greater than three months, which were considered available-for-sale securities. As of December 31, 2018, the Company had $63,243 commercial paper issued and outstanding, of which $15,192 had original maturities greater than three months and were considered available-for-sale securities.
The Company’s contingent consideration liabilities are measured at fair value using a probability-weighted discounted cash flow analysis or a simulation-based methodology for the acquired companies, which are Level 3 inputs. The Company recognizes changes to the fair value of its contingent consideration liabilities in selling, general and administrative expenses in the condensed consolidated statements of comprehensive income.
The following tables present information about the above-referenced assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value:
 
Fair Value Measurements as of March 31, 2019
 
Total
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Money market funds
$
2,473

 
$
2,473

 
$

 
$

Commercial paper
61,786

 

 
61,786

 

Acquisition contingent consideration liabilities
(8,500
)
 

 

 
(8,500
)

 
Fair Value Measurements as of December 31, 2018
 
Total
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Money market funds
$
2,461

 
$
2,461

 
$

 
$

Commercial paper
63,243

 

 
63,243

 

Acquisition contingent consideration liabilities
(7,700
)
 

 

 
(7,700
)

9


Level 3 Information
The following tables set forth a reconciliation of changes in the fair value of contingent consideration liabilities classified as Level 3 in the fair value hierarchy:
 
Three Months Ended March 31,
 
2019
 
2018
Balance as of January 1,
$
(7,700
)

$
(2,070
)
Settlement of HSG contingent consideration liability for year ended December 31, 2016

 
70

Settlement of HSG contingent consideration liability for year ended December 31, 2017

 
2,000

Change in fair value of contingent consideration liability from Medpartners acquisition
700

 

Contingent consideration liability from Silversheet acquisition on January 30, 2019
(1,500
)
 

Balance as of March 31,
$
(8,500
)
 
$

Assets Measured on a Non-Recurring Basis
The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets, and equity investments.
The Company evaluates goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs, including the market capitalization of the Company, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determines the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.
The Company’s equity investment represents an investment in a non-controlled corporation without a readily determinable market value. The Company has elected to measure the investment at cost minus impairment, if any, plus or minus changes resulting from observable price changes. The fair value is determined by using quoted prices for identical or similar investments of the same issuer, which are Level 2 inputs. The Company recognizes changes to the fair value of its equity investment in interest expense, net, and other in the condensed consolidated statements of comprehensive income.
The balance of the equity investment classified as Level 2 in the fair value hierarchy was $15,449 as of both March 31, 2019 and December 31, 2018. There were no changes to the fair value of the equity investment recognized during the three months ended March 31, 2019.
There were no triggering events identified, no indication of impairment of the Company’s goodwill, indefinite-lived intangible assets, long-lived assets, or equity investments, and no impairment charges recorded during the three months ended March 31, 2019 and 2018.
Fair Value of Financial Instruments
The Company is required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. As of March 31, 2019, the Company’s senior notes have a carrying amount of $325,000 and an estimated fair value of $320,531. As of December 31, 2018, the senior notes had a carrying amount of $325,000 and an estimated fair value of $310,375. Quoted market prices in active markets for identical liabilities based inputs (Level 1) were used to estimate fair value. The senior notes were issued in October 2016 and have a fixed rate of 5.125%. See additional information in “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (7), Notes Payable and Credit Agreement” of our 2018 Annual Report.
The fair value of the Company’s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.

8. LEASES


10


The Company leases certain office facilities, data centers, and equipment under various operating leases. Leases with an initial term of 12 months or less (primarily related to housing arrangements for healthcare professionals on assignment) are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term. Most leases include one or more options to renew, with renewal terms that can extend the lease term up to 10 years. Certain leases also include options to terminate the leases within 3 years.

The components of lease expense were as follows:
 
 
Three Months Ended March 31,
 
 
2019
Lease Cost
 
 
Operating lease cost
 
$
4,536

Short-term lease cost
 
5,922

Variable and other lease cost
 
717

Net lease cost
 
$
11,175


The maturity of lease liabilities as of March 31, 2019 were as follows: 
 
 
Operating Leases
Years ending December 31,
 
 
2019 (excluding the three months ended March 31, 2019)
 
$
13,091

2020
 
17,698

2021
 
18,183

2022
 
18,057

2023
 
17,795

Thereafter
 
50,318

Total lease payments
 
$
135,142

Less imputed interest
 
(22,855
)
Present value of lease liabilities
 
$
112,287


Supplemental cash flow information related to leases was as follows: 
 
 
Three Months Ended March 31,
 
 
2019
Cash paid for amounts included in the measurement of operating lease liabilities (operating cash flows)
 
$
4,338

Operating lease right-of-use assets obtained in exchange for lease obligations
 
$

Weighted average remaining lease term
 
7 years

Weighted average discount rate
 
4.8
%


11


Future minimum lease payments under noncancelable operating leases (with initial or remaining lease terms in excess of one year) as of December 31, 2018 were as follows: 
 
 
Operating Leases
Years ending December 31,
 

2019
 
$
18,218

2020
 
18,149

2021
 
18,349

2022
 
18,144

2023
 
17,990

Thereafter
 
50,436

Total minimum lease payments
 
$
141,286


Rent expense under operating leases (with initial lease terms in excess of one year) was $21,402 for the year ended December 31, 2018.

9. INCOME TAXES
The Company is subject to taxation in the U.S. and various states and foreign jurisdictions. With few exceptions, as of March 31, 2019, the Company is no longer subject to state, local or foreign examinations by tax authorities for tax years before 2009 and the Company is no longer subject to U.S. federal income or payroll tax examinations for tax years before 2015. The IRS conducted, completed, and settled audits of the Company’s 2011-2012 and 2013 tax years related to income and employment tax issues for the Company’s treatment of certain non-taxable per diem allowances and travel benefits in November 2017 and May 2018, respectively.

The Company believes its reserve for unrecognized tax benefits and contingent tax issues is adequate with respect to all open years. Notwithstanding the foregoing, the Company could adjust its provision for income taxes and contingent tax liability based on future developments.

10. COMMITMENTS AND CONTINGENCIES: LEGAL PROCEEDINGS

From time to time, the Company is involved in various lawsuits, claims, investigations, and proceedings that arise in the ordinary course of business. These matters typically relate to professional liability, tax, compensation, contract, competitor disputes and employee-related matters and include individual and class action lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company’s employment and compensation practices. Additionally, some of the Company’s clients may also become subject to claims, governmental inquiries and investigations, and legal actions relating to services provided by the Company’s healthcare professionals. Depending upon the particular facts and circumstances, the Company may also be subject to indemnification obligations under its contracts with such clients relating to these matters. The Company records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. The most significant matters for which the Company has established loss contingencies are class actions related to wage and hour claims under California and Federal law. Specifically, among other claims in these lawsuits, it is alleged that employees were not afforded required breaks or compensated for all time worked, employees’ wage statements are not sufficiently clear, and certain expense reimbursements should be included in the regular rate of pay for purposes of calculating overtime rates. The Company believes that its wage and hour practices conform with law in all material respects, but litigation is always subject to inherent uncertainty. As a result, the Company entered into settlement agreements relating to claims in two wage and hour class actions during September and October 2018. The settlement agreements are subject to court approval, which is considered probable. The Company recorded increases to its accruals established in connection with these matters amounting to $12,140 during the third quarter of 2018.
With regard to outstanding loss contingencies as of March 31, 2019, which are included in accounts payable and accrued expenses in the condensed consolidated balance sheet, the Company believes that such matters will not, either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations, or cash flows.


12


11. BALANCE SHEET DETAILS

The consolidated balance sheets detail is as follows as of March 31, 2019 and December 31, 2018:
 
 
March 31, 2019
 
December 31, 2018
Other current assets:
 
 
 
 
Restricted cash and cash equivalents
 
$
16,522

 
$
26,329

Income tax receivable
 

 
799

Other
 
14,687

 
12,759

Other current assets
 
$
31,209

 
$
39,887

 
 
 
 
 
Fixed assets:
 
 
 
 
Furniture and equipment
 
$
36,313

 
$
34,211

Software
 
168,030

 
162,006

Leasehold improvements
 
8,771

 
8,615

 
 
213,114

 
204,832

Accumulated depreciation
 
(119,489
)
 
(114,413
)
Fixed assets, net
 
$
93,625

 
$
90,419

 
 
 
 
 
Other assets:
 
 
 
 
Life insurance cash surrender value
 
$
64,500

 
$
55,028

Other
 
41,090

 
41,124

Other assets
 
$
105,590

 
$
96,152

 
 
 
 
 
Accounts payable and accrued expenses:
 
 
 
 
Trade accounts payable
 
$
23,203

 
$
31,537

Subcontractor payable
 
55,575

 
50,892

Accrued expenses
 
37,831

 
30,236

Loss contingencies
 
24,578

 
24,549

Professional liability reserve
 
7,961

 
8,633

Other
 
4,418

 
3,756

Accounts payable and accrued expenses
 
$
153,566

 
$
149,603

 
 
 
 
 
Accrued compensation and benefits:
 
 
 
 
Accrued payroll
 
$
39,933

 
$
42,571

Accrued bonuses
 
13,546

 
18,021

Accrued travel expense
 
2,684

 
3,417

Health insurance reserve
 
3,582

 
3,559

Workers compensation reserve
 
8,378

 
7,817

Deferred compensation
 
65,820

 
55,720

Other
 
1,849

 
3,954

Accrued compensation and benefits
 
$
135,792

 
$
135,059

 
 
 
 
 
Other current liabilities:
 
 
 
 
Acquisition related liabilities
 
$
7,668

 
$
7,918

Other
 
12,444


2,325

Other current liabilities
 
$
20,112


$
10,243

 
 
 
 
 
Other long-term liabilities:
 
 
 
 
Workers compensation reserve
 
$
18,953

 
$
19,454

Professional liability reserve
 
38,058

 
38,324

Deferred rent
 

 
15,012

Unrecognized tax benefits
 
4,916

 
4,862

Deferred revenue
 
769

 
865

Other
 
1,050

 
11

Other long-term liabilities
 
$
63,746

 
$
78,528


13



12. SUBSEQUENT EVENTS

On April 29, 2019, the Company entered into an agreement to acquire Advanced Medical Personnel Services, Inc. (“Advanced”) for $200,000 in cash and tiered contingent consideration of up to $20,000. Advanced is a national healthcare staffing company that specializes in placing therapists and nurses across multiple settings, including hospitals, schools, clinics, skilled nursing facilities, and home health. The closing of the acquisition is contingent upon satisfaction of certain conditions and, upon consummation, Advanced will become a wholly owned subsidiary of the Company.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results
of Operations
 
The following discussion should be read in conjunction with our consolidated financial statements and the notes thereto and other financial information included elsewhere herein and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018, filed with the Securities and Exchange Commission (“SEC”) on February 21, 2019 (“2018 Annual Report”). Certain statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” are “forward-looking statements.” See “Special Note Regarding Forward-Looking Statements.” We undertake no obligation to update the forward-looking statements in this Quarterly Report. References in this Quarterly Report to “AMN Healthcare,” the “Company,” “we,” “us” and “our” refer to AMN Healthcare Services, Inc. and its wholly owned subsidiaries.
Overview of Our Business
 
We provide healthcare workforce solutions and staffing services to healthcare facilities across the nation. As an innovative workforce solutions partner, our managed services programs, or “MSP,” vendor management systems, or “VMS,” workforce consulting services, predictive modeling, staff scheduling, mid-revenue cycle solutions and the placement of physicians, nurses, allied healthcare professionals and healthcare leaders into temporary and permanent positions enable our clients to successfully reduce staffing complexity, increase efficiency and lead their organizations within the rapidly evolving healthcare environment.
We conduct business through three reportable segments: (1) nurse and allied solutions, (2) locum tenens solutions, and (3) other workforce solutions. For the three months ended March 31, 2019, we recorded revenue of $532.4 million, as compared to $522.5 million for the same period last year.
Nurse and allied solutions segment revenue comprised 63% and 65% of total consolidated revenue for the three months ended March 31, 2019 and 2018, respectively. Through our nurse and allied solutions segment, we provide hospitals and other healthcare facilities with a comprehensive managed services solution in which we manage and staff all of the temporary nursing and allied staffing needs of a client and traditional clinical staffing solutions of variable assignment lengths.
 
Locum tenens solutions segment revenue comprised 15% and 20% of total consolidated revenue for the three months ended March 31, 2019 and 2018, respectively. Through our locum tenens solutions segment, we provide a comprehensive managed services solution in which we manage all of the locum tenens needs of a client and place physicians of all specialties, as well as dentists and advanced practice providers, with clients on a temporary basis as independent contractors. These locum tenens providers are used by our clients to fill temporary vacancies created by vacation and leave schedules and to bridge the gap while they seek permanent candidates or explore expansion. Our locum tenens clients represent a diverse group of healthcare organizations throughout the United States, including hospitals, health systems, medical groups, occupational medical clinics, psychiatric facilities, government institutions, and insurance entities. The professionals we place are recruited nationwide and are typically placed on contracts with assignment lengths ranging from a few days to one year.
 

14


Other workforce solutions segment revenue comprised 22% and 15% of total consolidated revenue for the three months ended March 31, 2019 and 2018, respectively. Through our other workforce solutions segment, we provide hospitals and other healthcare facilities with a range of workforce solutions, including: (1) identifying and recruiting physicians and healthcare leaders for permanent placement, (2) placing interim leaders and executives across all healthcare settings, (3) a software-as-a-service (“SaaS”) VMS through which our clients can manage all of their temporary staffing needs, (4) RPO services that leverage our expertise and support systems to replace or complement a client’s existing internal recruitment function for permanent placement needs, (5) an education program that provides custom healthcare education, research, professional practice tools, and professional development services, (6) mid-revenue cycle management and related consulting services, (7) workforce optimization services that include consulting, data analytics, predictive modeling, and SaaS-based scheduling technology, and (8) credentialing services.

As part of our long-term growth strategy to add value for our clients, healthcare professionals, and shareholders, on January 30, 2019, April 6, 2018 and April 9, 2018, we acquired Silversheet, Phillips DiPisa and Leaders For Today (“PDA” and “LFT”) and MedPartners HIM (“MedPartners”), respectively. Silversheet provides innovative credentialing software solutions to clinicians and healthcare enterprises. PDA and LFT offer a range of leadership staffing and permanent placement solutions for the healthcare industry. MedPartners provides mid-revenue cycle management solutions, including case management, clinical documentation improvement, medical coding and registry services to hospitals and physician medical groups nationwide. See additional information in the accompanying Note (2), “Acquisitions.”
Recent Trends

15



Demand for our temporary and permanent placement staffing services is driven in part by U.S. economic and labor trends. The U.S. Bureau of Labor Statistics’ survey data reflects near record levels of healthcare job openings and quits. We view this data, along with a nearly 20-year-low unemployment rate and continued economic growth as positive trends for the healthcare staffing industry. The low unemployment rate has led to some wage growth to attract healthcare professionals.

The increasing consolidation within the healthcare industry is creating larger, more sophisticated and complex health systems that we believe has elevated the need for strategic workforce solutions capable of partnering to solve their recruiting, staffing and workforce optimization requirements. Given the increasing need for partners capable of offering a comprehensive workforce solution, we continue to see the benefits of our workforce solutions strategy, particularly with our MSPs. As a result of our ongoing focus on these strategic MSP relationships, the percentage of our staffing revenue derived from our MSP clients continues to increase, and we believe these strategic, longer-term relationships will continue to comprise a greater proportion of revenue in our staffing operating segments.

In our nurse and allied solutions segment, overall demand is strong, although our financial results have been impacted by fewer contingent nurse staffing needs from a large client. Our allied staffing business continues its steady growth, with favorable trends across most modalities.

In our locum tenens solutions segment, we implemented operating model changes together with new front and back office technologies over the last 18 months. Although these changes are expected to have a long-term positive impact on our growth and profitability, they have been significantly more disruptive than anticipated to our current sales productivity and revenue. Although demand for hospitalists and emergency room physicians has significantly declined over the past 12 months, the overall demand environment for locum tenens has been relatively stable and client interest in managed service programs is increasing. Approximately 20% of our revenue in this segment is now derived through managed service programs.

In our other workforce solutions segment, our acquisitions in the mid-revenue cycle, interim leadership and executive search businesses continue to contribute to the segment’s growth. Our businesses in these markets are expected to comprise a bigger portion of our organic profitability growth in 2019.

Critical Accounting Policies and Estimates
The preparation of our consolidated financial statements in conformity with United States generally accepted accounting principles (“U.S. GAAP”) requires us to make estimates and judgments that affect our reported amounts of assets and liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, earn-out liabilities, and income taxes. We base these estimates on the information that is currently available to us and on various other assumptions that we believe are reasonable under the circumstances. Actual results could vary from these estimates under different assumptions or conditions. If these estimates differ significantly from actual results, our consolidated financial statements and future results of operations may be materially impacted. There have been no material changes in our critical accounting policies and estimates, other than the adoption of the Accounting Standards Update (“ASU”) 2016-02 described in Item 1. Condensed Consolidated Financial Statements—Note 1, “Basis of Presentation,” as compared to the critical accounting policies and estimates described in our 2018 Annual Report.
 

16


Results of Operations
The following table sets forth, for the periods indicated, selected unaudited condensed consolidated statements of operations data as a percentage of revenue. Our results of operations include three reportable segments: (1) nurse and allied solutions, (2) locum tenens solutions, and (3) other workforce solutions. The PDA, LFT, MedPartners and Silversheet acquisitions impact the comparability of the results between the three months ended March 31, 2019 and 2018 depending on the timing of the applicable acquisition. Our historical results are not necessarily indicative of our future results of operations.
 
Three Months Ended March 31,
 
2019
 
2018
Unaudited Condensed Consolidated Statements of Operations:
 
 
 
Revenue
100.0
%
 
100.0
%
Cost of revenue
66.8

 
67.9

Gross profit
33.2

 
32.1

Selling, general and administrative
22.5

 
20.0

Depreciation and amortization
2.2

 
1.5

Income from operations
8.5

 
10.6

Interest expense, net, and other
1.1

 
1.1

Income before income taxes
7.4

 
9.5

Income tax expense
1.0

 
1.3

Net income
6.4
%
 
8.2
%

 
Comparison of Results for the Three Months Ended March 31, 2019 to the Three Months Ended March 31, 2018
 
RevenueRevenue increased 2% to $532.4 million for the three months ended March 31, 2019 from $522.5 million for the same period in 2018, primarily attributable to additional revenue of $34.3 million from our PDA, LFT, MedPartners and Silversheet acquisitions. Excluding the additional revenue from acquisitions, revenue decreased 5%.
Nurse and allied solutions segment revenue decreased less than 1% to $337.0 million for the three months ended March 31, 2019 from $338.2 million for the same period in 2018. The $1.2 million decrease was primarily attributable to a 1% decrease in the average bill rate, partially offset by a slight increase in the average number of healthcare professionals on assignment during the three months ended March 31, 2019.
 Locum tenens solutions segment revenue decreased 22% to $80.5 million for the three months ended March 31, 2019 from $103.1 million for the same period in 2018. The $22.6 million decrease was primarily attributable to a 23% decrease in the number of days filled during the three months ended March 31, 2019, partially offset by a 2% increase in the revenue per day filled.
Other workforce solutions segment revenue increased 42% to $114.9 million for the three months ended March 31, 2019 from $81.2 million for the same period in 2018. Of the $33.7 million increase, $34.3 million was attributable to additional revenue in connection with the PDA, LFT, MedPartners and Silversheet acquisitions, partially offset by a decline in our interim leadership and mid-revenue cycle management businesses during the three months ended March 31, 2019.
 
Gross Profit. Gross profit increased 5% to $176.8 million for the three months ended March 31, 2019 from $167.8 million for the same period in 2018, representing gross margins of 33.2% and 32.1%, respectively. The gross margin for the three months ended March 31, 2019 was positively impacted by higher-than-average gross margins from PDA, LFT, MedPartners and Silversheet and a change in our physician permanent placement business model that prompted a $4.3 million classification of certain recruiter compensation expenses to SG&A (as defined below) that was previously in cost of revenue. Net of these factors, our year-over-year gross margin declined slightly primarily due to a lower margin in our locum tenens solutions segment. Gross margin by reportable segment for the three months ended March 31, 2019 and 2018 was 27.9% and 28.0% for nurse and allied solutions, 27.7% and 28.7% for locum tenens solutions, and 52.6% and 53.6% for other workforce solutions, respectively. The year-over-year gross margin decline in the locum tenens solutions segment was driven by lower perm conversion fees and lower bill-to-pay spreads. The other workforce solutions segment decrease during the three months ended March 31, 2019 was primarily due to the change in sales mix resulting from the additions of PDA, LFT and MedPartners.
 

17


Selling, General and Administrative Expenses. Selling, general and administrative (“SG&A”) expenses were $120.0 million, representing 22.5% of revenue, for the three months ended March 31, 2019, as compared to $104.7 million, representing 20.0% of revenue, for the same period in 2018. The increase in SG&A expenses was primarily due to $8.7 million of additional SG&A expenses from the PDA, LFT, MedPartners and Silversheet acquisitions, the above-mentioned $4.3 million classification of certain recruiter compensation expenses to SG&A that was previously in cost of revenue, a $3.5 million increase in acquisition, integration and extraordinary legal expenses, and other expenses associated with our revenue growth. SG&A expenses broken down among the reportable segments, unallocated corporate overhead, and share-based compensation are as follows:      
 
(In Thousands)
Three Months Ended March 31,
 
2019
 
2018
Nurse and allied solutions
$
46,181

 
$
42,985

Locum tenens solutions
16,562

 
19,591

Other workforce solutions
34,205

 
23,634

Unallocated corporate overhead
17,863

 
15,663

Share-based compensation
5,186

 
2,864

 
$
119,997

 
$
104,737

Depreciation and Amortization Expenses. Amortization expense increased 52% to $6.7 million for the three months ended March 31, 2019 from $4.4 million for the same period in 2018, with the increase attributable to additional amortization expenses related to the intangible assets acquired in the PDA, LFT, MedPartners and Silversheet acquisitions. Depreciation expense increased 46% to $5.1 million for the three months ended March 31, 2019 from $3.5 million for the same period in 2018, primarily attributable to an increase in purchased and developed hardware and software placed in service for our ongoing front and back office information technology initiatives.
Interest Expense, Net, and OtherInterest expense, net, and other, was $5.7 million during the three months ended March 31, 2019 as compared to $5.3 million for the same period in 2018. The increase is primarily due to higher average debt outstanding balance for the three months ended March 31, 2019, which resulted from borrowings used to finance the MedPartners and Silversheet acquisitions.

Income Tax Expense. Income tax expense was $5.3 million for the three months ended March 31, 2019 as compared to $7.2 million for the same period in 2018, reflecting effective income tax rates of 13% and 14% for the three months ended March 31, 2019 and 2018, respectively. The decrease in the effective income tax rate was primarily attributable to the Company’s discrete tax benefits of $6.4 million and $7.1 million in relation to income before income taxes of $39.4 million and $49.9 million for the three months ended March 31, 2019 and 2018, respectively. We currently estimate our annual effective tax rate to be approximately 26% for 2019. The 13% effective tax rate for the three months ended March 31, 2019 differs from our estimated annual effective tax rate of 26% primarily due to a discrete tax benefit of $4.6 million during the three months ended March 31, 2019 relating to equity awards vested and exercised and a tax benefit of $1.5 million recorded by the Company during the three months ended March 31, 2019 relating to fair value changes in the cash surrender value of its Company Owned Life Insurance.


18


Liquidity and Capital Resources
 
In summary, our cash flows were:

 
(In Thousands)
Three Months Ended March 31,
 
2019
 
2018
 
 
Net cash provided by operating activities
$
36,214

 
$
59,735

Net cash used in investing activities
(36,248
)
 
(9,613
)
Net cash provided by (used in) financing activities
1,790

 
(14,970
)
Historically, our primary liquidity requirements have been for acquisitions, working capital requirements, and debt service under our credit facilities and the Notes. We have funded these requirements through internally generated cash flow and funds borrowed under our credit facilities. On February 9, 2018, we replaced our then-existing credit agreement with our New Credit Agreement (as defined below). As of March 31, 2019, $150 million was drawn with $234.7 million of available credit under the Senior Credit Facility (as defined below) and the aggregate principal amount of our 5.125% Senior Notes due 2024 (the “Notes”) outstanding equaled $325.0 million. We describe in further detail our New Credit Agreement, under which our Senior Credit Facility is governed, and the Notes in “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (7), Notes Payable and Credit Agreement” of our 2018 Annual Report on Form 10-K.
We believe that cash generated from operations and available borrowings under our Senior Credit Facility will be sufficient to fund our operations, including expected capital expenditures, for the next 12 months and beyond. We intend to finance potential future acquisitions with cash provided from operations, borrowings under our Senior Credit Facility or other borrowings under our New Credit Agreement, bank loans, debt or equity offerings, or some combination of the foregoing. The following discussion provides further details of our liquidity and capital resources.
 
Operating Activities
 
Net cash provided by operating activities for the three months ended March 31, 2019 was $36.2 million, compared to $59.7 million for the same period in 2018. The decrease in net cash provided by operating activities was primarily attributable to (1) declined operating results, (2) increases in accounts receivable and subcontractor receivables, and (3) increases in income tax receivable, prepaid expenses and other current assets. The overall decrease was partially offset by increases in accounts payable and accrued expenses, accrued compensation and benefits and other liabilities between periods due to timing of payments. Our Days Sales Outstanding (“DSO”) was 62 days at March 31, 2019, 64 days at December 31, 2018, and 58 days at March 31, 2018.
 
Investing Activities
 
Net cash used in investing activities for the three months ended March 31, 2019 was $36.2 million, compared to $9.6 million for the same period in 2018. The increase was primarily due to $29.5 million used for acquisitions during the three months ended March 31, 2019, as compared to no cash paid for acquisitions during the three months ended March 31, 2018. The increase was partially offset by net proceeds of restricted investments related to our captive insurance company of $4.3 million during the three months ended March 31, 2019, as compared to $0.8 million during the three months ended March 31, 2018. See additional information in the accompanying Note (2), “Acquisitions.” Capital expenditures were $7.4 million and $5.7 million for the three months ended March 31, 2019 and 2018, respectively.

Financing Activities

Net cash provided by financing activities during the three months ended March 31, 2019 was $1.8 million, primarily due to borrowings of $30.0 million under the Senior Credit Facility (as defined below), partially offset by (1) $17.9 million paid in connection with the repurchase of our common stock and (2) $10.3 million in cash paid for shares withheld for payroll taxes resulting from the vesting of employee equity awards. Net cash used in financing activities during the three months ended March 31, 2018 was $15.0 million, due to (1) $2.3 million payment of financing costs in connection with the new credit agreement, (2) $1.7 million for acquisition contingent consideration earn-out payments, and (3) $10.9 million in cash paid for shares withheld for payroll taxes resulting from the vesting of employee equity awards.

New Credit Agreement


19


On February 9, 2018, we entered into a credit agreement (the “New Credit Agreement”) with several lenders to provide for a $400 million secured revolving credit facility (the “Senior Credit Facility”) to replace our then-existing Credit Agreement. The Senior Credit Facility includes a $50 million sublimit for the issuance of letters of credit and a $50 million sublimit for swingline loans. Our obligations under the New Credit Agreement and the Senior Credit Facility are secured by substantially all of our assets. Borrowings under the Senior Credit Facility bear interest at floating rates, at our option, based upon either LIBOR plus a spread of 1.00% to 2.00% or a base rate plus a spread of 0.00% to 1.00%. The applicable spread is determined quarterly based upon our consolidated net leverage ratio. The Senior Credit Facility is available for working capital, capital expenditures, permitted acquisitions and general corporate purposes. The maturity date of the Senior Credit Facility is February 9, 2023.

In connection with obtaining the New Credit Agreement, we incurred $2.3 million in fees paid to lenders and other third parties, which were capitalized and are amortized to interest expense over the term of the Senior Credit Facility. In addition, we wrote off $0.6 million of unamortized financing fees during the three months ended March 31, 2019 related to our prior credit facilities. To help finance the MedPartners acquisition, we borrowed $195.0 million from the Senior Credit Facility in April 2018. We paid down $45 million during 2018. The acquisition is more fully described in Note (2) to the accompanying Condensed Consolidated Financial Statements, “Acquisitions.”
 Letters of Credit
 At March 31, 2019, we maintained outstanding standby letters of credit totaling $17.6 million as collateral in relation to our workers’ compensation insurance agreements and a corporate office lease agreement. Of the $17.6 million of outstanding letters of credit, we have collateralized $2.4 million in cash and cash equivalents and the remaining amounts are collateralized by the Senior Credit Facility. Outstanding standby letters of credit at December 31, 2018 totaled $17.6 million.
 
Off-Balance Sheet Arrangements
 At March 31, 2019, we did not have any off-balance sheet arrangement that has or is reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.
Contractual Obligations
There have been no material changes during the three months ended March 31, 2019, other than the borrowings under the New Credit Agreement described in the accompanying Note (2), “Acquisitions,” to the table entitled “Contractual Obligations” in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” set forth in our 2018 Annual Report.

Recent Accounting Pronouncements
In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments.” The standard introduces new accounting models for determining and recognizing credit losses on certain financial instruments based on an estimate of current expected credit losses and is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. We will adopt this standard in the first quarter of 2020 and are currently evaluating the impact on our consolidated financial statements.
In January 2017, the FASB issued ASU 2017-04, “Simplifying the Test for Goodwill Impairment.” The standard simplifies the subsequent measurement of goodwill by removing the requirement to perform a hypothetical purchase price allocation to compute the implied fair value of goodwill to measure impairment. Instead, any goodwill impairment will equal the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. Further, the guidance eliminates the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. This standard is effective for annual or any interim goodwill impairment test in fiscal years beginning after December 15, 2019, with early adoption permitted for impairment tests performed after January 1, 2017. While we continue to assess the timing of adopting this standard, we do not expect the adoption to have a material impact on our consolidated financial statements.
In August 2018, the FASB issued ASU 2018-13, “Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement.” The standard modifies the current disclosure requirements on fair value measurements and is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. We will adopt this standard in the first quarter of 2020 and are currently evaluating the effect that adopting it will have on our disclosures.
In August 2018, the FASB issued ASU 2018-15, “Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.” The standard aligns the requirements for capitalizing implementation

20


costs incurred in a cloud computing arrangement service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This standard is effective on a prospective or retrospective basis for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019, with early adoption permitted. We will adopt this standard in the first quarter of 2020 and are currently evaluating the effect that adopting it will have on our consolidated financial statements.
There have been no other new accounting pronouncements issued but not yet adopted that are expected to materially affect our consolidated financial condition or results of operations.

21


Special Note Regarding Forward-Looking Statements
This Quarterly Report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We base these forward-looking statements on our expectations, estimates, forecasts, and projections about future events and about the industry in which we operate. Forward-looking statements are identified by words such as “believe,” “anticipate,” “expect,” “intend,” “plan,” “will,” “should,” “would,” “project,” “may,” variations of such words, and other similar expressions. In addition, any statements that refer to projections of financial items, anticipated growth, future growth and revenues, future economic conditions and performance, plans, objectives and strategies for future operations, expectations, or other characterizations of future events or circumstances are forward-looking statements. All forward-looking statements involve risks and uncertainties. Our actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Factors that could cause actual results to differ materially from those implied by the forward-looking statements in this Quarterly Report are set forth in our 2018 Annual Report and include but are not limited to:
the effects of economic downturns or slow recoveries, which could result in less demand for our services and pricing pressures;
any inability on our part to anticipate and quickly respond to changing marketplace conditions, such as alternative modes of healthcare delivery, reimbursement, or client needs;
the negative effects that intermediary organizations may have on our ability to secure new and profitable contracts with our clients;
the level of consolidation and concentration of buyers of healthcare workforce solutions and staffing services, which could affect the pricing of our services and our ability to mitigate concentration risk;
the ability of our clients to increase the efficiency and effectiveness of their staffing management and recruiting efforts, through predictive analytics, online recruiting or otherwise, which may negatively affect our revenue, results of operations, and cash flows;
the repeal or significant erosion of the Patient Protection and Affordable Care Act without a corresponding replacement may negatively affect the demand for our services;
any inability on our part to grow and operate our business profitably in compliance with federal and state healthcare industry regulation, including conduct of operations, costs and payment for services and payment for referrals as well as laws regarding employment and compensation practices and government contracting; 
any challenge to the classification of certain of our healthcare professionals as independent contractors, which could adversely affect our profitability;
the effect of investigations, claims, and legal proceedings alleging medical malpractice, violations of employment, privacy and wage regulations and other legal theories of liability asserted against us, which could subject us to substantial liabilities;
any technology disruptions or our inability to implement new infrastructure and technology systems effectively may adversely affect our operating results and ability to manage our business effectively;
any failure to further develop and evolve our current workforce solutions technology offerings and capabilities, which may harm our business;
disruption to or failures of our SaaS-based technology or our inability to adequately protect our intellectual property rights with respect to such technology, which could reduce client satisfaction, harm our reputation and negatively affect our business;
security breaches and cybersecurity incidents that could compromise our information and systems, which could adversely affect our business operations and reputation and could subject us to substantial liabilities;
any inability on our part to recruit and retain sufficient quality healthcare professionals at reasonable costs, which could increase our operating costs and negatively affect our business and profitability;
any inability on our part to quickly and properly credential and match quality healthcare professionals with suitable placements, which may adversely affect demand for our services;

22


any inability on our part to continue to attract, develop and retain our sales and operations team members, which may deteriorate our operations;
our increasing dependence on third parties for the execution of certain critical functions;
the loss of our key officers and management personnel, which could adversely affect our business and operating results;
any inability to consummate and effectively incorporate acquisitions into our business operations, which may adversely affect our long-term growth and our results of operations;
businesses we acquire may have liabilities or adverse operating issues, which could harm our operating results;
any increase to our business and operating risks as we develop new services and clients, enter new lines of business, and focus more of our business on providing a full range of client solutions;
any inability on our part to maintain our positive brand awareness and identity, which may adversely affect our results of operation;
the expansion of social media platforms presents new risks and challenges, which could cause damage to our brand reputation;
any recognition of an impairment to the substantial amount of goodwill or indefinite-lived intangibles on our balance sheet;
our indebtedness, which could adversely affect our ability to raise additional capital to fund operations, limit our ability to react to changes in the economy or our industry, and expose us to interest rate risk to the extent of any variable rate debt;
the terms of our debt instruments that impose restrictions on us that may affect our ability to successfully operate our business; and
the effect of significant adverse adjustments to our insurance-related accruals on our balance sheet, which could decrease our earnings or increase our losses and negatively impact our cash flows.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Market risk is the risk of loss arising from adverse changes in market rates and prices, such as interest rates, foreign currency exchange rates, and commodity prices. During the three months ended March 31, 2019, our primary exposure to market risk was interest rate risk associated with our variable interest debt instruments. A 100 basis point increase in interest rates on our variable rate debt would not have resulted in a material effect on our unaudited condensed consolidated financial statements for the three months ended March 31, 2019. During the three months ended March 31, 2019, we generated substantially all of our revenue in the United States. Accordingly, we believe that our foreign currency risk is immaterial.
Item 4. Controls and Procedures
We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of March 31, 2019 were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
 
There were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

23



PART II - OTHER INFORMATION
 
Item 1. Legal Proceedings
None.

Item 1A. Risk Factors
We do not believe that there have been any material changes to the risk factors disclosed in Part I, Item 1A of our 2018 Annual Report.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

From time to time, we may repurchase our common stock in the open market pursuant to programs approved by our Board. We may repurchase our common stock for a variety of reasons, such as acquiring shares to offset dilution related to equity-based incentives and optimizing our capital structure. On November 1, 2016, our Board authorized us to repurchase up to $150.0 million of our outstanding common stock in the open market. Under the repurchase program announced on November 1, 2016 (the “Company Repurchase Program”), share purchases may be made from time to time beginning in the fourth quarter of 2016, depending on prevailing market conditions and other considerations. The Company Repurchase Program has no expiration date and may be discontinued or suspended at any time.

During the first quarter of 2019, we purchased 378,317 shares of common stock at an average price of $47.37 per share, resulting in an aggregate purchase price of $17.9 million. The following table presents the detail of shares repurchased for the first quarter of 2019. All share repurchases reflected in the table below were made under the Company Repurchase Program, which is the sole repurchase program of the Company currently in effect.
 
 
 
 
 
Period
 
Total
Number of
Shares (or
Units)
Purchased 
 
Average
Price Paid
per Share
(or Unit) 
 
Total Number of
Shares (or Units)
Purchased as Part of
Publicly Announced
Program 
 
Maximum Dollar
Value of Shares (or Units)
that May Yet Be
Purchased Under the Program 
 
February 1 - 28, 2019
22,900

$50.50
22,900

$48,405,129
March 1 - 31, 2019
355,417

$47.16
355,417

$31,631,647
 
 

 
 

 
Total
378,317

$47.37
378,317

$31,631,647

Item 3. Defaults Upon Senior Securities
None.

Item 4. Mine Safety Disclosures
Not applicable.

Item 5. Other Information
None.

24



Item 6. Exhibits
 
Exhibit
Number
 
Description
 
 
 
31.1
 
 
 
 
31.2
 
 
 
 
32.1
 
 
 
 
32.2
 
 
 
 
10.1
 
10.2
 
10.3
 
10.4
 
10.5
 
101.INS
 
XBRL Instance Document.*
 
 
 
101.SCH
 
XBRL Taxonomy Extension Schema Document.*
 
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document.*
 
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document.*
 
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document.*
 
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document.*
 
*
 
Filed herewith.
 
 
 
 
 
 
 
 
 

25


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 3, 2019
 
AMN HEALTHCARE SERVICES, INC.
 
/S/    SUSAN R. SALKA
Susan R. Salka
President and Chief Executive Officer
(Principal Executive Officer)

 
Date: May 3, 2019
 

 
/S/    BRIAN M. SCOTT
Brian M. Scott
Chief Accounting Officer,
Chief Financial Officer and Treasurer
(Principal Accounting and Financial Officer)

26
EX-10.1 2 amn-ex101x20190331x10q.htm EXHIBIT 10.1 Exhibit
Exhibit 10.1
Executive Form

AMN HEALTHCARE
EQUITY PLAN
PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT
(ADJUSTED EBITDA MARGIN)
THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this ___________ ___, 2019, by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and ___________________ (the “Grantee”).
W I T N E S S E T H:
WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, the “Plan”), and desires to afford the Grantee the opportunity to share in the appreciation of the Company’s common stock, par value $.01 per share (“Stock”), thereunder, thereby strengthening the Grantee’s commitment to the welfare of the Company and Affiliates and promoting an identity of interest between stockholders and the Grantee.
NOW THEREFORE, in consideration of the covenants and agreements herein contained, the parties hereto hereby agree as follows:
1.    Definitions.
The following definitions shall be applicable throughout the Agreement. Where capitalized terms are used but not defined herein, their meaning shall be that set forth in the Plan (unless the context indicates otherwise).
(a)    Adjusted EBITDA” means for the Company and its wholly owned Subsidiaries on a consolidated basis, net income (loss) plus interest expense (net of interest income), income taxes, depreciation and amortization, acquisition related costs, stock-based compensation expense, integration expenses, debt refinancing and other corporate reorganizational costs, incentive awards recorded in its financial books and records, including long-term incentive awards and annual incentive awards, extraordinary legal costs (including damages, settlements and attorney’s fees), changes in GAAP treatment of revenue/expenses, discontinued operations, goodwill and other identified intangible asset impairments and expenses resulting from severance arrangements with terminated employees, and net income (loss) from discontinued operations, net of tax, and the impact of any additional extraordinary items that may be identified by the Committee in its sole discretion.
(b)    Adjusted EBITDA Margin” means for the Company and its wholly owned Subsidiaries on a consolidated basis, Adjusted EBITDA divided by gross revenue, expressed as a percentage.
(c)    Affiliate” means (i) any entity that directly or indirectly is controlled by, or is under common control with, the Company and (ii) any entity in which the Company has a significant equity interest, in either case, as determined by the Committee.

Page 1 of 10


Exhibit 10.1
Executive Form

(d)    Cause” means (i) the definition of “cause” provided in the employment or severance agreement in effect between the Grantee and the Company or any Affiliate or (ii) if no such agreement exists, then the occurrence of any of the following, as determined by the Company in its reasonable discretion: (A) Grantee’s failure to perform in any material respect his or her duties as an employee of the Company, (B) violation of the Company’s Code of Business Conduct, Code of Ethics for Senior Financial Officers and Principal Executive Officer (if applicable), and/or Securities Trading Policy, (C) the engaging by the Grantee in willful misconduct or gross negligence which is injurious to the Company or any of its Affiliates, monetarily or otherwise, (D) the commission by Grantee of an act of fraud or embezzlement against the Company or any of its Affiliates, (E) the conviction of the Grantee of a crime which constitutes a felony or any lesser crime that involves Company property or a pleading of guilty or nolo contendere with respect to a crime which constitutes a felony or any lesser crime that involves Company property, or (F) violation of any of the restrictive covenants in Section 9 hereof.
(e)    Change in Control” means:
(i)    the acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (a “Person”) of beneficial ownership (within the meaning of Rule 13d‑3 promulgated under the Exchange Act) of a majority of the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors;
(ii)    the sale of all or substantially all of the business or assets of the Company; or
(iii)    the consummation of a merger, consolidation or similar form of corporate transaction involving the Company that requires the approval of the Company’s stockholders, whether for such transaction or the issuance of securities in the transaction (a “Business Combination”), if immediately following such Business Combination: (A) a Person is or becomes the beneficial owner, directly or indirectly, of a majority of the combined voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation), or (B) the Company’s stockholders prior to the Business Combination thereafter cease to beneficially own, directly or indirectly, a majority of the combined voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation), counting for this purpose only voting securities of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) received by such stockholders in connection with the Business Combination. “Surviving Corporation” shall mean the corporation resulting from a Business Combination, and “Parent Corporation” shall mean the ultimate parent corporation that directly or indirectly has beneficial ownership of a majority of the combined voting power of the then outstanding voting securities of the Surviving Corporation entitled to vote generally in the election of directors.
(f)    Change in Control Termination” means the occurrence of either of the following events during the Protection Period: (i) the Company’s termination of the Grantee’s Service without Cause (other than due to death or Disability) or (ii) the Grantee’s termination of his or her Service with Good Reason at a time when the Grantee could not have been terminated for Cause.

Page 2 of 10


Exhibit 10.1
Executive Form

(g)    Credited Service” means the performance of Service on a substantially full time basis for a continuous twelve-month period. For this purpose, substantially full time basis shall mean that the employee or consultant provides regular and recurring services to the Company of at least 32 hours each week. The taking of approved paid time off or legally mandated leave, such as FMLA, does not interrupt this period of Credited Service. Notwithstanding the foregoing, the Committee may treat periods of less than full time employment, in whole or in part, as Credited Service in its sole discretion.
(h)    Disabled” has the meaning set forth in Section 13(c)(ii) of the Plan.
(i)    Good Reason” means (i) the definition of “good reason” provided in the employment or severance agreement in effect between the Grantee and the Company or any Affiliate or (ii) if no such agreement exists, then the occurrence of either of the following without the Grantee’s express written consent: (A) a material reduction in the Grantee’s base salary compared to the base salary in effect on the date immediately prior to the beginning of the Protection Period or (B) relocation of the Grantee’s principal place of employment to a place more than 50 miles from its location as of the date immediately prior to the beginning of the Protection Period.
(j)    Grant Date” means ___________ ___, 2019, which is the date the Committee authorized this PRSU grant.
(k)    NQDC Plan” means the Company’s 2005 Amended and Restated Executive Nonqualified Excess Plan, as may be amended from time to time.
(l)    Performance Period” means January 1, 2021 through December 31, 2021.
(m)    Performance Restricted Stock Unit(s)” or “PRSU(s)” means the performance restricted stock units granted under Section 2.
(n)    Protection Period” means the period beginning on the date that is six (6) months before the effective date of a Change in Control and ending on the second anniversary of the effective date of the Change in Control.
(o)    Retirement” means termination of an employee’s Service (other than for Cause or due to a Change in Control Termination) on or after attainment of age 55 with at least 15 full years of aggregate Service. For clarity, only twelve (12) months of continuous Service shall count as a full year of Service for purposes of determining if an employee is eligible for Retirement.
(p)    Service” means the performance of services for the Company (or any Affiliate) by a person in the capacity of an officer or other employee or key person (including consultants).
(q)    Vesting Date” means the date on which the Grantee has performed three full periods of Credited Service the first period of which shall commence on the Grant Date.
2.    Grant of Performance Restricted Stock Units. Subject to the terms and conditions set forth herein, the Company hereby grants to the Grantee ______ (the “Target Number”) PRSUs. The Committee will determine the number of PRSUs at the end of the Performance Period (“Actual PRSUs”) in accordance with the Adjusted EBITDA Margin Table attached hereto as Schedule

Page 3 of 10


Exhibit 10.1
Executive Form

I (the “Adjusted EBITDA Margin Table”), which Actual PRSUs will be subject to additional time-based vesting. The number of Actual PRSUs may be greater or fewer than the Target Number.
3.    Vesting Schedule. Except as otherwise set forth in this Agreement or in the Plan, the Actual PRSUs (as determined in accordance with the Adjusted EBITDA Margin Table) shall vest on the Vesting Date. All PRSUs that do not become Actual PRSUs shall be cancelled and be null and void on the date the Committee calculates the Adjusted EBITDA Margin for the Performance Period, which shall occur within sixty (60) days of the end of the Performance Period (the “Calculation Date”).
4.    Settlement and Deferral of PRSUs.
(a)    Each vested Actual PRSU entitles the Grantee to receive one share of Stock on the “Settlement Date,” which shall be the later of (i) the Vesting Date (or the Calculation Date, if later than the Vesting Date), and (ii) the end of the deferral period specified by the Grantee. The deferral period shall be no less than four (4) years and five (5) days from the Grant Date. Such deferral election shall be made within 30 days of the Grant Date. Any deferral of the PRSUs shall be subject to the NQDC Plan and the applicable deferral election form.
(b)    Shares of Stock underlying the vested Actual PRSUs shall be issued and delivered to the Grantee in accordance with paragraph (a) and upon compliance to the satisfaction of the Committee with all requirements under applicable laws or regulations in connection with such issuance and with the requirements hereof and of the Plan. The determination of the Committee as to such compliance shall be final and binding on the Grantee. The shares of Stock delivered to the Grantee pursuant to this Section 4 shall be free and clear of all liens, fully paid and non-assessable. In no event shall fractional shares of Stock be issued.
(c)    Until such time as shares of Stock have been issued to the Grantee pursuant to paragraph (b) above, and except as set forth in Section 5 below regarding dividend equivalents, the Grantee shall not have any rights as a holder of the shares of Stock underlying this Grant including but not limited to voting rights.
(d)    The Grantee may be required to pay to the Company or any Affiliate, and the Company or any Affiliate shall have the right and is hereby authorized to withhold from any shares of Stock or other property deliverable in respect of a vested Actual PRSU or from any compensation or other amounts owing to the Grantee the amount (in cash, Stock or other property) of any required tax withholding and payroll taxes in respect of such Actual PRSUs vesting or settlement and to take such other action as may be necessary in the opinion of the Company to satisfy all obligations for the payment of such taxes.
(e)    Without limiting the generality of clause (d) above, in the Committee’s sole discretion the Grantee may satisfy, in whole or in part, the foregoing withholding liability by having the Company withhold from the number of shares of Stock otherwise issuable pursuant to the settlement of vested Actual PRSUs a number of shares with a Fair Market Value equal to such withholding liability.
5.    Dividend Equivalents. If on any date the Company shall pay any cash dividend on shares of Stock of the Company, the number of Actual PRSUs credited to the Grantee

Page 4 of 10


Exhibit 10.1
Executive Form

pursuant to the Adjusted EBITDA Margin Table shall, as of such date (or as of the Calculation Date if such dividend occurs before the Calculation Date), be increased by an amount determined by the following formula:
W = (X multiplied by Y) divided by Z, where:
W = the number of additional PRSUs to be credited to the Grantee on such dividend payment date;
X = the aggregate number of PRSUs (whether vested or unvested) credited to the Grantee as of the record date of the dividend (or the Calculation Date, as applicable);
Y = the cash dividend per share amount; and
Z = the Fair Market Value per share of Stock (as determined under the Plan) on the dividend payment date.
For the avoidance of doubt, no dividend equivalents shall be credited to PRSUs prior to the determination of the number of Actual PRSUs.
6.    Termination of Service.
(a)    Except as provided below, if the Grantee’s Service terminates for any reason prior to the Settlement Date, then all unvested PRSUs (or all unvested Actual PRSUs, as applicable) shall be forfeited.
(b)    If the Grantee’s Service terminates due to Retirement at any time after 6 (six) months from the Grant Date but before the Settlement Date, then the Grantee shall continue to vest in all of the Grantee’s unvested PRSUs (or all unvested Actual PRSUs, as applicable) according to the terms of this Agreement as though the Grantee’s Service had not terminated. For clarity, the Grantee’s Actual PRSUs shall be determined at the end of the Performance Period according to the Adjusted EBITDA Margin Table based on actual performance, and such Actual PRSUs shall be settled at the time specified in Section 4 hereof.
(c)    If the Grantee’s Service terminates due to a Change in Control Termination after the Grant Date but before the end of the Performance Period, then on the date of the Grantee’s termination (or, if later, on the effective date of the Change in Control), 100% of the Target Number of PRSUs shall become immediately vested, be considered Actual PRSUs and settled according to Section 4 hereof. If the Grantee’s Service terminates due to a Change in Control Termination after the end of the Performance Period but before the Settlement Date, then on the date of the Grantee’s termination (or, if later, on the effective date of the Change in Control), all of the Grantee’s Actual PRSUs shall become immediately vested and settled according to Section 4 hereof.
(d)    In the event of the Grantee’s death or if the Committee’s determines, in its sole discretion, that the Grantee has become Disabled, in each case, after the Grant Date and prior to the end of the Performance Period), 100% of the Target Number of PRSUs shall become immediately vested, be considered Actual PRSUs and, regardless of the Grantee’s deferral election, the Company, as soon as reasonably practicable, shall issue shares of Stock to the Grantee (or the Grantee’s

Page 5 of 10


Exhibit 10.1
Executive Form

designated beneficiary or estate executor in the event of the Grantee’s death) with respect to the Target Number of PRSUs. In the event the Grantee dies or becomes Disabled (as determined by the Committee in its sole discretion) on or after the end of the Performance Period and prior to (or on) the Settlement Date, the Grantee shall be entitled to receive shares of Stock underlying all vested Actual PRSUs, and regardless of the Grantee’s deferral election, the Company, as soon as reasonably practicable, shall issue the applicable number of shares of Stock to the Grantee (or the Grantee’s designated beneficiary or estate executor in the event of the Grantee’s death).
(e)    If the Grantee’s employment is terminated due to a reason specified in (b)-(d) above but, after such termination, the Committee determines that it would have had Cause to terminate the Grantee’s Service if all the relevant facts had been known to the Committee as of the date of the Grantee’s termination, then all PRSUs and Actual PRSUs shall immediately be forfeited and cancelled, whether or not vested, as of the date of the Committee’s determination.
7.    Company; Grantee.
(a)    The term “Company” as used in this Agreement with reference to employment shall include the Company, its Subsidiaries and its Affiliates, as appropriate.
(b)    Whenever the word “Grantee” is used in any provision of this Agreement under circumstances where the provision should logically be construed to apply to the beneficiaries, the executors, the administrators, or the person or persons to whom the PRSUs may be transferred by will or by the laws of descent and distribution, the word “Grantee” shall be deemed to include such person or persons.
8.    Non-Transferability.  The PRSUs granted herein are not transferable by the Grantee other than to a designated beneficiary upon death, by will or the laws of descent and distribution, to a trust solely for the benefit of the Grantee or his/her immediate family or, in the case of the PRSUs being held by such a trust, by the trustee.
9.    Forfeiture for Violation of Restrictive Covenants.
(a)    Non-Compete. The Grantee agrees that during the term of the Grantee’s employment and for a period of two years thereafter (the “Coverage Period”) the Grantee will not engage in, consult with, participate in, hold a position as shareholder, director, officer, consultant, employee, partner or investor, or otherwise assist any business entity (i) in any State of the United States of America or (ii) in any other country in which the Company (which, for the avoidance of doubt, includes for all purposes of this Section 9 any and all of its divisions, Affiliates or Subsidiaries) has business activities, in either case, that is engaged in (A) any activities that are competitive with the business of providing (I) healthcare or other personnel on a temporary or permanent placement basis to hospitals, healthcare facilities, healthcare provider practice groups or other entities, (II) clinical workforce management services, or (III) healthcare workforce technology platforms, or (B) any other business in which the Company is then engaged, in each case, including any and all business activities reasonably related thereto.

Page 6 of 10


Exhibit 10.1
Executive Form

(b)    Non-Solicit. The Grantee agrees that during the Coverage Period, the Grantee shall not solicit, attempt to solicit or endeavor to entice away from the Company any person who, at any time during the term of the Grantee’s employment was a healthcare professional (including a healthcare executive) of the Company, or an employee, customer, permanent placement candidate, client or supplier of the Company.
(c)    Confidential and Proprietary Information. The Grantee agrees that the Grantee will not, at any time make use of or divulge to any other person, firm or corporation any confidential or proprietary information concerning the business or policies of the Company (which includes, for the avoidance of doubt, any and all of its divisions, Affiliates or Subsidiaries). For purposes of this Agreement, any confidential information shall constitute any information designated as confidential or proprietary by the Company or otherwise known by the Grantee to be confidential or proprietary information including, without limitation, customer information. The Grantee acknowledges and agrees that for purposes of this Agreement, “customer information” includes without limitation, customer lists, all lists of professional personnel, names, addresses, phone numbers, contact persons, preferences, pricing arrangements, requirements and practices. The Grantee’s obligation under this Section 9(c) shall not apply to any information that (i) is known publicly; (ii) is in the public domain or hereafter enters the public domain without the fault of the Grantee; or (iii) is hereafter disclosed to the Grantee by a third party not under an obligation of confidence to the Company. The Grantee agrees not to remove from the premises of the Company, except as an employee of the Company in pursuit of the business of the Company or except as specifically permitted in writing by the Company, any document or other object containing or reflecting any such confidential or proprietary information. The Grantee recognizes that all such information, whether developed by the Grantee or by someone else, will be the sole exclusive property of the Company. Upon termination of employment, the Grantee shall forthwith deliver to the Company all such confidential or proprietary information, including without limitation all lists of customers, pricing methods, financial structures, correspondence, accounts, records and any other documents, computer disks, computer programs, software, laptops, modems or property made or held by the Grantee or under the Grantee’s control in relation to the business or affairs of the Company, and no copy of any such confidential or proprietary information shall be retained by the Grantee.
(d)    Forfeiture for Violations. If the Grantee shall at any time violate the provisions of Section 9(a), (b), or (c), the Grantee shall immediately forfeit his/her Actual PRSUs (whether vested or unvested) and any issuance of shares of Stock that occurs after (or within six (6) months before) any such violation shall be void ab initio.
(e)    Additional Agreement. For the avoidance of doubt, this Section 9 shall be in addition to and shall not supersede (or be superseded by) any other agreements related to the subject matter of this Section 9 contained in any confidentiality agreement, noncompetition agreement or any other agreement between the Grantee and the Company.

Page 7 of 10


Exhibit 10.1
Executive Form

10.    Rights as Stockholder.  The Grantee or a transferee of the Actual PRSUs shall have no rights as a stockholder with respect to any share of Stock covered by the Actual PRSUs until the Grantee shall have become the holder of record of such share of Stock and no adjustment shall be made for dividends or distributions or other rights in respect of such share of Stock for which the record date is prior to the date upon which Grantee shall become the holder of record thereof.
11.    Successor. The obligations of the Company under this Agreement shall be binding upon any successor corporation or organization resulting from the merger, consolidation or other reorganization of the Company, or upon any successor corporation or organization succeeding to substantially all of the assets and business of the Company. The Company agrees that it will make appropriate provisions for the preservation of the Grantee’s rights under this Agreement in any agreement or plan that it may enter into or adopt to effect any such merger, consolidation, reorganization or transfer of assets.
12.    Notice. Every notice or other communication relating to this Agreement shall be in writing, and shall be mailed to or delivered to the party for whom it is intended at such address as may from time to time be designated by it in a notice mailed or delivered to the other party as herein provided, provided that, unless and until some other address be so designated, all notices or communications by the Grantee to the Company shall be mailed or delivered to the Company at its principal executive office, and all notices or communications by the Company to the Grantee may be given to the Grantee personally or may be mailed to the Grantee at the Grantee’s address as recorded in the records of the Company.
13.    No Right to Continued Employment.  This Agreement shall not be construed as giving the Grantee the right to be retained in the employ or service of the Company, a Subsidiary or an Affiliate. Further, the Company or an Affiliate may at any time dismiss the Grantee or discontinue any consulting relationship, free from any liability or any claim under this Agreement, except as otherwise expressly provided herein.
14.    Binding Effect. Subject to Section 8 hereof, this Agreement shall be binding upon the heirs, executors, administrators and successors of the parties hereto.
15.    Amendment of Agreement. The Committee may, to the extent consistent with the terms of this Agreement, waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate, any portion of the PRSUs heretofore granted, prospectively or retroactively; provided that any such waiver, amendment, alteration, suspension, discontinuance, cancellation or termination that would adversely impair the rights of the Grantee in respect of any PRSUs already granted shall not to that extent be effective without the consent of the Grantee.
16.    PRSUs Subject to Plan and NQDC Plan. By entering into this Agreement, the Grantee agrees and acknowledges that the Grantee has received and read a copy of the Plan and a copy of the NQDC Plan. The PRSUs are subject to the terms of Plan, and the NQDC Plan if the PRSUs are deferred under the NQDC Plan. The terms and provisions of the plans as they may be amended from time to time are hereby incorporated herein by reference. In the event of a conflict between any term or provision contained herein and a term or provision of either the Plan or the NQDC Plan, the applicable terms and provisions of the applicable plan will govern and prevail.

Page 8 of 10


Exhibit 10.1
Executive Form

17.    Governing Law.  This Agreement shall be construed and interpreted in accordance with the internal laws of the State of Delaware without regard to the principles of conflicts of law thereof, or principles of conflicts of laws of any other jurisdiction that could cause the application of the laws of any jurisdiction other than the State of Delaware.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.
AMN HEALTHCARE SERVICES, INC.
By:
        
Name:    Susan R. Salka
Title:    President and CEO
GRANTEE
By:

Name:    










Page 9 of 10


Exhibit 10.1
Executive Form

SCHEDULE I
Adjusted EBITDA Margin Table
Actual PRSUs as defined in this Agreement shall be determined by the Committee in accordance with the table below based on the Adjusted EBITDA Margin generated during the Performance Period:

Page 10 of 10

EX-10.2 3 amn-ex102x20190331x10q.htm EXHIBIT 10.2 Exhibit
Exhibit 10.2
Executive Form

AMN HEALTHCARE
EQUITY PLAN
PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT
(TOTAL SHAREHOLDER RETURN)
THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this ____________ ___, 2019 by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and _______________ (the “Grantee”).
W I T N E S S E T H:
WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, the “Plan”), and desires to afford the Grantee the opportunity to share in the appreciation of the Company’s common stock, par value $.01 per share (“Stock”), thereunder, thereby strengthening the Grantee’s commitment to the welfare of the Company and Affiliates and promoting an identity of interest between stockholders and the Grantee.
NOW THEREFORE, in consideration of the covenants and agreements herein contained, the parties hereto hereby agree as follows:
1.    Definitions.
The following definitions shall be applicable throughout the Agreement. Where capitalized terms are used but not defined herein, their meaning shall be that set forth in the Plan (unless the context indicates otherwise).
(a)    Accumulated Shares” means, for a given day, and for a given Peer Company or the Company, the sum of (i) one share of common stock of the applicable company (as included on the Russell 2000), plus (ii) a cumulative number of shares of common stock purchased with dividends declared on the common stock, assuming same day reinvestment of the dividends into shares of common stock at the closing price on the ex-dividend date, for ex-dividend dates during the Opening Average Period or for the period between January 1, 2019 and the last day of the Closing Average Period, as the case may be.
(b)    Affiliate” means (i) any entity that directly or indirectly is controlled by, or is under common control with, the Company and (ii) any entity in which the Company has a significant equity interest, in either case, as determined by the Committee.
(c)    Cause” means (i) the definition of “cause” provided in the employment or severance agreement in effect between the Grantee and the Company or any Affiliate or (ii) if no such agreement exists, then the occurrence of any of the following: (A) Grantee’s failure to perform in any material respect his or her duties as an employee of the Company, (B) Grantee’s violation of the Company’s Code of Business Conduct, Code of Ethics for Senior Financial Officers and Principal Executive Officer, and/or Securities Trading Policy, (C) the engaging by Grantee in willful misconduct or gross negligence which is injurious to the Company or any of its affiliates, monetarily or otherwise, (D) the commission by the Grantee of an act of fraud or embezzlement against the Company or any of

Page 1 of 11

Exhibit 10.2
Executive Form

its affiliates, (E) the conviction of the Grantee of a crime which constitutes a felony or any lesser crime that involves Company property or a pleading of guilty or nolo contendere with respect to a crime which constitutes a felony or any lesser crime that involves Company property, or (F) violation of any of the restrictive covenants in Section 9 hereof.
(d)    Change in Control” means:
(i)    the acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (a “Person”) of beneficial ownership (within the meaning of Rule 13d‑3 promulgated under the Exchange Act) of a majority of the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors;
(ii)    the sale of all or substantially all of the business or assets of the Company; or
(iii)    the consummation of a merger, consolidation or similar form of corporate transaction involving the Company that requires the approval of the Company’s stockholders, whether for such transaction or the issuance of securities in the transaction (a “Business Combination”), if immediately following such Business Combination: (A) a Person is or becomes the beneficial owner, directly or indirectly, of a majority of the combined voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation), or (B) the Company’s stockholders prior to the Business Combination thereafter cease to beneficially own, directly or indirectly, a majority of the combined voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation), counting for this purpose only voting securities of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) received by such stockholders in connection with the Business Combination. “Surviving Corporation” shall mean the corporation resulting from a Business Combination, and “Parent Corporation” shall mean the ultimate parent corporation that directly or indirectly has beneficial ownership of a majority of the combined voting power of the then outstanding voting securities of the Surviving Corporation entitled to vote generally in the election of directors.
(e)    Change in Control Termination” means the occurrence of either of the following events during the Protection Period: (i) the Company’s termination of the Grantee’s Service without Cause (other than due to death or Disability) or (ii) the Grantee’s termination of his or her Service with Good Reason at a time when the Grantee could not have been terminated for Cause.
(f)    Closing Average Period” means the ninety (90)-day period ending on the last day of the Performance Period.
(g)    Closing Average Share Value” means, for each of the Peer Companies and the Company, the average, over the days in the Closing Average Period, of the closing price of its common stock multiplied by the Accumulated Shares for each day during the Closing Average Period.
(h)    Disabled” has the meaning set forth in Section 13(c)(ii) of the Plan.

Page 2 of 11

Exhibit 10.2
Executive Form

(i)    Good Reason” means (i) the definition of “good reason” provided in the employment or severance agreement in effect between the Grantee and the Company or any Affiliate or (ii) if no such agreement exists, then the occurrence of any of the following events without the Grantee’s express written consent: (A) a material reduction in the Grantee’s base salary or target annual bonus compensation as in effect on the date immediately prior to a Change in Control, (B) the Company’s assignment to the Grantee without the Grantee’s consent of duties materially and adversely inconsistent with the Grantee’s position, duties or responsibilities as in effect immediately before the Change in Control, including, but not limited to, any material reduction in such position, duties or responsibilities, or a change in the Grantee’s title or office, as then in effect, or any removal of the Grantee from any of such positions, titles or offices, or (C) the Company’s relocation of the Grantee’s principal place of employment to a locale that is more than fifty (50) miles from the Grantee’s principal place of employment immediately prior to the Change in Control.
(j)    Grant Date” means _________ ___, 2019, which is the date the Committee authorized this PRSU grant.
(k)    NQDC Plan” means the Company’s 2005 Amended and Restated Executive Nonqualified Excess Plan, as may be amended from time to time.
(l)    Opening Average Period” means the ninety (90)-day period ended on December 31, 2018.
(m)    Opening Average Share Value” means, for each of the Peer Companies and the Company, the average during the Opening Average Period of the closing price of its common stock multiplied by the Accumulated Shares for each trading day during the Opening Average Period.
(n)    Peer Companies” means the companies included in the Russell 2000 on December 31, 2017. In the event of a merger, acquisition or business combination transaction of a Peer Company with or by another Peer Company, the surviving entity shall remain a Peer Company. In the event of a merger of a Peer Company with an entity that is not a Peer Company, or the acquisition or business combination transaction by or with a Peer Company, or with an entity that is not a Peer Company, in each case, where the Peer Company is the surviving entity and remains publicly traded, the surviving entity shall remain a Peer Company. In the event of a merger or acquisition or business combination transaction of a Peer Company by or with an entity that is not a Peer Company, a “going private” transaction involving a Peer Company or the liquidation of a Peer Company, where the Peer Company is not the surviving entity or is otherwise no longer publicly traded, the company shall no longer be a Peer Company. In the event of a bankruptcy of a Peer Company, such company shall remain a Peer Company.
(o)    Performance Period” means January 1, 2019 through December 31, 2021.
(p)    Performance Restricted Stock Unit(s)” or “PRSU(s)” means the performance restricted stock units granted under Section 2.
(q)    Protection Period” means the period beginning on the date that is six (6) months before the effective date of a Change in Control and ending on the second anniversary of the effective date of the Change in Control.

Page 3 of 11

Exhibit 10.2
Executive Form

(r)    Relative Total Shareholder Return” or “Relative TSR” means the Company’s TSR relative to the TSR of the Peer Companies. Following the calculation of the TSR of the Company and each Peer Company for the Performance Period, the Company and each Peer Company will be ranked in order of maximum to minimum according to their respective TSR for the Performance Period. After this ranking, the percentile performance of the Company relative to the Peer Companies will be determined as follows:
amnex1022019033110qimage1.gif
where:    “P” represents the percentile performance, which will be rounded, if necessary, to the nearest whole percentile by application of standard scientific rounding conventions.
“N” represents the number of Peer Companies, plus one (i.e., the Company).
“R” represents the Company’s ranking versus the Peer Companies.
Example: If there are 1000 Peer Companies, and the Company ranked 501st out of 1001 (i.e., 1000 Peer Companies, plus the Company), the performance would be at the 50th percentile: .50 = 1 – ((501-1)/(1001-1)).
(s)    Retirement” means termination of an employee’s Service (other than for Cause or due to a Change in Control Termination) on or after attainment of age 55 with at least 15 full years of aggregate Service. For clarity, only twelve (12) months of continuous Service shall count as a full year of Service for purposes of determining if an employee is eligible for Retirement.
(t)    Service” means the performance of services for the Company (or any Affiliate) by a person in the capacity of an officer or other employee or key person (including consultants).
(u)    Total Shareholder Return” or “TSR” means for each of the Company and the Peer Companies, the company’s total shareholder return, which will be calculated by dividing (i) the Closing Average Share Value by (ii) the Opening Average Share Value, and then subtracting one (1).
(v)    Vesting Date” means the date on which the Committee determines the TSR and Relative TSR.
2.    Grant of Performance Restricted Stock Units. Subject to the terms and conditions set forth herein, the Company hereby grants to the Grantee ______ PRSUs, which shall be the target number. The actual number of PRSUs that can vest may be more or less than the target number, as determined in accordance with the table (the “Vesting Table”) set forth on Schedule I.
3.    Vesting Schedule. No PRSUs may be settled until they have vested, which shall occur, if at all, on the Vesting Date. Except as otherwise set forth in this Agreement or in the Plan, the PRSUs shall only vest on the Vesting Date if the Grantee has provided Service to the Company continuously from the Grant Date through the Vesting Date. Except as otherwise set forth in this Agreement or in the Plan, the number of PRSU’s that shall vest on the Vesting Date will be determined in accordance with the Vesting Table, based on the Company’s achievement of Total

Page 4 of 11

Exhibit 10.2
Executive Form

Shareholder Return and Relative Total Shareholder Return for the Performance Period. Any fractional share resulting from the application of the percentages in the Vesting Table shall be rounded to the nearest whole number of shares. The Committee shall determine the Total Shareholder Return and Relative TSR, if any, within 30 days after the end of the Performance Period. On the Vesting Date, all PRSUs that do not vest shall be automatically cancelled and the right to receive any PRSUs that do not vest hereunder shall automatically expire.
4.    Settlement and Deferral of PRSUs.
(a)    Each vested PRSU entitles the Grantee to receive one share of Stock on the “Settlement Date,” which shall be the later of (i) the Vesting Date, and (ii) the end of the deferral period specified by the Grantee. The deferral period shall be no less than four (4) years and five (5) days from the Grant Date. Such deferral election shall be made within 30 days of the Grant Date. Any deferral of the PRSUs shall be subject to the NQDC Plan and the applicable deferral election form.
(b)    Shares of Stock underlying the PRSUs shall be issued and delivered to the Grantee in accordance with paragraph (a) and upon compliance to the satisfaction of the Committee with all requirements under applicable laws or regulations in connection with such issuance and with the requirements hereof and of the Plan. The determination of the Committee as to such compliance shall be final and binding on the Grantee. The shares of Stock delivered to the Grantee pursuant to this Section 4 shall be free and clear of all liens, fully paid and non-assessable. In no event shall fractional shares of Stock be issued.
(c)    Until such time as shares of Stock have been issued to the Grantee pursuant to paragraph (b) above, and except as set forth in Section 5 below regarding dividend equivalents, the Grantee shall not have any rights as a holder of the shares of Stock underlying this Grant including but not limited to voting rights.
(d)    The Grantee may be required to pay to the Company or any Affiliate, and the Company or any Affiliate shall have the right and is hereby authorized to withhold from any shares of Stock or other property deliverable under the PRSU or from any compensation or other amounts owing to the Grantee the amount (in cash, Stock or other property) of any required tax withholding and payroll taxes in respect of a PRSU vesting or settlement and to take such other action as may be necessary in the opinion of the Company to satisfy all obligations for the payment of such taxes.
(e)    Without limiting the generality of clause (d) above, in the Committee’s sole discretion the Grantee may satisfy, in whole or in part, the foregoing withholding liability by having the Company withhold from the number of shares of Stock otherwise issuable pursuant to the settlement of the PRSU a number of shares with a Fair Market Value equal to such withholding liability.
5.    Dividend Equivalents. If on any date the Company shall pay any cash dividend on shares of Stock of the Company, the number of PRSUs credited to the Grantee pursuant to the Vesting Table shall, as of such date, be increased by an amount determined by the following formula:
W = (X multiplied by Y) divided by Z, where:

Page 5 of 11

Exhibit 10.2
Executive Form

W = the number of additional PRSUs to be credited to the Grantee on such dividend payment date;
X = the aggregate number of PRSUs (whether vested or unvested) credited to the Grantee as of the record date of the dividend;
Y = the cash dividend per share amount; and
Z = the Fair Market Value per share of Stock (as determined under the Plan) on the dividend payment date.
For the avoidance of doubt, no dividend equivalents shall be credited to PRSUs prior to the Committee determining the Total Shareholder Return and Relative TSR (and thus the actual number of PRSUs subject to vesting).
6.    Termination of Service.
(a)    Except as provided below, if the Grantee’s Service terminates for any reason prior to the Settlement Date, then all unvested PRSUs shall be forfeited.
(b)    If the Grantee’s Service terminates due to Retirement at any time after six (6) months from the Grant Date but before the Settlement Date, then the Grantee shall continue to vest in all of the Grantee’s unvested PRSUs according to the terms of this Agreement as though the Grantee’s Service had not terminated. For clarity, the actual number of PRSUs that shall vest shall be determined at the end of the Performance Period according to the Vesting Table based on actual performance, and such vested PRSUs shall be settled at the time specified in Section 4 hereof.
(c)    If the Grantee’s Service terminates due to a Change in Control Termination after the Grant Date but before the end of the Performance Period, then on the date of the Grantee’s termination (or, if later, on the effective date of the Change in Control), 100% of the target number of PRSUs shall become immediately vested and settled according to Section 4 hereof, and any PRSUs in excess of the target number shall be forfeited. If the Grantee’s Service terminates due to a Change in Control Termination after the end of the Performance Period but before the Settlement Date, then on the date of the Grantee’s termination (or, if later, on the effective date of the Change in Control), the number of PRSUs that were earned based on actual performance according to the Vesting Table shall become immediately vested and settled according to Section 4 hereof.
(d)    In the event of the Grantee’s death or if the Committee determines, in its sole discretion, that the Grantee has become Disabled, in each case, after the Grant Date and prior to the end of the Performance Period, (i) 100% of the target number of PRSUs shall become immediately vested and, regardless of the Grantee’s deferral election, the Company, as soon as reasonably practicable, shall issue shares of Stock to the Grantee (or the Grantee’s designated beneficiary or estate executor in the event of the Grantee’s death) with respect to the target number of PRSUs and (ii) any PRSUs in excess of the target number shall be forfeited. In the event the Grantee dies or becomes Disabled (as determined by the Committee in its sole discretion) on or after the end of the Performance Period and prior to (or on) the Settlement Date, the Grantee shall be entitled to receive shares of Stock underlying all vested PRSUs, and regardless of the Grantee’s deferral election, the Company, as soon

Page 6 of 11

Exhibit 10.2
Executive Form

as reasonably practicable, shall issue the applicable number of shares of Stock to the Grantee (or the Grantee’s designated beneficiary or estate executor in the event of the Grantee’s death).
(e)    If the Grantee’s employment is terminated due to a reason specified in (b)-(d) above but, after such termination, the Committee determines that it would have had Cause to terminate the Grantee’s Service if all the relevant facts had been known to the Committee as of the date of the Grantee’s termination, then all PRSUs and Actual PRSUs shall immediately be forfeited and cancelled, whether or not vested, as of the date of the Committee’s determination.
7.    Company; Grantee.
(a)    The term “Company” as used in this Agreement with reference to employment shall include the Company, its Subsidiaries and its Affiliates, as appropriate.
(b)    Whenever the word “Grantee” is used in any provision of this Agreement under circumstances where the provision should logically be construed to apply to the beneficiaries, the executors, the administrators, or the person or persons to whom the PRSUs may be transferred by will or by the laws of descent and distribution, the word “Grantee” shall be deemed to include such person or persons.
8.    Non-Transferability.  The PRSUs granted herein are not transferable by the Grantee other than to a designated beneficiary upon death, by will or the laws of descent and distribution, to a trust solely for the benefit of the Grantee or his/her immediate family or, in the case of the PRSUs being held by such a trust, by the trustee.
9.    Forfeiture for Violation of Restrictive Covenants.
(a)    Non-Compete. The Grantee agrees that during the term of the Grantee’s employment and for a period of two years thereafter (the “Coverage Period”) the Grantee will not engage in, consult with, participate in, hold a position as shareholder, director, officer, consultant, employee, partner or investor, or otherwise assist any business entity (i) in any State of the United States of America or (ii) in any other country in which the Company (which, for the avoidance of doubt, includes for all purposes of this Section 9 any and all of its divisions, Affiliates or Subsidiaries) has business activities, in either case, that is engaged in (A) any activities that are competitive with the business of providing (I) healthcare or other personnel on a temporary or permanent placement basis to hospitals, healthcare facilities, healthcare provider practice groups or other entities, (II) clinical workforce management services, or (III) healthcare workforce technology platforms, or (B) any other business in which the Company is then engaged, in each case, including any and all business activities reasonably related thereto.
(b)    Non-Solicit. The Grantee agrees that during the Coverage Period, the Grantee shall not solicit, attempt to solicit or endeavor to entice away from the Company any person who, at any time during the term of the Grantee’s employment was a healthcare professional (including a healthcare executive) of the Company, or an employee, customer, permanent placement candidate, client or supplier of the Company.

Page 7 of 11

Exhibit 10.2
Executive Form

(c)    Confidential and Proprietary Information. The Grantee agrees that the Grantee will not, at any time make use of or divulge to any other person, firm or corporation any confidential or proprietary information concerning the business or policies of the Company (which includes, for the avoidance of doubt, any and all of its divisions, Affiliates or Subsidiaries). For purposes of this Agreement, any confidential information shall constitute any information designated as confidential or proprietary by the Company or otherwise known by the Grantee to be confidential or proprietary information including, without limitation, customer information. The Grantee acknowledges and agrees that for purposes of this Agreement, “customer information” includes without limitation, customer lists, all lists of professional personnel, names, addresses, phone numbers, contact persons, preferences, pricing arrangements, requirements and practices. The Grantee’s obligation under this Section 9(c) shall not apply to any information that (i) is known publicly; (ii) is in the public domain or hereafter enters the public domain without the fault of the Grantee; or (iii) is hereafter disclosed to the Grantee by a third party not under an obligation of confidence to the Company. The Grantee agrees not to remove from the premises of the Company, except as an employee of the Company in pursuit of the business of the Company or except as specifically permitted in writing by the Company, any document or other object containing or reflecting any such confidential or proprietary information. The Grantee recognizes that all such information, whether developed by the Grantee or by someone else, will be the sole exclusive property of the Company. Upon termination of employment, the Grantee shall forthwith deliver to the Company all such confidential or proprietary information, including without limitation all lists of customers, pricing methods, financial structures, correspondence, accounts, records and any other documents, computer disks, computer programs, software, laptops, modems or property made or held by the Grantee or under the Grantee’s control in relation to the business or affairs of the Company, and no copy of any such confidential or proprietary information shall be retained by the Grantee.
(d)    Forfeiture for Violations. If the Grantee shall at any time violate the provisions of Section 9(a), (b), or (c), the Grantee shall immediately forfeit his/her PRSUs (whether vested or unvested) and any issuance of shares of Stock that occurs after (or within six (6) months before) any such violation shall be void ab initio.
(e)    Additional Agreement. For the avoidance of doubt, this Section 9 shall be in addition to and shall not supersede (or be superseded by) any other agreements related to the subject matter of this Section 9 contained in any confidentiality agreement, noncompetition agreement or any other agreement between the Grantee and the Company.
10.    Rights as Stockholder.  The Grantee or a transferee of the PRSUs shall have no rights as a stockholder with respect to any share of Stock covered by the PRSUs until the Grantee shall have become the holder of record of such share of Stock and no adjustment shall be made for dividends or distributions or other rights in respect of such share of Stock for which the record date is prior to the date upon which Grantee shall become the holder of record thereof.

Page 8 of 11

Exhibit 10.2
Executive Form

11.    Successor. The obligations of the Company under this Agreement shall be binding upon any successor corporation or organization resulting from the merger, consolidation or other reorganization of the Company, or upon any successor corporation or organization succeeding to substantially all of the assets and business of the Company. The Company agrees that it will make appropriate provisions for the preservation of the Grantee’s rights under this Agreement in any agreement or plan that it may enter into or adopt to effect any such merger, consolidation, reorganization or transfer of assets.
12.    Notice. Every notice or other communication relating to this Agreement shall be in writing, and shall be mailed to or delivered to the party for whom it is intended at such address as may from time to time be designated by it in a notice mailed or delivered to the other party as herein provided, provided that, unless and until some other address be so designated, all notices or communications by the Grantee to the Company shall be mailed or delivered to the Company at its principal executive office, and all notices or communications by the Company to the Grantee may be given to the Grantee personally or may be mailed to the Grantee at the Grantee’s address as recorded in the records of the Company.
13.    No Right to Continued Employment.  This Agreement shall not be construed as giving the Grantee the right to be retained in the employ or service of the Company, a Subsidiary or an Affiliate. Further, the Company or an Affiliate may at any time dismiss the Grantee or discontinue any consulting relationship, free from any liability or any claim under this Agreement, except as otherwise expressly provided herein.
14.    Binding Effect. Subject to Section 8 hereof, this Agreement shall be binding upon the heirs, executors, administrators and successors of the parties hereto.
15.    Amendment of Agreement. The Committee may, to the extent consistent with the terms of this Agreement, waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate, any portion of the PRSUs heretofore granted, prospectively or retroactively; provided that any such waiver, amendment, alteration, suspension, discontinuance, cancellation or termination that would adversely impair the rights of the Grantee in respect of any PRSUs already granted shall not to that extent be effective without the consent of the Grantee.
16.    PRSUs Subject to Plan and NQDC Plan. By entering into this Agreement, the Grantee agrees and acknowledges that the Grantee has received and read a copy of the Plan and a copy of the NQDC Plan. The PRSUs are subject to the terms of Plan, and the NQDC Plan if the PRSUs are deferred under the NQDC Plan. The terms and provisions of the plans as they may be amended from time to time are hereby incorporated herein by reference. In the event of a conflict between any term or provision contained herein and a term or provision of either the Plan or the NQDC Plan, the applicable terms and provisions of the applicable plan will govern and prevail.
17.    Governing Law.  This Agreement shall be construed and interpreted in accordance with the internal laws of the State of Delaware without regard to the principles of conflicts of law thereof, or principles of conflicts of laws of any other jurisdiction that could cause the application of the laws of any jurisdiction other than the State of Delaware.

Page 9 of 11

Exhibit 10.2
Executive Form

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.
AMN HEALTHCARE SERVICES, INC.
By:
        
Name:    Susan R. Salka
Title:    President and CEO
GRANTEE
By:
        
Name:    


















Page 10 of 11

Exhibit 10.2
Executive Form

SCHEDULE I
VESTING TABLE


Page 11 of 11
EX-10.3 4 amn-ex103x20190331x10q.htm EXHIBIT 10.3 Exhibit
Exhibit 10.3
Non-Executive Form

AMN HEALTHCARE
EQUITY PLAN
PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT
(ADJUSTED EBITDA MARGIN)
THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this ___________ ___, 2019, by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and ___________________ (the “Grantee”).
W I T N E S S E T H:
WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, the “Plan”), and desires to afford the Grantee the opportunity to share in the appreciation of the Company’s common stock, par value $.01 per share (“Stock”), thereunder, thereby strengthening the Grantee’s commitment to the welfare of the Company and Affiliates and promoting an identity of interest between stockholders and the Grantee.
NOW THEREFORE, in consideration of the covenants and agreements herein contained, the parties hereto hereby agree as follows:
1.    Definitions.
The following definitions shall be applicable throughout the Agreement. Where capitalized terms are used but not defined herein, their meaning shall be that set forth in the Plan (unless the context indicates otherwise).
(a)    Adjusted EBITDA” means for the Company and its wholly owned Subsidiaries on a consolidated basis, net income (loss) plus interest expense (net of interest income), income taxes, depreciation and amortization, acquisition related costs, stock-based compensation expense, integration expenses, debt refinancing and other corporate reorganizational costs, incentive awards recorded in its financial books and records, including long-term incentive awards and annual incentive awards, extraordinary legal costs (including damages, settlements and attorney’s fees), changes in GAAP treatment of revenue/expenses, discontinued operations, goodwill and other identified intangible asset impairments and expenses resulting from severance arrangements with terminated employees, and net income (loss) from discontinued operations, net of tax, and the impact of any additional extraordinary items that may be identified by the Committee in its sole discretion.
(b)    Adjusted EBITDA Margin” means for the Company and its wholly owned Subsidiaries on a consolidated basis, Adjusted EBITDA divided by gross revenue, expressed as a percentage.
(c)    Affiliate” means (i) any entity that directly or indirectly is controlled by, or is under common control with, the Company and (ii) any entity in which the Company has a significant equity interest, in either case, as determined by the Committee.

Page 1 of 10


Exhibit 10.3
Non-Executive Form

(d)    Cause” means (i) the definition of “cause” means any of the following: (A) Grantee’s failure to perform in any material respect his or her duties as an employee of the Company, (B) violation of the Company’s Code of Business Conduct, Code of Ethics for Senior Financial Officers and Principal Executive Officer (if applicable), and/or Securities Trading Policy, (C) the engaging by the Grantee in willful misconduct or gross negligence which is injurious to the Company or any of its Affiliates, monetarily or otherwise, (D) the commission by Grantee of an act of fraud or embezzlement against the Company or any of its Affiliates, (E) the conviction of the Grantee of a crime which constitutes a felony or any lesser crime that involves Company property or a pleading of guilty or nolo contendere with respect to a crime which constitutes a felony or any lesser crime that involves Company property, or (F) violation of any of the restrictive covenants in Section 9 hereof.
(e)    Change in Control” means:
(i)    the acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (a “Person”) of beneficial ownership (within the meaning of Rule 13d‑3 promulgated under the Exchange Act) of a majority of the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors;
(ii)    the sale of all or substantially all of the business or assets of the Company; or
(iii)    the consummation of a merger, consolidation or similar form of corporate transaction involving the Company that requires the approval of the Company’s stockholders, whether for such transaction or the issuance of securities in the transaction (a “Business Combination”), if immediately following such Business Combination: (A) a Person is or becomes the beneficial owner, directly or indirectly, of a majority of the combined voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation), or (B) the Company’s stockholders prior to the Business Combination thereafter cease to beneficially own, directly or indirectly, a majority of the combined voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation), counting for this purpose only voting securities of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) received by such stockholders in connection with the Business Combination. “Surviving Corporation” shall mean the corporation resulting from a Business Combination, and “Parent Corporation” shall mean the ultimate parent corporation that directly or indirectly has beneficial ownership of a majority of the combined voting power of the then outstanding voting securities of the Surviving Corporation entitled to vote generally in the election of directors.
(f)    Change in Control Termination” means the Company’s termination of the Grantee’s Service without Cause (other than due to death or Disability) during the Protection Period.
(g)    Credited Service” means the performance of Service on a substantially full time basis for a continuous twelve-month period. For this purpose, substantially full time basis shall mean that the employee or consultant provides regular and recurring services to the Company of at least 32 hours each week. The taking of approved paid time off or legally mandated leave, such as FMLA, does not interrupt this period of Credited Service. Notwithstanding the foregoing, the

Page 2 of 10


Exhibit 10.3
Non-Executive Form

Committee may treat periods of less than full time employment, in whole or in part, as Credited Service in its sole discretion.
(h)    Disabled” has the meaning set forth in Section 13(c)(ii) of the Plan.
(i)    Grant Date” means ___________ ___, 2019, which is the date the Committee authorized this PRSU grant.
(j)    NQDC Plan” means the Company’s 2005 Amended and Restated Executive Nonqualified Excess Plan, as may be amended from time to time.
(k)    Performance Period” means January 1, 2021 through December 31, 2021.
(l)    Performance Restricted Stock Unit(s)” or “PRSU(s)” means the performance restricted stock units granted under Section 2.
(m)    Protection Period” means the period beginning on the date that is six (6) months before the effective date of a Change in Control and ending on the second anniversary of the effective date of the Change in Control.
(n)    Retirement” means termination of an employee’s Service on or after attainment of age 55 with at least 15 full years of aggregate Service. For clarity, only twelve (12) months of continuous Service shall count as a full year of Service for purposes of determining if an employee is eligible for Retirement.
(o)    Service” means the performance of services for the Company (or any Affiliate) by a person in the capacity of an officer or other employee or key person (including consultants).
(p)    Vesting Date” means the date on which the Grantee has performed three full periods of Credited Service, the first period of which shall commence on the Grant Date; provided, however, that in the event of a Change in Control, the Vesting Date shall be the effective date of the Change in Control.

Page 3 of 10


Exhibit 10.3
Non-Executive Form

2.    Grant of Performance Restricted Stock Units. Subject to the terms and conditions set forth herein, the Company hereby grants to the Grantee ______ (the “Target Number”) PRSUs. The Committee will determine the number of PRSUs at the end of the Performance Period (“Actual PRSUs”) in accordance with the Adjusted EBITDA Margin Table attached hereto as Schedule I (the “Adjusted EBITDA Margin Table”), which Actual PRSUs will be subject to additional time-based vesting. The number of Actual PRSUs may be greater or fewer than the Target Number.
3.    Vesting Schedule. Except as otherwise set forth in this Agreement or in the Plan, the Actual PRSUs (as determined in accordance with the Adjusted EBITDA Margin Table) shall vest on the Vesting Date. All PRSUs that do not become Actual PRSUs shall be cancelled and be null and void on the date the Committee calculates the Adjusted EBITDA Margin for the Performance Period, which shall occur within sixty (60) days of the end of the Performance Period (the “Calculation Date”).
4.    Settlement and Deferral of PRSUs.
(a)    Each vested Actual PRSU entitles the Grantee to receive one share of Stock on the “Settlement Date,” which shall be the later of (i) the Vesting Date (or the Calculation Date, if later than the Vesting Date), and (ii) the end of the deferral period specified by the Grantee. The deferral period shall be no less than four (4) years and five (5) days from the Grant Date. Such deferral election shall be made within 30 days of the Grant Date. Any deferral of the PRSUs shall be subject to the NQDC Plan and the applicable deferral election form.
(b)    Shares of Stock underlying the vested Actual PRSUs shall be issued and delivered to the Grantee in accordance with paragraph (a) and upon compliance to the satisfaction of the Committee with all requirements under applicable laws or regulations in connection with such issuance and with the requirements hereof and of the Plan. The determination of the Committee as to such compliance shall be final and binding on the Grantee. The shares of Stock delivered to the Grantee pursuant to this Section 4 shall be free and clear of all liens, fully paid and non-assessable. In no event shall fractional shares of Stock be issued.
(c)    Until such time as shares of Stock have been issued to the Grantee pursuant to paragraph (b) above, and except as set forth in Section 5 below regarding dividend equivalents, the Grantee shall not have any rights as a holder of the shares of Stock underlying this Grant including but not limited to voting rights.
(d)    The Grantee may be required to pay to the Company or any Affiliate, and the Company or any Affiliate shall have the right and is hereby authorized to withhold from any shares of Stock or other property deliverable in respect of a vested Actual PRSU or from any compensation or other amounts owing to the Grantee the amount (in cash, Stock or other property) of any required tax withholding and payroll taxes in respect of such Actual PRSUs vesting or settlement and to take such other action as may be necessary in the opinion of the Company to satisfy all obligations for the payment of such taxes.
(e)    Without limiting the generality of clause (d) above, in the Committee’s sole discretion the Grantee may satisfy, in whole or in part, the foregoing withholding liability by having the Company withhold from the number of shares of Stock otherwise issuable pursuant to the

Page 4 of 10


Exhibit 10.3
Non-Executive Form

settlement of vested Actual PRSUs a number of shares with a Fair Market Value equal to such withholding liability.
5.    Dividend Equivalents. If on any date the Company shall pay any cash dividend on shares of Stock of the Company, the number of Actual PRSUs credited to the Grantee pursuant to the Adjusted EBITDA Margin Table shall, as of such date (or as of the Calculation Date if such dividend occurs before the Calculation Date), be increased by an amount determined by the following formula:
W = (X multiplied by Y) divided by Z, where:
W = the number of additional PRSUs to be credited to the Grantee on such dividend payment date;
X = the aggregate number of PRSUs (whether vested or unvested) credited to the Grantee as of the record date of the dividend (or the Calculation Date, as applicable);
Y = the cash dividend per share amount; and
Z = the Fair Market Value per share of Stock (as determined under the Plan) on the dividend payment date.
For the avoidance of doubt, no dividend equivalents shall be credited to PRSUs prior to the determination of the number of Actual PRSUs.
6.    Termination of Service.
(a)    Except as provided below, if the Grantee’s Service terminates for any reason prior to the Settlement Date, then all unvested PRSUs (or all unvested Actual PRSUs, as applicable) shall be forfeited.
(b)    If the Grantee’s Service terminates due to Retirement at any time after 6 (six) months from the Grant Date but before the Settlement Date, then the Grantee shall continue to vest in all of the Grantee’s unvested PRSUs (or all unvested Actual PRSUs, as applicable) according to the terms of this Agreement as though the Grantee’s Service had not terminated. For clarity, the Grantee’s Actual PRSUs shall be determined at the end of the Performance Period according to the Adjusted EBITDA Margin Table based on actual performance, and such Actual PRSUs shall be settled at the time specified in Section 4 hereof.
(c)    If the Grantee’s Service terminates due to a Change in Control Termination after the Grant Date but before the end of the Performance Period, then on the date of the Grantee’s termination (or, if later, on the effective date of the Change in Control), 100% of the Target Number of PRSUs shall become immediately vested, be considered Actual PRSUs and settled according to Section 4 hereof. If the Grantee’s Service terminates due to a Change in Control Termination after the end of the Performance Period but before the Settlement Date, then on the date of the Grantee’s termination (or, if later, on the effective date of the Change in Control), all of the Grantee’s Actual PRSUs shall become immediately vested and settled according to Section 4 hereof.

Page 5 of 10


Exhibit 10.3
Non-Executive Form

(d)    In the event of the Grantee’s death or if the Committee’s determines, in its sole discretion, that the Grantee has become Disabled, in each case, after the Grant Date and prior to the end of the Performance Period), (i) 100% of the Target Number of PRSUs shall become immediately vested, be considered Actual PRSUs and, regardless of the Grantee’s deferral election, the Company, as soon as reasonably practicable, shall issue shares of Stock to the Grantee (or the Grantee’s designated beneficiary or estate executor in the event of the Grantee’s death) with respect to the Target Number of PRSUs, and (ii) any PRSUs in excess of the Target Number shall be forfeited. In the event the Grantee dies or becomes Disabled (as determined by the Committee in its sole discretion) on or after the end of the Performance Period and prior to (or on) the Settlement Date, the Grantee shall be entitled to receive shares of Stock underlying all vested Actual PRSUs, and regardless of the Grantee’s deferral election, the Company, as soon as reasonably practicable, shall issue the applicable number of shares of Stock to the Grantee (or the Grantee’s designated beneficiary or estate executor in the event of the Grantee’s death).
(e)    If the Grantee’s employment is terminated due to a reason specified in (b)-(d) above but, after such termination, the Committee determines that it would have had Cause to terminate the Grantee’s Service if all the relevant facts had been known to the Committee as of the date of the Grantee’s termination, then all PRSUs and Actual PRSUs shall immediately be forfeited and cancelled, whether or not vested, as of the date of the Committee’s determination.
7.    Company; Grantee.
(a)    The term “Company” as used in this Agreement with reference to employment shall include the Company, its Subsidiaries and its Affiliates, as appropriate.
(b)    Whenever the word “Grantee” is used in any provision of this Agreement under circumstances where the provision should logically be construed to apply to the beneficiaries, the executors, the administrators, or the person or persons to whom the PRSUs may be transferred by will or by the laws of descent and distribution, the word “Grantee” shall be deemed to include such person or persons.
8.    Non-Transferability.  The PRSUs granted herein are not transferable by the Grantee other than to a designated beneficiary upon death, by will or the laws of descent and distribution, to a trust solely for the benefit of the Grantee or his/her immediate family or, in the case of the PRSUs being held by such a trust, by the trustee.
9.    Forfeiture for Violation of Restrictive Covenants.
(a)    Non-Compete. The Grantee agrees that during the term of the Grantee’s employment and for a period of two years thereafter (the “Coverage Period”) the Grantee will not engage in, consult with, participate in, hold a position as shareholder, director, officer, consultant, employee, partner or investor, or otherwise assist any business entity (i) in any State of the United States of America or (ii) in any other country in which the Company (which, for the avoidance of doubt, includes for all purposes of this Section 9 any and all of its divisions, Affiliates or Subsidiaries) has business activities, in either case, that is engaged in (A) any activities that are competitive with the business of providing (I) healthcare or other personnel on a temporary or permanent placement basis to

Page 6 of 10


Exhibit 10.3
Non-Executive Form

hospitals, healthcare facilities, healthcare provider practice groups or other entities, (II) clinical workforce management services, or (III) healthcare workforce technology platforms, or (B) any other business in which the Company is then engaged, in each case, including any and all business activities reasonably related thereto.
(b)    Non-Solicit. The Grantee agrees that during the Coverage Period, the Grantee shall not solicit, attempt to solicit or endeavor to entice away from the Company any person who, at any time during the term of the Grantee’s employment was a healthcare professional (including a healthcare executive) of the Company, or an employee, customer, permanent placement candidate, client or supplier of the Company.
(c)    Confidential and Proprietary Information. The Grantee agrees that the Grantee will not, at any time make use of or divulge to any other person, firm or corporation any confidential or proprietary information concerning the business or policies of the Company (which includes, for the avoidance of doubt, any and all of its divisions, Affiliates or Subsidiaries). For purposes of this Agreement, any confidential information shall constitute any information designated as confidential or proprietary by the Company or otherwise known by the Grantee to be confidential or proprietary information including, without limitation, customer information. The Grantee acknowledges and agrees that for purposes of this Agreement, “customer information” includes without limitation, customer lists, all lists of professional personnel, names, addresses, phone numbers, contact persons, preferences, pricing arrangements, requirements and practices. The Grantee’s obligation under this Section 9(c) shall not apply to any information that (i) is known publicly; (ii) is in the public domain or hereafter enters the public domain without the fault of the Grantee; or (iii) is hereafter disclosed to the Grantee by a third party not under an obligation of confidence to the Company. The Grantee agrees not to remove from the premises of the Company, except as an employee of the Company in pursuit of the business of the Company or except as specifically permitted in writing by the Company, any document or other object containing or reflecting any such confidential or proprietary information. The Grantee recognizes that all such information, whether developed by the Grantee or by someone else, will be the sole exclusive property of the Company. Upon termination of employment, the Grantee shall forthwith deliver to the Company all such confidential or proprietary information, including without limitation all lists of customers, pricing methods, financial structures, correspondence, accounts, records and any other documents, computer disks, computer programs, software, laptops, modems or property made or held by the Grantee or under the Grantee’s control in relation to the business or affairs of the Company, and no copy of any such confidential or proprietary information shall be retained by the Grantee.
(d)    Forfeiture for Violations. If the Grantee shall at any time violate the provisions of Section 9(a), (b), or (c), the Grantee shall immediately forfeit his/her Actual PRSUs (whether vested or unvested) and any issuance of shares of Stock that occurs after (or within six (6) months before) any such violation shall be void ab initio.

Page 7 of 10


Exhibit 10.3
Non-Executive Form

(e)    Additional Agreement. For the avoidance of doubt, this Section 9 shall be in addition to and shall not supersede (or be superseded by) any other agreements related to the subject matter of this Section 9 contained in any confidentiality agreement, noncompetition agreement or any other agreement between the Grantee and the Company.
10.    Rights as Stockholder.  The Grantee or a transferee of the Actual PRSUs shall have no rights as a stockholder with respect to any share of Stock covered by the Actual PRSUs until the Grantee shall have become the holder of record of such share of Stock and no adjustment shall be made for dividends or distributions or other rights in respect of such share of Stock for which the record date is prior to the date upon which Grantee shall become the holder of record thereof.
11.    Successor. The obligations of the Company under this Agreement shall be binding upon any successor corporation or organization resulting from the merger, consolidation or other reorganization of the Company, or upon any successor corporation or organization succeeding to substantially all of the assets and business of the Company. The Company agrees that it will make appropriate provisions for the preservation of the Grantee’s rights under this Agreement in any agreement or plan that it may enter into or adopt to effect any such merger, consolidation, reorganization or transfer of assets.
12.    Notice. Every notice or other communication relating to this Agreement shall be in writing, and shall be mailed to or delivered to the party for whom it is intended at such address as may from time to time be designated by it in a notice mailed or delivered to the other party as herein provided, provided that, unless and until some other address be so designated, all notices or communications by the Grantee to the Company shall be mailed or delivered to the Company at its principal executive office, and all notices or communications by the Company to the Grantee may be given to the Grantee personally or may be mailed to the Grantee at the Grantee’s address as recorded in the records of the Company.
13.    No Right to Continued Employment.  This Agreement shall not be construed as giving the Grantee the right to be retained in the employ or service of the Company, a Subsidiary or an Affiliate. Further, the Company or an Affiliate may at any time dismiss the Grantee or discontinue any consulting relationship, free from any liability or any claim under this Agreement, except as otherwise expressly provided herein.
14.    Binding Effect. Subject to Section 8 hereof, this Agreement shall be binding upon the heirs, executors, administrators and successors of the parties hereto.
15.    Amendment of Agreement. The Committee may, to the extent consistent with the terms of this Agreement, waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate, any portion of the PRSUs heretofore granted, prospectively or retroactively; provided that any such waiver, amendment, alteration, suspension, discontinuance, cancellation or termination that would adversely impair the rights of the Grantee in respect of any PRSUs already granted shall not to that extent be effective without the consent of the Grantee.
16.    PRSUs Subject to Plan and NQDC Plan. By entering into this Agreement, the Grantee agrees and acknowledges that the Grantee has received and read a copy of the Plan and a copy of the NQDC Plan. The PRSUs are subject to the terms of Plan, and the NQDC Plan if the PRSUs are

Page 8 of 10


Exhibit 10.3
Non-Executive Form

deferred under the NQDC Plan. The terms and provisions of the plans as they may be amended from time to time are hereby incorporated herein by reference. In the event of a conflict between any term or provision contained herein and a term or provision of either the Plan or the NQDC Plan, the applicable terms and provisions of the applicable plan will govern and prevail.
17.    Governing Law.  This Agreement shall be construed and interpreted in accordance with the internal laws of the State of Delaware without regard to the principles of conflicts of law thereof, or principles of conflicts of laws of any other jurisdiction that could cause the application of the laws of any jurisdiction other than the State of Delaware.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.
AMN HEALTHCARE SERVICES, INC.
By:
        
Name:    Susan R. Salka
Title:    President and CEO
GRANTEE
By:

Name:    












Page 9 of 10


Exhibit 10.3
Non-Executive Form

SCHEDULE I
Adjusted EBITDA Margin Table
Actual PRSUs as defined in this Agreement shall be determined by the Committee in accordance with the table below based on the Adjusted EBITDA Margin generated during the Performance Period:

Page 10 of 10

EX-10.4 5 amn-ex104x20190331x10q.htm EXHIBIT 10.4 Exhibit
Exhibit 10.4
Non-Executive Form

AMN HEALTHCARE
EQUITY PLAN
PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT
(TOTAL SHAREHOLDER RETURN)
THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this ____________ ___, 2019 by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and _______________ (the “Grantee”).
W I T N E S S E T H:
WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, the “Plan”), and desires to afford the Grantee the opportunity to share in the appreciation of the Company’s common stock, par value $.01 per share (“Stock”), thereunder, thereby strengthening the Grantee’s commitment to the welfare of the Company and Affiliates and promoting an identity of interest between stockholders and the Grantee.
NOW THEREFORE, in consideration of the covenants and agreements herein contained, the parties hereto hereby agree as follows:
1.Definitions.
The following definitions shall be applicable throughout the Agreement. Where capitalized terms are used but not defined herein, their meaning shall be that set forth in the Plan (unless the context indicates otherwise).
(a)    Accumulated Shares” means, for a given day, and for a given Peer Company or the Company, the sum of (i) one share of common stock of the applicable company (as included on the Russell 2000), plus (ii) a cumulative number of shares of common stock purchased with dividends declared on the common stock, assuming same day reinvestment of the dividends into shares of common stock at the closing price on the ex-dividend date, for ex-dividend dates during the Opening Average Period or for the period between January 1, 2019 and the last day of the Closing Average Period, as the case may be.
(b)    Affiliate” means (i) any entity that directly or indirectly is controlled by, or is under common control with, the Company and (ii) any entity in which the Company has a significant equity interest, in either case, as determined by the Committee.
(c)    Cause” means (i) the definition of “cause” means any of the following: (A) Grantee’s failure to perform in any material respect his or her duties as an employee of the Company, (B) Grantee’s violation of the Company’s Code of Business Conduct, Code of Ethics for Senior Financial Officers and Principal Executive Officer, and/or Securities Trading Policy, (C) the engaging by Grantee in willful misconduct or gross negligence which is injurious to the Company or any of its affiliates, monetarily or otherwise, (D) the commission by the Grantee of an act of fraud or embezzlement against the Company or any of its affiliates, or (E) the conviction of the Grantee of a crime which constitutes a felony or any lesser crime that involves Company property or a pleading of

Page 1 of 10


Exhibit 10.4
Non-Executive Form

guilty or nolo contendere with respect to a crime which constitutes a felony or any lesser crime that involves Company property, or (F) violation of any of the restrictive covenants in Section 9 hereof.
(d)    Change in Control” means:
(i)    the acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (a “Person”) of beneficial ownership (within the meaning of Rule 13d‑3 promulgated under the Exchange Act) of a majority of the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors;
(ii)    the sale of all or substantially all of the business or assets of the Company; or
(iii)    the consummation of a merger, consolidation or similar form of corporate transaction involving the Company that requires the approval of the Company’s stockholders, whether for such transaction or the issuance of securities in the transaction (a “Business Combination”), if immediately following such Business Combination: (A) a Person is or becomes the beneficial owner, directly or indirectly, of a majority of the combined voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation), or (B) the Company’s stockholders prior to the Business Combination thereafter cease to beneficially own, directly or indirectly, a majority of the combined voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation), counting for this purpose only voting securities of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) received by such stockholders in connection with the Business Combination. “Surviving Corporation” shall mean the corporation resulting from a Business Combination, and “Parent Corporation” shall mean the ultimate parent corporation that directly or indirectly has beneficial ownership of a majority of the combined voting power of the then outstanding voting securities of the Surviving Corporation entitled to vote generally in the election of directors.
(e)    Change in Control Termination” means the Company’s termination of the Grantee’s Service without Cause (other than due to death or Disability) during the Protection Period.
(f)    Closing Average Period” means the ninety (90)-day period ending on the last day of the Performance Period.
(g)    Closing Average Share Value” means, for each of the Peer Companies and the Company, the average, over the days in the Closing Average Period, of the closing price of its common stock multiplied by the Accumulated Shares for each day during the Closing Average Period.
(h)    Disabled” has the meaning set forth in Section 13(c)(ii) of the Plan.
(i)    Grant Date” means _________ ___, 2019, which is the date the Committee authorized this PRSU grant.
(j)    NQDC Plan” means the Company’s 2005 Amended and Restated Executive Nonqualified Excess Plan, as may be amended from time to time.

Page 2 of 10


Exhibit 10.4
Non-Executive Form

(k)    Opening Average Period” means the ninety (90)-day period ended on December 31, 2018.
(l)    Opening Average Share Value” means, for each of the Peer Companies and the Company, the average during the Opening Average Period of the closing price of its common stock multiplied by the Accumulated Shares for each trading day during the Opening Average Period.
(m)    Peer Companies” means the companies included in the Russell 2000 on December 31, 2017. In the event of a merger, acquisition or business combination transaction of a Peer Company with or by another Peer Company, the surviving entity shall remain a Peer Company. In the event of a merger of a Peer Company with an entity that is not a Peer Company, or the acquisition or business combination transaction by or with a Peer Company, or with an entity that is not a Peer Company, in each case, where the Peer Company is the surviving entity and remains publicly traded, the surviving entity shall remain a Peer Company. In the event of a merger or acquisition or business combination transaction of a Peer Company by or with an entity that is not a Peer Company, a “going private” transaction involving a Peer Company or the liquidation of a Peer Company, where the Peer Company is not the surviving entity or is otherwise no longer publicly traded, the company shall no longer be a Peer Company. In the event of a bankruptcy of a Peer Company, such company shall remain a Peer Company.
(n)    Performance Period” means January 1, 2019 through December 31, 2021.
(o)    Performance Restricted Stock Unit(s)” or “PRSU(s)” means the performance restricted stock units granted under Section 2.
(p)    Protection Period” means the period beginning on the date that is six (6) months before the effective date of a Change in Control and ending on the second anniversary of the effective date of the Change in Control.
(q)    Relative Total Shareholder Return” or “Relative TSR” means the Company’s TSR relative to the TSR of the Peer Companies. Following the calculation of the TSR of the Company and each Peer Company for the Performance Period, the Company and each Peer Company will be ranked in order of maximum to minimum according to their respective TSR for the Performance Period. After this ranking, the percentile performance of the Company relative to the Peer Companies will be determined as follows:
amnex1042019033110qimage1.gif
where:    “P” represents the percentile performance, which will be rounded, if necessary, to the nearest whole percentile by application of standard scientific rounding conventions.
“N” represents the number of Peer Companies, plus one (i.e., the Company).
“R” represents the Company’s ranking versus the Peer Companies.
Example: If there are 1000 Peer Companies, and the Company ranked 501st out of 1001 (i.e., 1000 Peer Companies, plus the Company), the performance would be at the 50th percentile: .50 = 1 – ((501-1)/(1001-1)).

Page 3 of 10


Exhibit 10.4
Non-Executive Form

(r)    Retirement” means termination of an employee’s Service on or after attainment of age 55 with at least 15 full years of aggregate Service. For clarity, only twelve (12) months of continuous Service shall count as a full year of Service for purposes of determining if an employee is eligible for Retirement.
(s)    Service” means the performance of services for the Company (or any Affiliate) by a person in the capacity of an officer or other employee or key person (including consultants).
(t)    Total Shareholder Return” or “TSR” means for each of the Company and the Peer Companies, the company’s total shareholder return, which will be calculated by dividing (i) the Closing Average Share Value by (ii) the Opening Average Share Value, and then subtracting one (1).
(u)    Vesting Date” means the date on which the Committee determines the TSR and Relative TSR; provided, however, that in the event of a Change in Control, the Vesting Date shall be the effective date of the Change in Control.
2.    Grant of Performance Restricted Stock Units. Subject to the terms and conditions set forth herein, the Company hereby grants to the Grantee ______ PRSUs, which shall be the target number. The actual number of PRSUs that can vest may be more or less than the target number, as determined in accordance with the table (the “Vesting Table”) set forth on Schedule I.
3.    Vesting Schedule. No PRSUs may be settled until they have vested, which shall occur, if at all, on the Vesting Date. Except as otherwise set forth in this Agreement or in the Plan, the PRSUs shall only vest on the Vesting Date if the Grantee has provided Service to the Company continuously from the Grant Date through the Vesting Date. Except as otherwise set forth in this Agreement or in the Plan, the number of PRSU’s that shall vest on the Vesting Date will be determined in accordance with the Vesting Table, based on the Company’s achievement of Total Shareholder Return and Relative Total Shareholder Return for the Performance Period. Any fractional share resulting from the application of the percentages in the Vesting Table shall be rounded to the nearest whole number of shares. The Committee shall determine the Total Shareholder Return and Relative TSR, if any, within 30 days after the end of the Performance Period. On the Vesting Date, all PRSUs that do not vest shall be automatically cancelled and the right to receive any PRSUs that do not vest hereunder shall automatically expire.
4.    Settlement and Deferral of PRSUs.
(a)    Each vested PRSU entitles the Grantee to receive one share of Stock on the “Settlement Date,” which shall be the later of (i) the Vesting Date, and (ii) the end of the deferral period specified by the Grantee. The deferral period shall be no less than four (4) years and five (5) days from the Grant Date. Such deferral election shall be made within 30 days of the Grant Date. Any deferral of the PRSUs shall be subject to the NQDC Plan and the applicable deferral election form.
(b)    Shares of Stock underlying the PRSUs shall be issued and delivered to the Grantee in accordance with paragraph (a) and upon compliance to the satisfaction of the Committee with all requirements under applicable laws or regulations in connection with such issuance and with the requirements hereof and of the Plan. The determination of the Committee as to such compliance

Page 4 of 10


Exhibit 10.4
Non-Executive Form

shall be final and binding on the Grantee. The shares of Stock delivered to the Grantee pursuant to this Section 4 shall be free and clear of all liens, fully paid and non-assessable. In no event shall fractional shares of Stock be issued.
(c)    Until such time as shares of Stock have been issued to the Grantee pursuant to paragraph (b) above, and except as set forth in Section 5 below regarding dividend equivalents, the Grantee shall not have any rights as a holder of the shares of Stock underlying this Grant including but not limited to voting rights.
(d)    The Grantee may be required to pay to the Company or any Affiliate, and the Company or any Affiliate shall have the right and is hereby authorized to withhold from any shares of Stock or other property deliverable under the PRSU or from any compensation or other amounts owing to the Grantee the amount (in cash, Stock or other property) of any required tax withholding and payroll taxes in respect of a PRSU vesting or settlement and to take such other action as may be necessary in the opinion of the Company to satisfy all obligations for the payment of such taxes.
(e)    Without limiting the generality of clause (d) above, in the Committee’s sole discretion the Grantee may satisfy, in whole or in part, the foregoing withholding liability by having the Company withhold from the number of shares of Stock otherwise issuable pursuant to the settlement of the PRSU a number of shares with a Fair Market Value equal to such withholding liability.
5.    Dividend Equivalents. If on any date the Company shall pay any cash dividend on shares of Stock of the Company, the number of PRSUs credited to the Grantee pursuant to the Vesting Table shall, as of such date, be increased by an amount determined by the following formula:
W = (X multiplied by Y) divided by Z, where:
W = the number of additional PRSUs to be credited to the Grantee on such dividend payment date;
X = the aggregate number of PRSUs (whether vested or unvested) credited to the Grantee as of the record date of the dividend;
Y = the cash dividend per share amount; and
Z = the Fair Market Value per share of Stock (as determined under the Plan) on the dividend payment date.
For the avoidance of doubt, no dividend equivalents shall be credited to PRSUs prior to the Committee determining the Total Shareholder Return and Relative TSR (and thus the actual number of PRSUs subject to vesting).
6.    Termination of Service.
(a)    Except as provided below, if the Grantee’s Service terminates for any reason prior to the Settlement Date, then all unvested PRSUs shall be forfeited.

Page 5 of 10


Exhibit 10.4
Non-Executive Form

(b)    If the Grantee’s Service terminates due to Retirement at any time after 6 (six) months from the Grant Date but before the Settlement Date, then the Grantee shall continue to vest in all of the Grantee’s unvested PRSUs according to the terms of this Agreement as though the Grantee’s Service had not terminated. For clarity, the actual number of PRSUs that shall vest shall be determined at the end of the Performance Period according to the Vesting Table based on actual performance, and such vested PRSUs shall be settled at the time specified in Section 4 hereof.
(c)    If the Grantee’s Service terminates due to a Change in Control Termination after the Grant Date but before the end of the Performance Period, then on the date of the Grantee’s termination (or, if later, on the effective date of the Change in Control), 100% of the target number of PRSUs shall become immediately vested and settled according to Section 4 hereof, and any PRSUs in excess of the target number shall be forfeited. If the Grantee’s Service terminates due to a Change in Control Termination after the end of the Performance Period but before the Settlement Date, then on the date of the Grantee’s termination (or, if later, on the effective date of the Change in Control), the number of PRSUs that were earned based on actual performance according to the Vesting Table shall become immediately vested and settled according to Section 4 hereof.
(d)    In the event of the Grantee’s death or if the Committee determines, in its sole discretion, that the Grantee has become Disabled, in each case, after the Grant Date and prior to the end of the Performance Period, (i) 100% of the target number of PRSUs shall become immediately vested and, regardless of the Grantee’s deferral election, the Company, as soon as reasonably practicable, shall issue shares of Stock to the Grantee (or the Grantee’s designated beneficiary or estate executor in the event of the Grantee’s death) with respect to the target number of PRSUs and (ii) any PRSUs in excess of the target number shall be forfeited. In the event the Grantee dies or becomes Disabled (as determined by the Committee in its sole discretion) on or after the end of the Performance Period and prior to (or on) the Settlement Date, the Grantee shall be entitled to receive shares of Stock underlying all vested PRSUs, and regardless of the Grantee’s deferral election, the Company, as soon as reasonably practicable, shall issue the applicable number of shares of Stock to the Grantee (or the Grantee’s designated beneficiary or estate executor in the event of the Grantee’s death).
(e)    If the Grantee’s employment is terminated due to a reason specified in (b)-(d) above but, after such termination, the Committee determines that it would have had Cause to terminate the Grantee’s Service if all the relevant facts had been known to the Committee as of the date of the Grantee’s termination, then all PRSUs and Actual PRSUs shall immediately be forfeited and cancelled, whether or not vested, as of the date of the Committee’s determination.
7.    Company; Grantee.
(a)    The term “Company” as used in this Agreement with reference to employment shall include the Company, its Subsidiaries and its Affiliates, as appropriate.
(b)    Whenever the word “Grantee” is used in any provision of this Agreement under circumstances where the provision should logically be construed to apply to the beneficiaries, the executors, the administrators, or the person or persons to whom the PRSUs may be transferred by will or by the laws of descent and distribution, the word “Grantee” shall be deemed to include such person or persons.

Page 6 of 10


Exhibit 10.4
Non-Executive Form

8.    Non-Transferability.  The PRSUs granted herein are not transferable by the Grantee other than to a designated beneficiary upon death, by will or the laws of descent and distribution, to a trust solely for the benefit of the Grantee or his/her immediate family or, in the case of the PRSUs being held by such a trust, by the trustee.
9.    Forfeiture for Violation of Restrictive Covenants.
(a)    Non-Compete. The Grantee agrees that during the term of the Grantee’s employment and for a period of two years thereafter (the “Coverage Period”) the Grantee will not engage in, consult with, participate in, hold a position as shareholder, director, officer, consultant, employee, partner or investor, or otherwise assist any business entity (i) in any State of the United States of America or (ii) in any other country in which the Company (which, for the avoidance of doubt, includes for all purposes of this Section 9 any and all of its divisions, Affiliates or Subsidiaries) has business activities, in either case, that is engaged in (A) any activities that are competitive with the business of providing (I) healthcare or other personnel on a temporary or permanent placement basis to hospitals, healthcare facilities, healthcare provider practice groups or other entities, (II) clinical workforce management services, or (III) healthcare workforce technology platforms, or (B) any other business in which the Company is then engaged, in each case, including any and all business activities reasonably related thereto.
(b)    Non-Solicit. The Grantee agrees that during the Coverage Period, the Grantee shall not solicit, attempt to solicit or endeavor to entice away from the Company any person who, at any time during the term of the Grantee’s employment was a healthcare professional (including a healthcare executive) of the Company, or an employee, customer, permanent placement candidate, client or supplier of the Company.
(c)    Confidential and Proprietary Information. The Grantee agrees that the Grantee will not, at any time make use of or divulge to any other person, firm or corporation any confidential or proprietary information concerning the business or policies of the Company (which includes, for the avoidance of doubt, any and all of its divisions, Affiliates or Subsidiaries). For purposes of this Agreement, any confidential information shall constitute any information designated as confidential or proprietary by the Company or otherwise known by the Grantee to be confidential or proprietary information including, without limitation, customer information. The Grantee acknowledges and agrees that for purposes of this Agreement, “customer information” includes without limitation, customer lists, all lists of professional personnel, names, addresses, phone numbers, contact persons, preferences, pricing arrangements, requirements and practices. The Grantee’s obligation under this Section 9(c) shall not apply to any information that (i) is known publicly; (ii) is in the public domain or hereafter enters the public domain without the fault of the Grantee; or (iii) is hereafter disclosed to the Grantee by a third party not under an obligation of confidence to the Company. The Grantee agrees not to remove from the premises of the Company, except as an employee of the Company in pursuit of the business of the Company or except as specifically permitted in writing by the Company, any document or other object containing or reflecting any such

Page 7 of 10


Exhibit 10.4
Non-Executive Form

confidential or proprietary information. The Grantee recognizes that all such information, whether developed by the Grantee or by someone else, will be the sole exclusive property of the Company. Upon termination of employment, the Grantee shall forthwith deliver to the Company all such confidential or proprietary information, including without limitation all lists of customers, pricing methods, financial structures, correspondence, accounts, records and any other documents, computer disks, computer programs, software, laptops, modems or property made or held by the Grantee or under the Grantee’s control in relation to the business or affairs of the Company, and no copy of any such confidential or proprietary information shall be retained by the Grantee.
(d)    Forfeiture for Violations. If the Grantee shall at any time violate the provisions of Section 9(a), (b), or (c), the Grantee shall immediately forfeit his/her PRSUs (whether vested or unvested) and any issuance of shares of Stock that occurs after (or within six (6) months before) any such violation shall be void ab initio.
(e)    Additional Agreement. For the avoidance of doubt, this Section 9 shall be in addition to and shall not supersede (or be superseded by) any other agreements related to the subject matter of this Section 9 contained in any confidentiality agreement, noncompetition agreement or any other agreement between the Grantee and the Company.
10.    Rights as Stockholder.  The Grantee or a transferee of the PRSUs shall have no rights as a stockholder with respect to any share of Stock covered by the PRSUs until the Grantee shall have become the holder of record of such share of Stock and no adjustment shall be made for dividends or distributions or other rights in respect of such share of Stock for which the record date is prior to the date upon which Grantee shall become the holder of record thereof.
11.    Successor. The obligations of the Company under this Agreement shall be binding upon any successor corporation or organization resulting from the merger, consolidation or other reorganization of the Company, or upon any successor corporation or organization succeeding to substantially all of the assets and business of the Company. The Company agrees that it will make appropriate provisions for the preservation of the Grantee’s rights under this Agreement in any agreement or plan that it may enter into or adopt to effect any such merger, consolidation, reorganization or transfer of assets.
12.    Notice. Every notice or other communication relating to this Agreement shall be in writing, and shall be mailed to or delivered to the party for whom it is intended at such address as may from time to time be designated by it in a notice mailed or delivered to the other party as herein provided, provided that, unless and until some other address be so designated, all notices or communications by the Grantee to the Company shall be mailed or delivered to the Company at its principal executive office, and all notices or communications by the Company to the Grantee may be given to the Grantee personally or may be mailed to the Grantee at the Grantee’s address as recorded in the records of the Company.
13.    No Right to Continued Employment.  This Agreement shall not be construed as giving the Grantee the right to be retained in the employ or service of the Company, a Subsidiary or an Affiliate. Further, the Company or an Affiliate may at any time dismiss the Grantee or discontinue

Page 8 of 10


Exhibit 10.4
Non-Executive Form

any consulting relationship, free from any liability or any claim under this Agreement, except as otherwise expressly provided herein.
14.    Binding Effect. Subject to Section 8 hereof, this Agreement shall be binding upon the heirs, executors, administrators and successors of the parties hereto.
15.    Amendment of Agreement. The Committee may, to the extent consistent with the terms of this Agreement, waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate, any portion of the PRSUs heretofore granted, prospectively or retroactively; provided that any such waiver, amendment, alteration, suspension, discontinuance, cancellation or termination that would adversely impair the rights of the Grantee in respect of any PRSUs already granted shall not to that extent be effective without the consent of the Grantee.
16.    PRSUs Subject to Plan and NQDC Plan. By entering into this Agreement, the Grantee agrees and acknowledges that the Grantee has received and read a copy of the Plan and a copy of the NQDC Plan. The PRSUs are subject to the terms of Plan, and the NQDC Plan if the PRSUs are deferred under the NQDC Plan. The terms and provisions of the plans as they may be amended from time to time are hereby incorporated herein by reference. In the event of a conflict between any term or provision contained herein and a term or provision of either the Plan or the NQDC Plan, the applicable terms and provisions of the applicable plan will govern and prevail.
17.    Governing Law.  This Agreement shall be construed and interpreted in accordance with the internal laws of the State of Delaware without regard to the principles of conflicts of law thereof, or principles of conflicts of laws of any other jurisdiction that could cause the application of the laws of any jurisdiction other than the State of Delaware.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.
AMN HEALTHCARE SERVICES, INC.
By:
        
Name:    Susan R. Salka
Title:    President and CEO
GRANTEE
By:
        
Name:    



Page 9 of 10


Exhibit 10.4
Non-Executive Form

SCHEDULE I
VESTING TABLE















Page 10 of 10

EX-10.5 6 amn-ex105x20190331x10q.htm EXHIBIT 10.5 Exhibit
Exhibit 10.5
Non-Executive Form

AMN HEALTHCARE
EQUITY PLAN
RESTRICTED STOCK UNIT AGREEMENT
THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this _______________ ___, 2019, by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and _____________________ (the “Grantee”).
W I T N E S S E T H:
WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, the “Plan”), and desires to afford the Grantee the opportunity to share in the appreciation of the Company’s common stock, par value $.01 per share (“Stock”) thereunder, thereby strengthening the Grantee’s commitment to the welfare of the Company and Affiliates and promoting an identity of interest between stockholders and the Grantee.
NOW THEREFORE, in consideration of the covenants and agreements herein contained, the parties hereto hereby agree as follows:
1.    Definitions.
The following definitions shall be applicable throughout the Agreement. Where capitalized terms are used but not defined herein, their meaning shall be that set forth in the Plan (unless the context indicates otherwise).
(a)    Affiliate” means (i) any entity that directly or indirectly is controlled by, or is under common control with, the Company and (ii) any entity in which the Company has a significant equity interest, in either case, as determined by the Committee.
(b)    Cause” means (i) the definition of “cause” means any of the following: (A) Grantee’s failure to perform in any material respect his or her duties as an employee of the Company, (B) Grantee’s violation of the Company’s Code of Business Conduct, Code of Ethics for Senior Financial Officers and Principal Executive Officer, and/or Securities Trading Policy, (C) the engaging by Grantee in willful misconduct or gross negligence which is injurious to the Company or any of its affiliates, monetarily or otherwise, (D) the commission by the Grantee of an act of fraud or embezzlement against the Company or any of its affiliates, (E) the conviction of the Grantee of a crime which constitutes a felony or any lesser crime that involves Company property or a pleading of guilty or nolo contendere with respect to a crime which constitutes a felony or any lesser crime that involves Company property. or (F) violation of any of the restrictive covenants in Section 9 hereof
(c)    Change in Control” means:
(i)    the acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (a “Person”) of beneficial ownership (within the meaning of Rule 13d‑3

Page 1 of 8


Exhibit 10.5
Non-Executive Form

promulgated under the Exchange Act) of a majority of the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors;
(ii)    the sale of all or substantially all of the business or assets of the Company; or
(iii)    the consummation of a merger, consolidation or similar form of corporate transaction involving the Company that requires the approval of the Company’s stockholders, whether for such transaction or the issuance of securities in the transaction (a “Business Combination”), if immediately following such Business Combination: (A) a Person is or becomes the beneficial owner, directly or indirectly, of a majority of the combined voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation), or (B) the Company’s stockholders prior to the Business Combination thereafter cease to beneficially own, directly or indirectly, a majority of the combined voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation), counting for this purpose only voting securities of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) received by such stockholders in connection with the Business Combination. “Surviving Corporation” shall mean the corporation resulting from a Business Combination, and “Parent Corporation” shall mean the ultimate parent corporation that directly or indirectly has beneficial ownership of a majority of the combined voting power of the then outstanding voting securities of the Surviving Corporation entitled to vote generally in the election of directors.
(a)    Change in Control Termination” means the Company’s termination of the Grantee’s Service without Cause (other than due to death or Disability) during the Protection Period.
(b)    Credited Service” means the performance of Service on a substantially full time basis for a continuous twelve-month period. For this purpose, substantially full time basis shall mean that the employee or consultant provides regular and recurring services to the Company of at least 32 hours each week. The taking of approved paid time off or legally mandated leave, such as FMLA, does not interrupt this period of Credited Service. Notwithstanding the foregoing, the Committee may treat periods of less than full time employment, in whole or in part, as Credited Service in its sole discretion.
(c)    Disabled” has the meaning set forth in Section 13(c)(ii) of the Plan.
(d)    Grant Date” means ____________ ____, 2019, which is the date the Committee authorized this RSU grant.
(e)    NQDC Plan” means the Company’s 2005 Amended and Restated Executive Nonqualified Excess Plan, as may be amended from time to time.

Page 2 of 8


Exhibit 10.5
Non-Executive Form

(f)    Protection Period” means the period beginning on the date that is six (6) months before the effective date of a Change in Control and ending on the second anniversary of the effective date of the Change in Control.
(g)    Restricted Stock Unit(s)” or “RSU(s)” means the restricted stock unit granted under Section 2.
(h)    Retirement” means termination of an employee’s Service on or after attainment of age 55 with at least 15 full years of aggregate Service. For clarity, only twelve (12) months of continuous Service shall count as a full year of Service for purposes of determining if an employee is eligible for Retirement.
(i)    Service” means the performance of services for the Company (or any Affiliate) by a person in the capacity of an officer or other employee or key person (including consultants).
2.    Grant of Restricted Stock Units. Subject to the terms and conditions set forth herein, the Company hereby grants to the Grantee an aggregate of __________ Restricted Stock Units (“RSUs”).
3.    Vesting Schedule. No RSUs may be settled until they shall have vested. Except as otherwise set forth in this Agreement or in the Plan, the RSUs will vest in three tranches on each of the first, second and third anniversaries of the Grant Date and the Grantee’s provision of three periods of Credited Service. The first tranche, equal to 33% of the RSUs granted, will vest on the first anniversary of the Grant Date and the Grantee’s provision of one period of Credited Service. The second tranche, equal to 33% of the RSUs granted, will vest on the second anniversary of the Grant Date and the Grantee’s provision of a second period of Credited Service. The final tranche, equal to 34% of the RSUs granted, will vest on the third anniversary of the Grant Date and the Grantee’s provision of a third period of Credited Service.
4.    Settlement and Deferral of RSUs.
(a)    Each vested RSU entitles the Grantee to receive one share of Stock on the “Settlement Date,” which shall be the later of (i) the vesting date for such RSU, provided, however, if there is an accelerated vesting of all or a portion of the RSUs under Section 6 hereof, then the Settlement Date for any such accelerated RSUs shall be the date on which it is determined that the conditions to acceleration have been met or (ii) the end of the deferral period specified by the Grantee. The deferral period shall be no less than four (4) years and five (5) days from the Grant Date. Such deferral election shall be made within 30 days of the Grant Date. The deferral of RSUs shall be subject to the NQDC Plan and the applicable deferral election.
(b)    Shares of Stock underlying the RSUs shall be issued and delivered to the Grantee in accordance with paragraph (a) and upon compliance to the satisfaction of the Committee with all requirements under applicable laws or regulations in connection with such issuance and with the requirements hereof and of the Plan. The determination of the Committee

Page 3 of 8


Exhibit 10.5
Non-Executive Form

as to such compliance shall be final and binding on the Grantee. The shares of Stock delivered to the Grantee pursuant to this Section 4 shall be free and clear of all liens, fully paid and non-assessable. In no event shall fractional shares of Stock be issued.
(c)    Until such time as shares of Stock have been issued to the Grantee pursuant to paragraph (b) above, and except as set forth in Section 5 below regarding dividend equivalents, the Grantee shall not have any rights as a holder of the shares of Stock underlying this Grant including but not limited to voting rights.
(d)    The Grantee may be required to pay to the Company or any Affiliate, and the Company or any Affiliate shall have the right and is hereby authorized to withhold from any shares of Stock or other property deliverable under the RSU or from any compensation or other amounts owing to the Grantee the amount (in cash, Stock or other property) of any required tax withholding and payroll taxes in respect of an RSU vesting or settlement and to take such other action as may be necessary in the opinion of the Company to satisfy all obligations for the payment of such taxes.
(e)    Without limiting the generality of clause (d) above, in the Committee’s sole discretion the Grantee may satisfy, in whole or in part, the foregoing withholding liability by having the Company withhold from the number of shares of Stock otherwise issuable pursuant to the settlement of the RSU a number of shares with a Fair Market Value equal to such withholding liability.
5.    Dividend Equivalents. If on any date the Company shall pay any cash dividend on shares of Stock of the Company, the number of RSUs credited to the Grantee shall, as of such date, be increased by an amount determined by the following formula:
W = (X multiplied by Y) divided by Z, where:
W = the number of additional RSUs to be credited to the Grantee on such dividend payment date;
X = the aggregate number of RSUs (whether vested or unvested) credited to the Grantee as of the record date of the dividend;
Y = the cash dividend per share amount; and
Z = the Fair Market Value per share of Stock (as determined under the Plan) on the dividend payment date.
6.    Termination of Service.
(a)    Except as provided below, if the Grantee’s Service terminates for any reason prior to the Settlement Date, then all vested RSUs shall be settled in accordance with Section 4, and any unvested RSUs shall be forfeited.

Page 4 of 8


Exhibit 10.5
Non-Executive Form

(b)    If the Grantee’s Service terminates due to Retirement at any time after 6 (six) months from the Grant Date but before the Settlement Date, then the Grantee shall continue to vest in all of the Grantee’s RSUs according to the schedule established in Section 3 as though the Grantee’s Service had not terminated (and, for the sake of clarity, as though the Grantee met all Credited Service requirements), and such RSUs shall be settled at the time specified in Section 4 hereof.
(c)    If the Grantee’s Service terminates due to a Change in Control Termination after the Grant Date but before the Settlement Date, then on the date of the Grantee’s termination (or, if later, on the effective date of the Change in Control), 100% of the RSUs shall become immediately vested and settled according to Section 4 hereof.
(d)    In the event of the Grantee’s death or if the Committee determines, in its sole discretion, that the Grantee has become Disabled, in each case, after the Grant Date and prior to third anniversary of the Grant Date), 100% of the RSUs shall become immediately vested and, regardless of the Grantee’s deferral election, the Company as soon as reasonably practicable shall issue shares of Stock to the Grantee (or the Grantee’s designated beneficiary or estate executor in the event of the Grantee’s death) with respect to the RSUs that have vested hereunder but for which shares of Stock had not yet been issued to the Grantee.
(e)    If the Grantee’s service terminates for Cause, then any outstanding RSUs, whether vested or unvested, shall be forfeited and cancelled as of the Grantee’s termination date. If the Grantee’s employment is terminated due to a reason specified in (b)-(d) above but, after such termination, the Committee determines that it would have had Cause to terminate the Grantee’s Service if all the relevant facts had been known to the Committee as of the date of the Grantee’s termination, then all outstanding RSUs shall immediately be forfeited and cancelled, whether or not vested, as of the date of the Committee’s determination.
7.    Company; Grantee.
(a)    The term “Company” as used in this Agreement with reference to employment shall include the Company, its Subsidiaries and its Affiliates, as appropriate.
(b)    Whenever the word “Grantee” is used in any provision of this Agreement under circumstances where the provision should logically be construed to apply to the beneficiaries, the executors, the administrators, or the person or persons to whom the RSUs may be transferred by will or by the laws of descent and distribution, the word “Grantee” shall be deemed to include such person or persons.
8.    Non-Transferability.  The RSUs granted herein are not transferable by the Grantee other than to a designated beneficiary upon death, by will or the laws of descent and distribution, to a trust solely for the benefit of the Grantee or his/her immediate family or, in the case of the RSUs being held by such a trust, by the trustee.

Page 5 of 8


Exhibit 10.5
Non-Executive Form

9.    Forfeiture for Violation of Restrictive Covenants.
(a)    Non-Compete. The Grantee agrees that during the term of the Grantee’s employment and for a period of two years thereafter (the “Coverage Period”) the Grantee will not engage in, consult with, participate in, hold a position as shareholder, director, officer, consultant, employee, partner or investor, or otherwise assist any business entity (i) in any State of the United States of America or (ii) in any other country in which the Company (which, for the avoidance of doubt, includes for all purposes of this Section 9 any and all of its divisions, Affiliates or Subsidiaries) has business activities, in either case, that is engaged in (A) any activities that are competitive with the business of providing (I) healthcare or other personnel on a temporary or permanent placement basis to hospitals, healthcare facilities, healthcare provider practice groups or other entities, (II) clinical workforce management services, or (III) healthcare workforce technology platforms, or (B) any other business in which the Company is then engaged, in each case, including any and all business activities reasonably related thereto.
(b)    Non-Solicit. The Grantee agrees that during the Coverage Period, the Grantee shall not solicit, attempt to solicit or endeavor to entice away from the Company any person who, at any time during the term of the Grantee’s employment was a healthcare professional (including a healthcare executive) of the Company, or an employee, customer, permanent placement candidate, client or supplier of the Company.
(c)    Confidential and Proprietary Information. The Grantee agrees that the Grantee will not, at any time make use of or divulge to any other person, firm or corporation any confidential or proprietary information concerning the business or policies of the Company (which includes, for the avoidance of doubt, any and all of its divisions, Affiliates or Subsidiaries). For purposes of this Agreement, any confidential information shall constitute any information designated as confidential or proprietary by the Company or otherwise known by the Grantee to be confidential or proprietary information including, without limitation, customer information. The Grantee acknowledges and agrees that for purposes of this Agreement, “customer information” includes without limitation, customer lists, all lists of professional personnel, names, addresses, phone numbers, contact persons, preferences, pricing arrangements, requirements and practices. The Grantee’s obligation under this Section 9(c) shall not apply to any information that (i) is known publicly; (ii) is in the public domain or hereafter enters the public domain without the fault of the Grantee; or (iii) is hereafter disclosed to the Grantee by a third party not under an obligation of confidence to the Company. The Grantee agrees not to remove from the premises of the Company, except as an employee of the Company in pursuit of the business of the Company or except as specifically permitted in writing by the Company, any document or other object containing or reflecting any such confidential or proprietary information. The Grantee recognizes that all such information, whether developed by the Grantee or by someone else, will be the sole exclusive property of the Company. Upon termination of employment, the Grantee shall forthwith deliver to the Company all such confidential or proprietary information, including without limitation all lists of customers, pricing methods, financial structures, correspondence, accounts, records and any other documents, computer disks, computer programs, software, laptops, modems or property made or held by the Grantee or under the Grantee’s control in relation to the business or affairs of the

Page 6 of 8


Exhibit 10.5
Non-Executive Form

Company, and no copy of any such confidential or proprietary information shall be retained by the Grantee.
(d)    Forfeiture for Violations. If the Grantee shall at any time violate the provisions of Section 9(a), (b), or (c), the Grantee shall immediately forfeit his/her RSUs (whether vested or unvested) and any issuance of shares of Stock that occurs after (or within six (6) months before) any such violation shall be void ab initio.
(e)    Additional Agreement. For the avoidance of doubt, this Section 9 shall be in addition to and shall not supersede (or be superseded by) any other agreements related to the subject matter of this Section 9 contained in any confidentiality agreement, noncompetition agreement or any other agreement between the Grantee and the Company.
10.     Rights as Stockholder.  The Grantee or a transferee of the RSUs shall have no rights as a stockholder with respect to any share of Stock covered by the RSUs until the Grantee shall have become the holder of record of such share of Stock and no adjustment shall be made for dividends or distributions or other rights in respect of such share of Stock for which the record date is prior to the date upon which Grantee shall become the holder of record thereof.
11.    Successor. The obligations of the Company under this Agreement shall be binding upon any successor corporation or organization resulting from the merger, consolidation or other reorganization of the Company, or upon any successor corporation or organization succeeding to substantially all of the assets and business of the Company. The Company agrees that it will make appropriate provisions for the preservation of the Grantee’s rights under this Agreement in any agreement or plan that it may enter into or adopt to effect any such merger, consolidation, reorganization or transfer of assets.
12.    Notice. Every notice or other communication relating to this Agreement shall be in writing, and shall be mailed to or delivered to the party for whom it is intended at such address as may from time to time be designated by it in a notice mailed or delivered to the other party as herein provided, provided that, unless and until some other address be so designated, all notices or communications by the Grantee to the Company shall be mailed or delivered to the Company at its principal executive office, and all notices or communications by the Company to the Grantee may be given to the Grantee personally or may be mailed to the Grantee at the Grantee’s address as recorded in the records of the Company.
13.    No Right to Continued Employment.  This Agreement shall not be construed as giving the Grantee the right to be retained in the employ or service of the Company, a Subsidiary or an Affiliate. Further, the Company or an Affiliate may at any time dismiss the Grantee or discontinue any consulting relationship, free from any liability or any claim under this Agreement, except as otherwise expressly provided herein.
14.    Binding Effect. Subject to Section 8 hereof, this Agreement shall be binding upon the heirs, executors, administrators and successors of the parties hereto.

Page 7 of 8


Exhibit 10.5
Non-Executive Form

15.    Amendment of Agreement. The Committee may, to the extent consistent with the terms of this Agreement, waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate, any portion of the RSUs heretofore granted, prospectively or retroactively; provided that any such waiver, amendment, alteration, suspension, discontinuance, cancellation or termination that would adversely impair the rights of the Grantee in respect of any RSUs already granted shall not to that extent be effective without the consent of the Grantee.
16.    RSUs Subject to Plan and NQDC Plan. By entering into this Agreement, the Grantee agrees and acknowledges that the Grantee has received and read a copy of the Plan and a copy of the NQDC Plan. The RSUs are subject to the terms of Plan, and the NQDC Plan if the RSUs are deferred under the NQDC Plan. The terms and provisions of the plans as they may be amended from time to time are hereby incorporated herein by reference. In the event of a conflict between any term or provision contained herein and a term or provision of either the Plan or the NQDC Plan, the applicable terms and provisions of the applicable plan will govern and prevail.
17.    Governing Law.  This Agreement shall be construed and interpreted in accordance with the internal laws of the State of Delaware without regard to the principles of conflicts of law thereof, or principles of conflicts of laws of any other jurisdiction that could cause the application of the laws of any jurisdiction other than the State of Delaware.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.
AMN HEALTHCARE SERVICES, INC.
By:
        
Name:    Susan R. Salka
Title:    President and CEO

GRANTEE
By:

Name:    


Page 8 of 8

EX-31.1 7 amn-ex311x20190331x10q.htm EXHIBIT 31.1 Exhibit
Exhibit 31.1
 
Certification Pursuant To
Rule 13a-14(a) of the Securities Exchange Act of 1934
 
I, Susan R. Salka, certify that:
 
1. I have reviewed this report on Form 10-Q of AMN Healthcare Services, Inc.;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

  
/S/    SUSAN R. SALKA
Susan R. Salka
Director, President and Chief Executive Officer
(Principal Executive Officer)
 
Date: May 3, 2019


EX-31.2 8 amn-ex312x20190331x10q.htm EXHIBIT 31.2 Exhibit
Exhibit 31.2
 
Certification Pursuant To
Rule 13a-14(a) of the Securities Exchange Act of 1934
 
I, Brian M. Scott, certify that:
 
1. I have reviewed this report on Form 10-Q of AMN Healthcare Services, Inc.;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

  
/S/    BRIAN M. SCOTT
Brian M. Scott
Chief Accounting Officer,
Chief Financial Officer and Treasurer
(Principal Accounting and Financial Officer)
 
Date: May 3, 2019


EX-32.1 9 amn-ex321x20190331x10q.htm EXHIBIT 32.1 Exhibit
Exhibit 32.1
 
AMN Healthcare Services, Inc.
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report of AMN Healthcare Services, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Susan R. Salka, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
  
/S/    SUSAN R. SALKA
Susan R. Salka
Director, President and Chief Executive Officer
(Principal Executive Officer)

 
Date: May 3, 2019


EX-32.2 10 amn-ex322x20190331x10q.htm EXHIBIT 32.2 Exhibit
Exhibit 32.2
 
AMN Healthcare Services, Inc.
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report of AMN Healthcare Services, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brian M. Scott, Chief Accounting Officer, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

  
/S/    BRIAN M. SCOTT
Brian M. Scott
Chief Accounting Officer,
Chief Financial Officer and Treasurer
(Principal Accounting and Financial Officer)

 
Date: May 3, 2019


EX-101.INS 11 ahs-20190331.xml XBRL INSTANCE DOCUMENT 0001142750 2019-01-01 2019-03-31 0001142750 2019-05-01 0001142750 2019-03-31 0001142750 2018-12-31 0001142750 2018-01-01 2018-03-31 0001142750 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001142750 us-gaap:RetainedEarningsMember 2018-12-31 0001142750 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0001142750 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001142750 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001142750 us-gaap:CommonStockMember 2019-03-31 0001142750 us-gaap:CommonStockMember 2018-12-31 0001142750 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001142750 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001142750 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001142750 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001142750 us-gaap:TreasuryStockMember 2018-12-31 0001142750 us-gaap:TreasuryStockMember 2019-03-31 0001142750 us-gaap:RetainedEarningsMember 2019-03-31 0001142750 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001142750 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0001142750 2017-12-31 0001142750 us-gaap:TreasuryStockMember 2018-03-31 0001142750 us-gaap:RetainedEarningsMember 2018-03-31 0001142750 us-gaap:CommonStockMember 2018-03-31 0001142750 us-gaap:TreasuryStockMember 2017-12-31 0001142750 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001142750 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001142750 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001142750 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0001142750 2018-01-01 0001142750 us-gaap:CommonStockMember 2017-12-31 0001142750 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001142750 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001142750 us-gaap:RetainedEarningsMember 2017-12-31 0001142750 us-gaap:RetainedEarningsMember 2018-01-01 0001142750 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001142750 2018-03-31 0001142750 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 2019-01-01 0001142750 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001142750 ahs:SilversheetInc.Member us-gaap:TrademarksMember 2019-01-30 0001142750 ahs:SilversheetInc.Member 2019-01-30 0001142750 ahs:MedPartnersHIMLLCMember 2018-04-09 2018-04-09 0001142750 ahs:SilversheetInc.Member 2019-01-30 2019-01-30 0001142750 ahs:PhillipsDiPisaAndLeadersForTodayMember 2018-04-06 0001142750 ahs:MedPartnersHIMLLCMember 2018-04-09 0001142750 ahs:PhillipsDiPisaAndLeadersForTodayMember 2018-04-06 2018-04-06 0001142750 ahs:SilversheetInc.Member ahs:EarnOutPaymentPerformanceConditionTwoMember 2019-01-30 0001142750 ahs:MedPartnersHIMLLCMember ahs:EarnOutPaymentPerformanceConditionFourMember 2018-04-09 0001142750 ahs:MedPartnersHIMLLCMember 2018-07-01 2018-09-30 0001142750 ahs:PhillipsDiPisaAndLeadersForTodayMember ahs:StaffingDatabasesMember 2018-04-06 0001142750 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2018-02-09 0001142750 ahs:SilversheetInc.Member us-gaap:DevelopedTechnologyRightsMember 2019-01-30 0001142750 ahs:SilversheetInc.Member ahs:EarnOutPaymentPerformanceConditionOneMember 2019-01-30 0001142750 ahs:MedPartnersHIMLLCMember ahs:EarnOutPaymentPerformanceConditionThreeMember 2018-04-09 0001142750 ahs:PhillipsDiPisaAndLeadersForTodayMember us-gaap:CustomerRelationshipsMember 2018-04-06 0001142750 ahs:PhillipsDiPisaAndLeadersForTodayMember 2018-07-01 2018-09-30 0001142750 ahs:PhillipsDiPisaAndLeadersForTodayMember us-gaap:TrademarksMember 2018-04-06 0001142750 ahs:MedPartnersHIMLLCMember us-gaap:TrademarksAndTradeNamesMember 2018-04-09 0001142750 ahs:MedPartnersHIMLLCMember us-gaap:TrademarksAndTradeNamesMember 2018-04-09 2018-04-09 0001142750 ahs:MedPartnersHIMLLCMember us-gaap:CustomerRelationshipsMember 2018-04-09 0001142750 ahs:MedPartnersHIMLLCMember us-gaap:CustomerRelationshipsMember 2018-04-09 2018-04-09 0001142750 ahs:ManagedServicesProgramArrangementsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ahs:LocumTenensStaffingMember 2019-01-01 2019-03-31 0001142750 ahs:ManagedServicesProgramArrangementsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ahs:OtherWorkforceSolutionsMember 2019-01-01 2019-03-31 0001142750 ahs:ManagedServicesProgramArrangementsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ahs:LocumTenensStaffingMember 2018-01-01 2018-03-31 0001142750 ahs:ManagedServicesProgramArrangementsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ahs:NurseAndAlliedHealthcareStaffingMember 2019-01-01 2019-03-31 0001142750 ahs:ManagedServicesProgramArrangementsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ahs:NurseAndAlliedHealthcareStaffingMember 2018-01-01 2018-03-31 0001142750 ahs:ManagedServicesProgramArrangementsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ahs:OtherWorkforceSolutionsMember 2018-01-01 2018-03-31 0001142750 us-gaap:OperatingSegmentsMember ahs:OtherWorkforceSolutionsMember 2018-01-01 2018-03-31 0001142750 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-03-31 0001142750 us-gaap:OperatingSegmentsMember 2018-01-01 2018-03-31 0001142750 us-gaap:OperatingSegmentsMember ahs:NurseAndAlliedHealthcareStaffingMember 2019-01-01 2019-03-31 0001142750 us-gaap:OperatingSegmentsMember ahs:LocumTenensStaffingMember 2018-01-01 2018-03-31 0001142750 us-gaap:OperatingSegmentsMember 2019-01-01 2019-03-31 0001142750 us-gaap:OperatingSegmentsMember ahs:LocumTenensStaffingMember 2019-01-01 2019-03-31 0001142750 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-03-31 0001142750 us-gaap:OperatingSegmentsMember ahs:OtherWorkforceSolutionsMember 2019-01-01 2019-03-31 0001142750 us-gaap:OperatingSegmentsMember ahs:NurseAndAlliedHealthcareStaffingMember 2018-01-01 2018-03-31 0001142750 ahs:LocumTenensStaffingMember 2019-03-31 0001142750 ahs:MedPartnersHIMLLCMember 2019-01-01 2019-03-31 0001142750 ahs:OtherWorkforceSolutionsMember 2018-12-31 0001142750 ahs:OtherWorkforceSolutionsMember 2019-03-31 0001142750 ahs:SilversheetInc.Member 2019-01-01 2019-03-31 0001142750 ahs:SilversheetInc.Member ahs:NurseAndAlliedHealthcareStaffingMember 2019-01-01 2019-03-31 0001142750 ahs:LocumTenensStaffingMember 2018-12-31 0001142750 ahs:SilversheetInc.Member ahs:OtherWorkforceSolutionsMember 2019-01-01 2019-03-31 0001142750 ahs:PhillipsDiPisaAndLeadersForTodayMember 2019-01-01 2019-03-31 0001142750 ahs:NurseAndAlliedHealthcareStaffingMember 2019-03-31 0001142750 ahs:NurseAndAlliedHealthcareStaffingMember 2018-12-31 0001142750 ahs:MedPartnersHIMLLCMember ahs:OtherWorkforceSolutionsMember 2019-01-01 2019-03-31 0001142750 ahs:SilversheetInc.Member ahs:LocumTenensStaffingMember 2019-01-01 2019-03-31 0001142750 ahs:PhillipsDiPisaAndLeadersForTodayMember ahs:OtherWorkforceSolutionsMember 2019-01-01 2019-03-31 0001142750 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2018-02-09 2018-02-09 0001142750 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2018-02-09 2018-02-09 0001142750 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-02-09 2018-02-09 0001142750 us-gaap:LineOfCreditMember 2019-01-01 2019-03-31 0001142750 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-02-09 2018-02-09 0001142750 us-gaap:LineOfCreditMember 2019-03-31 0001142750 us-gaap:LetterOfCreditMember us-gaap:LineOfCreditMember 2018-02-09 0001142750 ahs:RevolvingCreditFacilitySwingLineLoanMember us-gaap:LineOfCreditMember 2018-02-09 0001142750 ahs:FivePointOneTwoFivePercentSeniorNotesDueTwoThousandTwentyFourMember us-gaap:SeniorNotesMember 2016-10-31 0001142750 ahs:A5.125SeniorNotesdue2024Member us-gaap:SeniorNotesMember 2019-03-31 0001142750 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001142750 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2019-03-31 0001142750 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001142750 ahs:A5.125SeniorNotesdue2024Member us-gaap:SeniorNotesMember 2018-12-31 0001142750 ahs:SilversheetInc.Member us-gaap:FairValueInputsLevel3Member ahs:ContingentConsiderationMember 2018-01-01 2018-03-31 0001142750 ahs:HealthSourceGlobalStaffingMember ahs:TwoThousandSeventeenEarnOutMember us-gaap:FairValueInputsLevel3Member ahs:ContingentConsiderationMember 2019-01-01 2019-03-31 0001142750 ahs:SilversheetInc.Member us-gaap:FairValueInputsLevel3Member ahs:ContingentConsiderationMember 2019-01-01 2019-03-31 0001142750 us-gaap:FairValueInputsLevel3Member ahs:ContingentConsiderationMember 2018-03-31 0001142750 ahs:HealthSourceGlobalStaffingMember ahs:TwoThousandSeventeenEarnOutMember us-gaap:FairValueInputsLevel3Member ahs:ContingentConsiderationMember 2018-01-01 2018-03-31 0001142750 us-gaap:FairValueInputsLevel3Member ahs:ContingentConsiderationMember 2018-12-31 0001142750 us-gaap:FairValueInputsLevel3Member ahs:ContingentConsiderationMember 2019-03-31 0001142750 ahs:HealthSourceGlobalStaffingMember ahs:TwoThousandSixteenEarnOutMember us-gaap:FairValueInputsLevel3Member ahs:ContingentConsiderationMember 2019-01-01 2019-03-31 0001142750 us-gaap:FairValueInputsLevel3Member ahs:ContingentConsiderationMember 2017-12-31 0001142750 ahs:MedPartnersHIMLLCMember us-gaap:FairValueInputsLevel3Member ahs:ContingentConsiderationMember 2018-01-01 2018-03-31 0001142750 ahs:HealthSourceGlobalStaffingMember ahs:TwoThousandSixteenEarnOutMember us-gaap:FairValueInputsLevel3Member ahs:ContingentConsiderationMember 2018-01-01 2018-03-31 0001142750 ahs:MedPartnersHIMLLCMember us-gaap:FairValueInputsLevel3Member ahs:ContingentConsiderationMember 2019-01-01 2019-03-31 0001142750 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001142750 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001142750 ahs:ContingentConsiderationMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001142750 ahs:ContingentConsiderationMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001142750 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001142750 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001142750 ahs:ContingentConsiderationMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001142750 ahs:ContingentConsiderationMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001142750 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001142750 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001142750 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001142750 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001142750 ahs:ContingentConsiderationMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001142750 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001142750 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001142750 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001142750 ahs:ContingentConsiderationMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001142750 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001142750 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001142750 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001142750 ahs:ContingentConsiderationMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001142750 ahs:ContingentConsiderationMember us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001142750 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2018-12-31 0001142750 2018-01-01 2018-12-31 0001142750 srt:MinimumMember 2019-03-31 0001142750 ahs:WageAndHourClaimsMember us-gaap:PendingLitigationMember 2018-07-01 2018-09-30 0001142750 ahs:WageAndHourClaimsMember us-gaap:PendingLitigationMember 2018-10-31 0001142750 ahs:AdvancedMedicalPersonnelServicesInc.Member us-gaap:SubsequentEventMember 2019-04-29 0001142750 ahs:AdvancedMedicalPersonnelServicesInc.Member us-gaap:SubsequentEventMember 2019-04-29 2019-04-29 ahs:claim iso4217:USD xbrli:shares iso4217:USD ahs:aquisition xbrli:shares xbrli:pure ahs:segment 149603000 153566000 50892000 55575000 50143000 55607000 3417000 2684000 222000 465000 4373000 28510000 1692000 -1985000 5465000 92000 P3Y 2331000 0 1500000 1713000 0 2860000 2566000 0 26494000 0 6880000 99516000 96917000 15663000 17863000 false --12-31 Q1 2019 2019-03-31 10-Q 0001142750 46619697 false Large Accelerated Filer AMN HEALTHCARE SERVICES INC false 149603000 153566000 31537000 23203000 365871000 365231000 18021000 13546000 3559000 3582000 30236000 37831000 42571000 39933000 114413000 119489000 151000 50000 P12Y P16Y P8Y 452730000 447632000 2864000 2864000 5186000 5186000 10560000 11716000 9000 66000 0 0 1492721000 1637825000 482166000 488887000 15192000 10938000 35503000 200711000 31676000 0 -700000 7000000 20000000 10000000 10000000 25000000 6000000 19000000 20000000 5700000 4400000 1500000 7918000 7668000 351000 8403000 651000 19110000 5710000 8000000 5400000 103000000 57000000 46000000 6880000 5300000 1500000 4764000 11848000 3390000 162006000 168030000 13856000 19116000 98894000 134027000 84324000 85979000 35133000 1655000 55028000 64500000 0.01 0.01 200000000 200000000 48809000 49122000 46643000 46578000 488000 491000 42662000 -19000 42681000 -101000 34122000 34021000 0.14 0.63 0.09 0.24 0.67 0.07 12365000 11459000 865000 769000 354665000 355682000 2089000 2089000 0.01 0.02 0 0.01 325000000 325000000 310375000 320531000 0.05125 55720000 65820000 -5113000 -9036000 27326000 20079000 15012000 0 7886000 11710000 0.89 0.73 0.87 0.71 -19000 -101000 135059000 135792000 15449000 15449000 0 -700000 0 1500000 -2000000 -70000 0 0 2070000 0 7700000 8500000 0 0 -7700000 -7700000 0 63243000 0 63243000 2461000 0 0 2461000 0 0 -8500000 -8500000 0 61786000 0 61786000 2473000 0 0 2473000 0 1041000 P12Y P20Y 114924000 121575000 34211000 36313000 -5000 -4000 -574000 0 438506000 19743000 103107000 315656000 464923000 19743000 103107000 342073000 16784000 81049000 26494000 26494000 0 0 26494000 214939000 53940000 154444000 6555000 214939000 53940000 154444000 6555000 -64000 -64000 -13000 -13000 167824000 176759000 49866000 39379000 7185000 5257000 2731000 4192000 799000 0 -7816000 2949000 -9154000 1500000 -52000 -1418000 -4007000 330000 -9881000 -799000 -2825000 1783000 89000 6202000 -1498000 9630000 2375000 5387000 12000 -36000 326147000 326466000 5335000 5673000 104000 102000 201000 1524000 15000 120000 -15302000 11175000 8615000 8771000 0.048 135142000 50318000 17795000 18057000 18183000 17698000 13091000 22855000 P10Y P1Y 853731000 987839000 1492721000 1637825000 0 3390000 307270000 333270000 4862000 4916000 50000000 50000000 400000000 120000000 150000000 320607000 320798000 24549000 24578000 12140000 2 -14970000 1790000 -9613000 -36248000 59735000 36214000 42681000 34122000 3 3 112623000 131707000 55201000 81614000 9958000 51805000 19851000 79811000 5701000 47922000 26188000 45052000 4536000 112287000 -114807000 12341000 99946000 4338000 97055000 99525000 P7Y 141286000 18218000 17990000 18144000 18349000 18149000 50436000 21402000 3756000 4418000 39887000 31209000 41124000 41090000 12759000 14687000 96152000 105590000 -19000 -101000 -19000 -101000 3954000 1849000 10243000 20112000 78528000 63746000 600000 543000 2325000 12444000 11000 1050000 0 17930000 2331000 0 10926000 10280000 30268000 196533000 30176000 200000000 0 29525000 0 90000 2086000 7362000 4724000 3583000 5703000 7388000 0.01 0.01 10000000 10000000 0 0 0 0 0 0 12409000 17724000 0 30000000 2900000 11700000 204832000 213114000 90419000 93625000 2257000 2608000 26329000 16522000 59331000 61279000 15192000 10938000 286059000 320181000 522489000 522489000 103117000 338179000 81193000 532441000 80490000 337029000 114922000 532441000 0 8633000 7961000 38324000 38058000 104737000 119997000 2864000 5186000 48411000 930000 48760000 930000 48809000 2166000 49122000 2544000 5922000 349000 313000 -10926000 -10930000 4000 -10284000 3000 -10281000 562527000 -112000 453351000 484000 142229000 -33425000 599216000 -131000 445285000 488000 186999000 -33425000 638990000 151000 452730000 488000 286059000 -100438000 649986000 50000 447632000 491000 320181000 -118368000 2166000 2544000 378000 100438000 118368000 17930000 17930000 717000 1383000 988000 49116000 47772000 47733000 46784000 7817000 8378000 19454000 18953000 574000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average remaining lease term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated balance sheets detail is as follows as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.96875%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,522</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,329</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">799</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,687</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,759</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,209</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,887</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,313</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,211</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Software</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168,030</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162,006</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,771</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,615</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">213,114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">204,832</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated depreciation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(119,489</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(114,413</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Fixed assets, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,625</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90,419</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life insurance cash surrender value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,028</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,090</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,124</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105,590</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,152</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued expenses:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade accounts payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,203</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,537</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subcontractor payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,575</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,892</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,831</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,236</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss contingencies</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,578</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,549</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Professional liability reserve</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,961</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,633</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,418</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,756</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Accounts payable and accrued expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153,566</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149,603</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued compensation and benefits:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued payroll</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,933</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,571</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued bonuses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,546</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued travel expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,684</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,417</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health insurance reserve</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,582</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,559</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Workers compensation reserve</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,378</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,817</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65,820</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,720</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,849</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,954</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Accrued compensation and benefits</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135,792</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135,059</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition related liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,668</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,918</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,444</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,325</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,112</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,243</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Workers compensation reserve</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,953</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,454</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Professional liability reserve</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,058</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,324</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred rent</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,916</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,862</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">769</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">865</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,050</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63,746</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,528</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BASIS OF PRESENTATION</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The condensed consolidated balance sheets and related condensed consolidated statements of comprehensive income and cash flows contained in this Quarterly Report on Form&#160;10-Q (this &#8220;Quarterly Report&#8221;), which are unaudited, include the accounts of AMN&#160;Healthcare Services, Inc. and its wholly-owned subsidiaries (collectively, the &#8220;Company&#8221;). All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted of all normal recurring items. The results of operations for the interim period are not necessarily indicative of the results to be expected for any other interim period or for the entire fiscal year or for any future period. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited condensed consolidated financial statements do not include all information and notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;). Please refer to the Company&#8217;s audited consolidated financial statements and the related notes for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, contained in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, filed with the Securities and Exchange Commission on February 21, 2019 (&#8220;</font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> Annual Report&#8221;). </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, earn-out liabilities, and income taxes. Actual results could differ from those estimates under different assumptions or conditions. </font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) 2016-02,&#160;&#8220;Leases.&#8221;&#160;This standard requires organizations that lease assets to recognize the assets and liabilities created by those leases. The standard also will require disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. A modified retrospective transition approach is required, applying the standard to all leases existing at the date of initial application. In addition, the FASB has also issued several amendments to the standard, which clarify certain aspects of the guidance, including an optional transition method for adoption of this standard, which allows organizations to initially apply the new requirements at the effective date, recognize a cumulative effect adjustment to the opening balance of retained earnings, and continue to apply the legacy guidance in Accounting Standards Codification (&#8220;ASC&#8221;) 840, Leases, including its disclosure requirements, in the comparative periods presented. The new standard provides a number of optional practical expedients in transition. The Company elected the &#8216;package of practical expedients&#8217;, which permits organizations not to reassess under the new standard prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect to use the hindsight practical expedient to determine the lease term or evaluate impairment for existing leases.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted ASU 2016-02 effective </font><font style="font-family:inherit;font-size:10pt;">January&#160;1, 2019</font><font style="font-family:inherit;font-size:10pt;">, using the optional transition method described above. The Company recognized the cumulative effect of adopting this guidance as an adjustment as of the effective date, primarily related to the recognition of lease liabilities of </font><font style="font-family:inherit;font-size:10pt;">$114,807</font><font style="font-family:inherit;font-size:10pt;"> and corresponding right-of-use assets of </font><font style="font-family:inherit;font-size:10pt;">$99,525</font><font style="font-family:inherit;font-size:10pt;"> for existing operating leases. The Company also derecognized existing deferred rent liabilities of </font><font style="font-family:inherit;font-size:10pt;">$15,302</font><font style="font-family:inherit;font-size:10pt;">. These adjustments had no effect on opening retained earnings and prior periods were not retrospectively adjusted and continue to be reported in accordance with ASC 840. The new standard also provides practical expedients for an organization&#8217;s ongoing accounting. The Company elected the short-term lease recognition exemption and the practical expedient to not separate lease and non-lease components for all leases that qualify. The Company does not expect the adoption of this standard to impact its results of operations.</font></div><div style="line-height:120%;text-indent:30px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There was no other material impact to the Company&#8217;s condensed consolidated financial statements as a result of adopting this updated standard.</font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash, cash equivalents and restricted cash</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions and highly liquid investments. Restricted cash and cash equivalents primarily represent cash and money market funds on deposit with financial institutions and investments represents commercial paper that serves as collateral for the Company&#8217;s outstanding letters of credit and captive insurance subsidiary claim payments. See Note (6), &#8220;New Credit Agreement&#8221; and Note (7), &#8220;Fair Value Measurement&#8221; for additional information.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying condensed consolidated balance sheets and related notes to the amounts presented in the accompanying condensed consolidated statements of cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.4375%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,116</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,856</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash and cash equivalents (included in other current assets)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,522</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,329</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash, cash equivalents and investments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,279</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,331</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cash, cash equivalents and restricted cash and investments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,917</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99,516</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less restricted investments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,938</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,192</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cash, cash equivalents and restricted cash</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85,979</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84,324</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ACQUISITIONS </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As set forth below, the Company completed </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> acquisitions from </font><font style="font-family:inherit;font-size:10pt;">January&#160;1, 2018</font><font style="font-family:inherit;font-size:10pt;"> through </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">. The Company accounted for each acquisition using the acquisition method of accounting. Accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. Since the applicable date of acquisition, the Company has revised the allocation of the purchase price to the tangible and intangible assets acquired and liabilities assumed based on analysis of information that has been made available through </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">. The allocation will continue to be updated through the measurement period, if necessary. For each acquisition, the Company did not incur any material acquisition-related costs.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Silversheet Acquisition</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 30, 2019, the Company completed its acquisition of Silversheet, Inc. (&#8220;Silversheet&#8221;) which provides innovative software and services to reduce the complexities and challenges of the credentialing process for clinicians and healthcare organizations. The initial purchase price of </font><font style="font-family:inherit;font-size:10pt;">$31,676</font><font style="font-family:inherit;font-size:10pt;"> included (1) </font><font style="font-family:inherit;font-size:10pt;">$30,176</font><font style="font-family:inherit;font-size:10pt;"> cash consideration paid upon acquisition, funded primarily through borrowings under the Company&#8217;s </font><font style="font-family:inherit;font-size:10pt;">$400,000</font><font style="font-family:inherit;font-size:10pt;"> secured revolving credit facility (the &#8220;Senior Credit Facility&#8221;), provided for under a credit agreement (the &#8220;New Credit Agreement&#8221;), dated as of February 9, 2018, by and among the Company and several lenders, and (2) a contingent earn-out payment of up to </font><font style="font-family:inherit;font-size:10pt;">$25,000</font><font style="font-family:inherit;font-size:10pt;"> with an estimated fair value of </font><font style="font-family:inherit;font-size:10pt;">$1,500</font><font style="font-family:inherit;font-size:10pt;"> as of the acquisition date. The contingent earn-out payment is based on (A) up to </font><font style="font-family:inherit;font-size:10pt;">$6,000</font><font style="font-family:inherit;font-size:10pt;"> based on the operating results of Silversheet for the twelve months ending December 31, 2019, and (B) up to </font><font style="font-family:inherit;font-size:10pt;">$19,000</font><font style="font-family:inherit;font-size:10pt;"> based on the operating results of Silversheet for the twelve months ending December 31, 2020. The results of Silversheet have been included in the Company&#8217;s other workforce solutions segment since the date of acquisition. The New Credit Agreement is more fully described in Note (6), &#8220;New Credit Agreement.&#8221;</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preliminary allocation of the </font><font style="font-family:inherit;font-size:10pt;">$31,676</font><font style="font-family:inherit;font-size:10pt;"> purchase price consisted of (1) </font><font style="font-family:inherit;font-size:10pt;">$1,692</font><font style="font-family:inherit;font-size:10pt;"> of fair value of tangible assets acquired, which included </font><font style="font-family:inherit;font-size:10pt;">$651</font><font style="font-family:inherit;font-size:10pt;"> cash received, (2) </font><font style="font-family:inherit;font-size:10pt;">$3,390</font><font style="font-family:inherit;font-size:10pt;"> of liabilities assumed, (3) </font><font style="font-family:inherit;font-size:10pt;">$6,880</font><font style="font-family:inherit;font-size:10pt;"> of identified intangible assets, and (4) </font><font style="font-family:inherit;font-size:10pt;">$26,494</font><font style="font-family:inherit;font-size:10pt;"> of goodwill, none of which is deductible for tax purposes. The fair value of intangible assets primarily includes </font><font style="font-family:inherit;font-size:10pt;">$5,300</font><font style="font-family:inherit;font-size:10pt;"> of developed technology and </font><font style="font-family:inherit;font-size:10pt;">$1,500</font><font style="font-family:inherit;font-size:10pt;"> of trademarks with a weighted average useful life of approximately </font><font style="font-family:inherit;font-size:10pt;">eight</font><font style="font-family:inherit;font-size:10pt;"> years.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">MedPartners Acquisition</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 9, 2018, the Company completed its acquisition of MedPartners HIM (&#8220;MedPartners&#8221;), which provides case management, clinical documentation improvement, medical coding and registry services to hospitals and physician medical groups nationwide. The initial purchase price of </font><font style="font-family:inherit;font-size:10pt;">$200,711</font><font style="font-family:inherit;font-size:10pt;"> included (1) </font><font style="font-family:inherit;font-size:10pt;">$196,533</font><font style="font-family:inherit;font-size:10pt;"> cash consideration paid upon acquisition, funded primarily through borrowings under the Senior Credit Facility, and (2) a contingent earn-out payment of up to </font><font style="font-family:inherit;font-size:10pt;">$20,000</font><font style="font-family:inherit;font-size:10pt;"> with an estimated fair value of </font><font style="font-family:inherit;font-size:10pt;">$4,400</font><font style="font-family:inherit;font-size:10pt;"> as of the acquisition date. The contingent earn-out payment is based on (A) up to </font><font style="font-family:inherit;font-size:10pt;">$10,000</font><font style="font-family:inherit;font-size:10pt;"> based on the operating results of MedPartners for the twelve months ending December 31, 2018, which resulted in no earn-out payment, and (B) up to </font><font style="font-family:inherit;font-size:10pt;">$10,000</font><font style="font-family:inherit;font-size:10pt;"> based on the operating results of MedPartners for the six months ending June 30, 2019. The results of MedPartners have been included in the Company&#8217;s other workforce solutions segment since the date of acquisition. During the third quarter of 2018, </font><font style="font-family:inherit;font-size:10pt;">$222</font><font style="font-family:inherit;font-size:10pt;"> was returned to the Company for the final working capital settlement.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preliminary allocation of the </font><font style="font-family:inherit;font-size:10pt;">$200,711</font><font style="font-family:inherit;font-size:10pt;"> purchase price consisted of (1) </font><font style="font-family:inherit;font-size:10pt;">$28,510</font><font style="font-family:inherit;font-size:10pt;"> of fair value of tangible assets acquired, which included </font><font style="font-family:inherit;font-size:10pt;">$8,403</font><font style="font-family:inherit;font-size:10pt;"> cash received, (2) </font><font style="font-family:inherit;font-size:10pt;">$11,848</font><font style="font-family:inherit;font-size:10pt;"> of liabilities assumed, (3) </font><font style="font-family:inherit;font-size:10pt;">$103,000</font><font style="font-family:inherit;font-size:10pt;"> of identified intangible assets, and (4) </font><font style="font-family:inherit;font-size:10pt;">$81,049</font><font style="font-family:inherit;font-size:10pt;"> of goodwill, all of which is deductible for tax purposes. The intangible assets acquired have a weighted average useful life of approximately </font><font style="font-family:inherit;font-size:10pt;">sixteen</font><font style="font-family:inherit;font-size:10pt;"> years. The following table summarizes the fair value and useful life of each intangible asset acquired:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:68.1640625%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Useful Life</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in years)</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tradenames and Trademarks</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer Relationships</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Phillips DiPisa and Leaders For Today Acquisition</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 6, 2018, the Company completed its acquisition of two related entities, Phillips DiPisa and Leaders For Today (&#8220;PDA and LFT&#8221;), which offer a range of leadership staffing and permanent placement solutions for the healthcare industry. The initial purchase price of </font><font style="font-family:inherit;font-size:10pt;">$35,503</font><font style="font-family:inherit;font-size:10pt;"> included (1) </font><font style="font-family:inherit;font-size:10pt;">$30,268</font><font style="font-family:inherit;font-size:10pt;"> cash consideration paid upon acquisition, funded through cash on hand, and (2) a contingent earn-out payment of up to </font><font style="font-family:inherit;font-size:10pt;">$7,000</font><font style="font-family:inherit;font-size:10pt;"> with an estimated fair value of </font><font style="font-family:inherit;font-size:10pt;">$5,700</font><font style="font-family:inherit;font-size:10pt;"> as of the acquisition date. The contingent earn-out payment is based on the operating results of PDA and LFT for the twelve months ending December 31, 2018, which resulted in the full earn-out payment made in April 2019. The results of PDA and LFT have been included in the Company&#8217;s other workforce solutions segment since the date of acquisition. During the third quarter of 2018, </font><font style="font-family:inherit;font-size:10pt;">$465</font><font style="font-family:inherit;font-size:10pt;"> was returned to the Company for the final working capital settlement.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preliminary allocation of the </font><font style="font-family:inherit;font-size:10pt;">$35,503</font><font style="font-family:inherit;font-size:10pt;"> purchase price consisted of (1) </font><font style="font-family:inherit;font-size:10pt;">$4,373</font><font style="font-family:inherit;font-size:10pt;"> of fair value of tangible assets acquired, which included </font><font style="font-family:inherit;font-size:10pt;">$351</font><font style="font-family:inherit;font-size:10pt;"> cash received, (2) </font><font style="font-family:inherit;font-size:10pt;">$4,764</font><font style="font-family:inherit;font-size:10pt;"> of liabilities assumed, (3) </font><font style="font-family:inherit;font-size:10pt;">$19,110</font><font style="font-family:inherit;font-size:10pt;"> of identified intangible assets, and (4) </font><font style="font-family:inherit;font-size:10pt;">$16,784</font><font style="font-family:inherit;font-size:10pt;"> of goodwill, all of which is deductible for tax purposes. The fair value of intangible assets includes </font><font style="font-family:inherit;font-size:10pt;">$5,400</font><font style="font-family:inherit;font-size:10pt;"> of trademarks, </font><font style="font-family:inherit;font-size:10pt;">$8,000</font><font style="font-family:inherit;font-size:10pt;"> of customer relationships and </font><font style="font-family:inherit;font-size:10pt;">$5,710</font><font style="font-family:inherit;font-size:10pt;"> of staffing databases with a weighted average useful life of approximately </font><font style="font-family:inherit;font-size:10pt;">twelve</font><font style="font-family:inherit;font-size:10pt;"> years.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">COMMITMENTS AND CONTINGENCIES: LEGAL PROCEEDINGS</font></div><div style="line-height:120%;text-indent:32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, the Company is involved in various lawsuits, claims, investigations, and proceedings that arise in the ordinary course of business. These matters typically relate to professional liability, tax, compensation, contract, competitor disputes and employee-related matters and include individual and class action lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company&#8217;s employment and compensation practices. Additionally, some of the Company&#8217;s clients may also become subject to claims, governmental inquiries and investigations, and legal actions relating to services provided by the Company&#8217;s healthcare professionals. Depending upon the particular facts and circumstances, the Company may also be subject to indemnification obligations under its contracts with such clients relating to these matters. The Company records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. The most significant matters for which the Company has established loss contingencies are class actions related to wage and hour claims under California and Federal law. Specifically, among other claims in these lawsuits, it is alleged that employees were not afforded required breaks or compensated for all time worked, employees&#8217; wage statements are not sufficiently clear, and certain expense reimbursements should be included in the regular rate of pay for purposes of calculating overtime rates. The Company believes that its wage and hour practices conform with law in all material respects, but litigation is always subject to inherent uncertainty. As a result, the Company entered into settlement agreements relating to claims in </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> wage and hour class actions during September and October 2018. The settlement agreements are subject to court approval, which is considered probable. The Company recorded increases to its accruals established in connection with these matters amounting to </font><font style="font-family:inherit;font-size:10pt;">$12,140</font><font style="font-family:inherit;font-size:10pt;"> during the third quarter of 2018.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With regard to outstanding loss contingencies as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, which are included in accounts payable and accrued expenses in the condensed consolidated balance sheet, the Company believes that such matters will not, either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations, or cash flows.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NEW CREDIT AGREEMENT</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 9, 2018, the Company entered into the New Credit Agreement with several lenders to provide for the </font><font style="font-family:inherit;font-size:10pt;">$400,000</font><font style="font-family:inherit;font-size:10pt;"> Senior Credit Facility to replace its then-existing credit facilities. The Senior Credit Facility includes a </font><font style="font-family:inherit;font-size:10pt;">$50,000</font><font style="font-family:inherit;font-size:10pt;"> sublimit for the issuance of letters of credit and a </font><font style="font-family:inherit;font-size:10pt;">$50,000</font><font style="font-family:inherit;font-size:10pt;"> sublimit for swingline loans. The obligations of the Company under the New Credit Agreement and the Senior Credit Facility are secured by substantially all of the assets of the Company. Borrowings under the Senior Credit Facility bear interest at floating rates, at the Company&#8217;s option, based upon either LIBOR plus a spread of </font><font style="font-family:inherit;font-size:10pt;">1.00%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">2.00%</font><font style="font-family:inherit;font-size:10pt;"> or a base rate plus a spread of </font><font style="font-family:inherit;font-size:10pt;">0.00%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">1.00%</font><font style="font-family:inherit;font-size:10pt;">. The applicable spread is determined quarterly based upon the Company&#8217;s consolidated net leverage ratio. The Senior Credit Facility is available for working capital, capital expenditures, permitted acquisitions and general corporate purposes. The maturity date of the Senior Credit Facility is February 9, 2023.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with obtaining the New Credit Agreement, the Company incurred </font><font style="font-family:inherit;font-size:10pt;">$2,331</font><font style="font-family:inherit;font-size:10pt;"> in fees paid to lenders and other third parties, which were capitalized and are amortized to interest expense over the term of the New Credit Facility. In addition, the Company wrote off </font><font style="font-family:inherit;font-size:10pt;">$574</font><font style="font-family:inherit;font-size:10pt;"> of unamortized financing fees during 2018 relating to the prior credit facilities.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NET INCOME PER COMMON SHARE</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. The following table sets forth the computation of basic and diluted net income per common share for the three and </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, respectively:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,122</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,681</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income per common share - basic </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.73</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.89</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income per common share - diluted </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.71</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.87</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding - basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46,784</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,733</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plus dilutive effect of potential common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">988</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,383</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding - diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,772</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,116</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based awards to purchase </font><font style="font-family:inherit;font-size:10pt;">66</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">9</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock were not included in the above calculation of diluted net income per common share for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and 2018, respectively, because the effect of these instruments was anti-dilutive.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The balance of the equity investment classified as Level 2 in the fair value hierarchy was </font><font style="font-family:inherit;font-size:10pt;">$15,449</font><font style="font-family:inherit;font-size:10pt;"> as of both </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. There were no changes to the fair value of the equity investment recognized during the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FAIR VALUE MEASUREMENT</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s valuation techniques and inputs used to measure fair value and the definition of the three levels (Level 1, Level 2, and Level 3) of the fair value hierarchy are disclosed in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note 3&#8212;Fair Value Measurement&#8221; of the </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> Annual Report. The Company has not changed the valuation techniques or inputs it uses for its fair value measurement during the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Assets and Liabilities Measured on a Recurring Basis</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s restricted cash equivalents that serve as collateral for the Company&#8217;s outstanding letters of credit</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">typically consist of money market funds that are measured at fair value based on quoted prices, which are Level 1 inputs.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s restricted cash equivalents and investments that serve as collateral for the Company&#8217;s captive insurance company primarily consist of commercial paper that is measured at observable market prices for identical securities that are traded in less active markets, which are Level 2 inputs. Of the </font><font style="font-family:inherit;font-size:10pt;">$61,786</font><font style="font-family:inherit;font-size:10pt;"> commercial paper issued and outstanding as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$10,938</font><font style="font-family:inherit;font-size:10pt;"> had original maturities greater than three months, which were considered available-for-sale securities. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">$63,243</font><font style="font-family:inherit;font-size:10pt;"> commercial paper issued and outstanding, of which </font><font style="font-family:inherit;font-size:10pt;">$15,192</font><font style="font-family:inherit;font-size:10pt;"> had original maturities greater than three months and were considered available-for-sale securities.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s contingent consideration liabilities are measured at fair value using a probability-weighted discounted cash flow analysis or a simulation-based methodology for the acquired companies, which are Level 3 inputs. The Company recognizes changes to the fair value of its contingent consideration liabilities in selling, general and administrative expenses in the condensed consolidated statements of comprehensive income.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables present information about the above-referenced assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value: </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements as of March&#160;31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted&#160;Prices&#160;in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active&#160;Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">for Identical</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other Observable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Unobservable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Money market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,473</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,473</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,786</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,786</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition contingent consideration liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements as of December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted&#160;Prices&#160;in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active&#160;Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">for Identical</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other Observable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Unobservable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Money market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,461</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,461</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63,243</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63,243</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition contingent consideration liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Level 3 Information</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables set forth a reconciliation of changes in the fair value of contingent consideration liabilities classified as Level 3 in the fair value hierarchy:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.5078125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of January 1,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,070</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlement of HSG contingent consideration liability for year ended December 31, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlement of HSG contingent consideration liability for year ended December 31, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of contingent consideration liability from Medpartners acquisition </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">700</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration liability from Silversheet acquisition on January 30, 2019</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,500</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of March 31,</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Assets Measured on a Non-Recurring Basis</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets, and equity investments. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs, including the market capitalization of the Company, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determines the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s equity investment represents an investment in a non-controlled corporation without a readily determinable market value. The Company has elected to measure the investment at cost minus impairment, if any, plus or minus changes resulting from observable price changes. The fair value is determined by using quoted prices for identical or similar investments of the same issuer, which are Level 2 inputs. The Company recognizes changes to the fair value of its equity investment in interest expense, net, and other in the condensed consolidated statements of comprehensive income.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The balance of the equity investment classified as Level 2 in the fair value hierarchy was </font><font style="font-family:inherit;font-size:10pt;">$15,449</font><font style="font-family:inherit;font-size:10pt;"> as of both </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. There were no changes to the fair value of the equity investment recognized during the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There were no triggering events identified, no indication of impairment of the Company&#8217;s goodwill, indefinite-lived intangible assets, long-lived assets, or equity investments, and </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> impairment charges recorded during the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s senior notes have a carrying amount of </font><font style="font-family:inherit;font-size:10pt;">$325,000</font><font style="font-family:inherit;font-size:10pt;"> and an estimated fair value of </font><font style="font-family:inherit;font-size:10pt;">$320,531</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the senior notes had a carrying amount of </font><font style="font-family:inherit;font-size:10pt;">$325,000</font><font style="font-family:inherit;font-size:10pt;"> and an estimated fair value of </font><font style="font-family:inherit;font-size:10pt;">$310,375</font><font style="font-family:inherit;font-size:10pt;">. Quoted market prices in active markets for identical liabilities based inputs (Level 1) were used to estimate fair value. The senior notes were issued in October 2016 and have a fixed rate of </font><font style="font-family:inherit;font-size:10pt;">5.125%</font><font style="font-family:inherit;font-size:10pt;">. See additional information in &#8220;Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (7), Notes Payable and Credit Agreement&#8221; of our </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> Annual Report. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the Company&#8217;s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables set forth a reconciliation of changes in the fair value of contingent consideration liabilities classified as Level 3 in the fair value hierarchy:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.5078125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of January 1,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,070</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlement of HSG contingent consideration liability for year ended December 31, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlement of HSG contingent consideration liability for year ended December 31, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of contingent consideration liability from Medpartners acquisition </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">700</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration liability from Silversheet acquisition on January 30, 2019</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,500</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of March 31,</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s senior notes have a carrying amount of </font><font style="font-family:inherit;font-size:10pt;">$325,000</font><font style="font-family:inherit;font-size:10pt;"> and an estimated fair value of </font><font style="font-family:inherit;font-size:10pt;">$320,531</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the senior notes had a carrying amount of </font><font style="font-family:inherit;font-size:10pt;">$325,000</font><font style="font-family:inherit;font-size:10pt;"> and an estimated fair value of </font><font style="font-family:inherit;font-size:10pt;">$310,375</font><font style="font-family:inherit;font-size:10pt;">. Quoted market prices in active markets for identical liabilities based inputs (Level 1) were used to estimate fair value. The senior notes were issued in October 2016 and have a fixed rate of </font><font style="font-family:inherit;font-size:10pt;">5.125%</font><font style="font-family:inherit;font-size:10pt;">. See additional information in &#8220;Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (7), Notes Payable and Credit Agreement&#8221; of our </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> Annual Report. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the Company&#8217;s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Assets Measured on a Non-Recurring Basis</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets, and equity investments. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs, including the market capitalization of the Company, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determines the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Assets and Liabilities Measured on a Recurring Basis</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s restricted cash equivalents that serve as collateral for the Company&#8217;s outstanding letters of credit</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">typically consist of money market funds that are measured at fair value based on quoted prices, which are Level 1 inputs.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s restricted cash equivalents and investments that serve as collateral for the Company&#8217;s captive insurance company primarily consist of commercial paper that is measured at observable market prices for identical securities that are traded in less active markets, which are Level 2 inputs. Of the </font><font style="font-family:inherit;font-size:10pt;">$61,786</font><font style="font-family:inherit;font-size:10pt;"> commercial paper issued and outstanding as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$10,938</font><font style="font-family:inherit;font-size:10pt;"> had original maturities greater than three months, which were considered available-for-sale securities. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">$63,243</font><font style="font-family:inherit;font-size:10pt;"> commercial paper issued and outstanding, of which </font><font style="font-family:inherit;font-size:10pt;">$15,192</font><font style="font-family:inherit;font-size:10pt;"> had original maturities greater than three months and were considered available-for-sale securities.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INCOME TAXES</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is subject to taxation in the U.S. and various states and foreign jurisdictions. With few exceptions, as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, the Company is no longer subject to state, local or foreign examinations by tax authorities for tax years before 2009 and the Company is no longer subject to U.S. federal income or payroll tax examinations for tax years before 2015. The IRS conducted, completed, and settled audits of the Company&#8217;s 2011-2012 and 2013 tax years related to income and employment tax issues for the Company&#8217;s treatment of certain non-taxable per diem allowances and travel benefits in November 2017 and May 2018, respectively.</font></div><div style="line-height:120%;text-indent:32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company believes its reserve for unrecognized tax benefits and contingent tax issues is adequate with respect to all open years. Notwithstanding the foregoing, the Company could adjust its provision for income taxes and contingent tax liability based on future developments.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supplemental cash flow information related to leases was as follows:&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of operating lease liabilities (operating cash flows)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,338</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating lease right-of-use assets obtained in exchange for lease obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of lease expense were as follows:</font></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Lease Cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating lease cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,536</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term lease cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,922</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Variable and other lease cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">717</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net lease cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,175</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The maturity of lease liabilities as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> were as follows:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Years ending December&#160;31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019 (excluding the three months ended March 31, 2019)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,091</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,698</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,183</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,057</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,795</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,318</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135,142</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22,855</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Present value of lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112,287</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LEASES</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company leases certain office facilities, data centers, and equipment under various operating leases. Leases with an initial term of 12 months or less (primarily related to housing arrangements for healthcare professionals on assignment) are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term. Most leases include one or more options to renew, with renewal terms that can extend the lease term up to </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> years. Certain leases also include options to terminate the leases within </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;"> years. </font></div><div style="line-height:120%;text-indent:32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of lease expense were as follows:</font></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Lease Cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating lease cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,536</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term lease cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,922</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Variable and other lease cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">717</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net lease cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,175</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The maturity of lease liabilities as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> were as follows:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Years ending December&#160;31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019 (excluding the three months ended March 31, 2019)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,091</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,698</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,183</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,057</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,795</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,318</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135,142</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22,855</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Present value of lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112,287</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supplemental cash flow information related to leases was as follows:&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of operating lease liabilities (operating cash flows)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,338</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating lease right-of-use assets obtained in exchange for lease obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average remaining lease term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Future minimum lease payments under noncancelable operating leases (with initial or remaining lease terms in excess of one year) as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Years ending December&#160;31,</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,218</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,149</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,349</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,144</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,990</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,436</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total minimum lease payments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">141,286</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rent expense under operating leases (with initial lease terms in excess of </font><font style="font-family:inherit;font-size:10pt;">one year</font><font style="font-family:inherit;font-size:10pt;">) was </font><font style="font-family:inherit;font-size:10pt;">$21,402</font><font style="font-family:inherit;font-size:10pt;"> for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) 2016-02,&#160;&#8220;Leases.&#8221;&#160;This standard requires organizations that lease assets to recognize the assets and liabilities created by those leases. The standard also will require disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. A modified retrospective transition approach is required, applying the standard to all leases existing at the date of initial application. In addition, the FASB has also issued several amendments to the standard, which clarify certain aspects of the guidance, including an optional transition method for adoption of this standard, which allows organizations to initially apply the new requirements at the effective date, recognize a cumulative effect adjustment to the opening balance of retained earnings, and continue to apply the legacy guidance in Accounting Standards Codification (&#8220;ASC&#8221;) 840, Leases, including its disclosure requirements, in the comparative periods presented. The new standard provides a number of optional practical expedients in transition. The Company elected the &#8216;package of practical expedients&#8217;, which permits organizations not to reassess under the new standard prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect to use the hindsight practical expedient to determine the lease term or evaluate impairment for existing leases.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted ASU 2016-02 effective </font><font style="font-family:inherit;font-size:10pt;">January&#160;1, 2019</font><font style="font-family:inherit;font-size:10pt;">, using the optional transition method described above. The Company recognized the cumulative effect of adopting this guidance as an adjustment as of the effective date, primarily related to the recognition of lease liabilities of </font><font style="font-family:inherit;font-size:10pt;">$114,807</font><font style="font-family:inherit;font-size:10pt;"> and corresponding right-of-use assets of </font><font style="font-family:inherit;font-size:10pt;">$99,525</font><font style="font-family:inherit;font-size:10pt;"> for existing operating leases. The Company also derecognized existing deferred rent liabilities of </font><font style="font-family:inherit;font-size:10pt;">$15,302</font><font style="font-family:inherit;font-size:10pt;">. These adjustments had no effect on opening retained earnings and prior periods were not retrospectively adjusted and continue to be reported in accordance with ASC 840. The new standard also provides practical expedients for an organization&#8217;s ongoing accounting. The Company elected the short-term lease recognition exemption and the practical expedient to not separate lease and non-lease components for all leases that qualify. The Company does not expect the adoption of this standard to impact its results of operations.</font></div><div style="line-height:120%;text-indent:30px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There was no other material impact to the Company&#8217;s condensed consolidated financial statements as a result of adopting this updated standard.</font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash, cash equivalents and restricted cash</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions and highly liquid investments. Restricted cash and cash equivalents primarily represent cash and money market funds on deposit with financial institutions and investments represents commercial paper that serves as collateral for the Company&#8217;s outstanding letters of credit and captive insurance subsidiary claim payments. See Note (6), &#8220;New Credit Agreement&#8221; and Note (7), &#8220;Fair Value Measurement&#8221; for additional information.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying condensed consolidated balance sheets and related notes to the amounts presented in the accompanying condensed consolidated statements of cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.4375%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,116</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,856</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash and cash equivalents (included in other current assets)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,522</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,329</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash, cash equivalents and investments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,279</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,331</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cash, cash equivalents and restricted cash and investments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,917</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99,516</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less restricted investments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,938</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,192</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cash, cash equivalents and restricted cash</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85,979</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84,324</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue primarily consists of fees earned from the temporary and permanent placement of healthcare professionals and executives as well as from the Company&#8217;s SaaS-based technology, including its vendor management systems and its scheduling software. Revenue is recognized when control of these services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. Revenue from temporary staffing services is recognized as the services are rendered by clinical and non-clinical healthcare professionals. Under the Company&#8217;s managed services program arrangements, the Company manages all or a part of a customer&#8217;s supplemental workforce needs utilizing its own network of healthcare professionals along with those of third-party subcontractors. Revenue and the related direct costs under MSP arrangements are recorded in accordance with the accounting guidance on reporting revenue gross as a principal versus net as an agent. When the Company uses subcontractors and acts as an agent, revenue is recorded net of the related subcontractor&#8217;s expense. Revenue from executive search, physician permanent placement, and recruitment process outsourcing services is recognized as the services are rendered. The Company&#8217;s SaaS-based revenue is recognized ratably over the applicable arrangement&#8217;s service period.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s customers are primarily billed as services are rendered. Any fees billed in advance of being earned are recorded as deferred revenue. During the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, the amount recognized as revenue that was previously deferred was not material.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has elected to apply the following practical expedients and optional exemptions related to contract costs and revenue recognition:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognize incremental costs of obtaining a contract with amortization periods of one year or less as expense when incurred. These costs are recorded within selling, general and administrative expenses.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognize revenue in the amount of consideration to which the Company has a right to invoice the customer if that amount corresponds directly with the value to the customer of the Company&#8217;s services completed to date.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exemptions from disclosing the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, (ii) contracts for which revenue is recognized in the amount of consideration to which the Company has a right to invoice for services performed and (iii) contracts for which variable consideration is allocated entirely to a wholly unsatisfied performance obligation or to a wholly unsatisfied promise to transfer a distinct service that forms part of a single performance obligation.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">REVENUE RECOGNITION</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue primarily consists of fees earned from the temporary and permanent placement of healthcare professionals and executives as well as from the Company&#8217;s SaaS-based technology, including its vendor management systems and its scheduling software. Revenue is recognized when control of these services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. Revenue from temporary staffing services is recognized as the services are rendered by clinical and non-clinical healthcare professionals. Under the Company&#8217;s managed services program arrangements, the Company manages all or a part of a customer&#8217;s supplemental workforce needs utilizing its own network of healthcare professionals along with those of third-party subcontractors. Revenue and the related direct costs under MSP arrangements are recorded in accordance with the accounting guidance on reporting revenue gross as a principal versus net as an agent. When the Company uses subcontractors and acts as an agent, revenue is recorded net of the related subcontractor&#8217;s expense. Revenue from executive search, physician permanent placement, and recruitment process outsourcing services is recognized as the services are rendered. The Company&#8217;s SaaS-based revenue is recognized ratably over the applicable arrangement&#8217;s service period.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s customers are primarily billed as services are rendered. Any fees billed in advance of being earned are recorded as deferred revenue. During the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, the amount recognized as revenue that was previously deferred was not material.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has elected to apply the following practical expedients and optional exemptions related to contract costs and revenue recognition:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognize incremental costs of obtaining a contract with amortization periods of one year or less as expense when incurred. These costs are recorded within selling, general and administrative expenses.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognize revenue in the amount of consideration to which the Company has a right to invoice the customer if that amount corresponds directly with the value to the customer of the Company&#8217;s services completed to date.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exemptions from disclosing the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, (ii) contracts for which revenue is recognized in the amount of consideration to which the Company has a right to invoice for services performed and (iii) contracts for which variable consideration is allocated entirely to a wholly unsatisfied performance obligation or to a wholly unsatisfied promise to transfer a distinct service that forms part of a single performance obligation.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note (5), &#8220;Segment Information&#8221; for additional information.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying condensed consolidated balance sheets and related notes to the amounts presented in the accompanying condensed consolidated statements of cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.4375%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,116</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,856</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash and cash equivalents (included in other current assets)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,522</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,329</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash, cash equivalents and investments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,279</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,331</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cash, cash equivalents and restricted cash and investments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,917</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99,516</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less restricted investments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,938</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,192</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cash, cash equivalents and restricted cash</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85,979</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84,324</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the computation of basic and diluted net income per common share for the three and </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, respectively:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,122</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,681</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income per common share - basic </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.73</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.89</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income per common share - diluted </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.71</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.87</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding - basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46,784</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,733</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plus dilutive effect of potential common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">988</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,383</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding - diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,772</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,116</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables present information about the above-referenced assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value: </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements as of March&#160;31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted&#160;Prices&#160;in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active&#160;Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">for Identical</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other Observable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Unobservable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Money market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,473</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,473</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,786</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,786</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition contingent consideration liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements as of December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted&#160;Prices&#160;in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active&#160;Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">for Identical</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other Observable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Unobservable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Money market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,461</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,461</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63,243</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63,243</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition contingent consideration liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the fair value and useful life of each intangible asset acquired:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:68.1640625%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Useful Life</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in years)</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tradenames and Trademarks</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer Relationships</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Future minimum lease payments under noncancelable operating leases (with initial or remaining lease terms in excess of one year) as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Years ending December&#160;31,</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,218</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,149</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,349</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,144</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,990</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,436</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total minimum lease payments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">141,286</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the activity related to the carrying value of goodwill by reportable segment:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nurse&#160;and&#160;Allied Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Locum&#160;Tenens Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Workforce Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, January&#160;1, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103,107</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,743</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">315,656</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">438,506</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill adjustment for MedPartners acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(64</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(64</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill adjustment for PDA and LFT acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill from Silversheet acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,494</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,494</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103,107</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,743</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342,073</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">464,923</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated impairment loss as of December 31, 2018 and March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">154,444</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53,940</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,555</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">214,939</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying condensed consolidated balance sheets and related notes to the amounts presented in the accompanying condensed consolidated statements of cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.4375%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,116</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,856</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash and cash equivalents (included in other current assets)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,522</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,329</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash, cash equivalents and investments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,279</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,331</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cash, cash equivalents and restricted cash and investments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,917</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99,516</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less restricted investments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,938</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,192</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cash, cash equivalents and restricted cash</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85,979</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84,324</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#8217;s internal financial information as used for corporate management purposes:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and allied solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">337,029</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">338,179</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Locum tenens solutions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,490</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103,117</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other workforce solutions</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114,922</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,193</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">532,441</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">522,489</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment operating income</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and allied solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,922</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,805</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Locum tenens solutions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,701</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,958</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other workforce solutions</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,188</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,851</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,811</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,614</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unallocated corporate overhead</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,863</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,663</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,710</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,886</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,186</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,864</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net, and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,673</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,335</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,379</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,866</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SEGMENT INFORMATION</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> reportable segments: nurse and allied solutions, locum tenens solutions, and other workforce solutions. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Company&#8217;s chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation, interest expense, net, and other, and unallocated corporate overhead. The Company&#8217;s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#8217;s internal financial information as used for corporate management purposes:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and allied solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">337,029</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">338,179</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Locum tenens solutions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,490</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103,117</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other workforce solutions</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114,922</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,193</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">532,441</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">522,489</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment operating income</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and allied solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,922</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,805</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Locum tenens solutions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,701</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,958</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other workforce solutions</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,188</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,851</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,811</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,614</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unallocated corporate overhead</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,863</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,663</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,710</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,886</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,186</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,864</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net, and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,673</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,335</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,379</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,866</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company offers a comprehensive managed services program, in which the Company manages all or a portion of a client&#8217;s contingent staffing needs. This service includes both the placement of the Company&#8217;s own healthcare professionals and the utilization of other staffing agencies to fulfill the client&#8217;s staffing needs. See additional information in Note (3), &#8220;Revenue Recognition.&#8221; For the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, revenue under the Company&#8217;s managed services program arrangements comprised approximately </font><font style="font-family:inherit;font-size:10pt;">67%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">63%</font><font style="font-family:inherit;font-size:10pt;"> for nurse and allied solutions revenue, </font><font style="font-family:inherit;font-size:10pt;">24%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">14%</font><font style="font-family:inherit;font-size:10pt;"> for locum tenens solutions revenue and </font><font style="font-family:inherit;font-size:10pt;">7%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">9%</font><font style="font-family:inherit;font-size:10pt;"> for other workforce solutions revenue, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the activity related to the carrying value of goodwill by reportable segment:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nurse&#160;and&#160;Allied Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Locum&#160;Tenens Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Workforce Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, January&#160;1, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103,107</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,743</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">315,656</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">438,506</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill adjustment for MedPartners acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(64</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(64</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill adjustment for PDA and LFT acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill from Silversheet acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,494</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,494</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103,107</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,743</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342,073</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">464,923</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated impairment loss as of December 31, 2018 and March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">154,444</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53,940</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,555</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">214,939</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation, interest expense, net, and other, and unallocated corporate overhead. The Company&#8217;s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUBSEQUENT EVENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 29, 2019, the Company entered into an agreement to acquire Advanced Medical Personnel Services, Inc. (&#8220;Advanced&#8221;) for </font><font style="font-family:inherit;font-size:10pt;">$200,000</font><font style="font-family:inherit;font-size:10pt;"> in cash and tiered contingent consideration of up to </font><font style="font-family:inherit;font-size:10pt;">$20,000</font><font style="font-family:inherit;font-size:10pt;">. Advanced is a national healthcare staffing company that specializes in placing therapists and nurses across multiple settings, including hospitals, schools, clinics, skilled nursing facilities, and home health. The closing of the acquisition is contingent upon satisfaction of certain conditions and, upon consummation, Advanced will become a wholly owned subsidiary of the Company.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BALANCE SHEET DETAILS</font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated balance sheets detail is as follows as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.96875%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,522</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,329</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">799</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,687</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,759</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,209</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,887</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,313</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,211</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Software</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168,030</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162,006</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,771</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,615</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">213,114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">204,832</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated depreciation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(119,489</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(114,413</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Fixed assets, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,625</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90,419</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life insurance cash surrender value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,028</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,090</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,124</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105,590</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,152</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued expenses:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade accounts payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,203</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,537</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subcontractor payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,575</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,892</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,831</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,236</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss contingencies</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,578</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,549</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Professional liability reserve</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,961</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,633</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,418</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,756</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Accounts payable and accrued expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153,566</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149,603</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued compensation and benefits:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued payroll</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,933</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,571</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued bonuses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,546</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued travel expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,684</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,417</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health insurance reserve</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,582</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,559</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Workers compensation reserve</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,378</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,817</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65,820</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,720</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,849</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,954</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Accrued compensation and benefits</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135,792</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135,059</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition related liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,668</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,918</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,444</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,325</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,112</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,243</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Workers compensation reserve</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,953</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,454</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Professional liability reserve</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,058</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,324</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred rent</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,916</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,862</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">769</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">865</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,050</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63,746</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,528</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, earn-out liabilities, and income taxes. Actual results could differ from those estimates under different assumptions or conditions. </font></div></div> EX-101.SCH 12 ahs-20190331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2303301 - Disclosure - Acquisition (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Acquisitions (Details) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Acquisitions - Schedule of Intangible Assets Acquired (Details) link:presentationLink link:calculationLink link:definitionLink 2123100 - Disclosure - Balance Sheet Details link:presentationLink link:calculationLink link:definitionLink 2423402 - Disclosure - Balance Sheet Details - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2323301 - Disclosure - Balance Sheet Details (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - Basis of Presentation Basis of Presentation - Recently Adopted Accounting Pronouncements (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - Basis of Presentation (Tables) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - Commitments and Contingencies: Legal Proceedings link:presentationLink link:calculationLink link:definitionLink 2422401 - Disclosure - Commitments and Contingencies: Legal Proceedings - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1005501 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Fair Value Measurement link:presentationLink link:calculationLink link:definitionLink 2419403 - Disclosure - Fair Value Measurement - Financial Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - Fair Value Measurement - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2419404 - Disclosure - Fair Value Measurement - Reconciliation of Changes in Contingent Consideration Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - Fair Value Measurement (Tables) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2420406 - Disclosure - Leases - Assumptions Used for Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2420403 - Disclosure - Leases - Components of Lease Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2420404 - Disclosure - Leases - Maturity of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2420404 - Disclosure - Leases - Maturity of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2420407 - Disclosure - Leases - Minimum Lease Payments Under ASC 840 (Details) link:presentationLink link:calculationLink link:definitionLink 2420402 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2420405 - Disclosure - Leases - Supplemental Cash Flow Information Regarding Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2320301 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Net Income Per Common Share link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Net Income Per Common Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Net Income Per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - New Credit Agreement link:presentationLink link:calculationLink link:definitionLink 2418401 - Disclosure - New Credit Agreement - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Segment Information - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Segment Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2124100 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2424401 - Disclosure - Subsequent Events - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 13 ahs-20190331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 14 ahs-20190331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 15 ahs-20190331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Debt Disclosure [Abstract] New Credit Agreement Debt Disclosure [Text Block] Business Combinations [Abstract] Schedule of Intangible Assets Acquired Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Statement of Cash Flows [Abstract] Interest capitalized Interest Paid, Capitalized, Investing Activities Subsequent Events [Abstract] Subsequent Event [Table] Subsequent Event [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Advanced Advanced Medical Personnel Services, Inc. [Member] Advanced Medical Personnel Services, Inc. [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Cash consideration Payments to Acquire Businesses, Gross Tiered contingent earn-out payment Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] MedPartners MedPartners HIM, LLC [Member] MedPartners HIM, LLC [Member] PDA and LFT Phillips DiPisa And Leaders For Today [Member] Phillips DiPisa and Leaders For Today [Member] Silversheet Silversheet, Inc. [Member] Silversheet, Inc. [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Nurse and Allied Solutions Nurse and Allied Healthcare Staffing [Member] Nurse and allied healthcare staffing. Locum Tenens Solutions Locum Tenens Staffing [Member] Locum tenens staffing. Other Workforce Solutions Other Workforce Solutions [Member] Other Workforce Solutions [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Goodwill [Roll Forward] Goodwill [Roll Forward] Goodwill, beginning balance Goodwill Goodwill, adjustments Goodwill, Purchase Accounting Adjustments Goodwill acquired Goodwill, Acquired During Period Goodwill, ending balance Accumulated impairment loss Goodwill, Impaired, Accumulated Impairment Loss Balance Sheet Related Disclosures [Abstract] BALANCE SHEET DETAILS Supplemental Balance Sheet Disclosures [Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Letter of Credit Letter of Credit [Member] Revolving Credit Facility, Swing Line Loan Revolving Credit Facility, Swing Line Loan [Member] Revolving Credit Facility, Swing Line Loan [Member] Revolving Credit Facility Revolving Credit Facility [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Line of Credit Line of Credit [Member] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] London Interbank Offered Rate (LIBOR) London Interbank Offered Rate (LIBOR) [Member] Base Rate Base Rate [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Fees paid to lenders and other third parties Loan Issuance Costs, Incurred Loan Issuance Costs, Incurred Unamortized financing fees written off Write off of Deferred Debt Issuance Cost Organization, Consolidation and Presentation of Financial Statements [Abstract] Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2016-02 Accounting Standards Update 2016-02 [Member] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Present value of lease liabilities Operating Lease, Liability Derecognition of existing deferred rent liabilities Operating Leases, Rent Expense Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Restricted cash and cash equivalents (included in other current assets) Restricted Cash and Cash Equivalents Restricted cash, cash equivalents and investments Restricted Cash and Investments, Noncurrent Total cash, cash equivalents and restricted cash and investments Total Cash, Cash Equivalents, And Restricted Cash, Cash Equivalents, and Investments Total Cash, Cash Equivalents, And Restricted Cash, Cash Equivalents, and Investments Less restricted investments Restricted Investments Cash, cash equivalents and restricted cash at the end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Schedule of Restricted Cash Restrictions on Cash and Cash Equivalents [Table Text Block] Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Recently Adopted Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Net Income per Common Share Earnings Per Share, Policy [Policy Text Block] Segment Information Segment Reporting, Policy [Policy Text Block] Fair Value of Financial Instruments Fair Value Measurement, Policy [Policy Text Block] Schedule of Supplemental Balance Sheet Disclosures Schedule of Supplemental Balance Sheet Disclosures [Table Text Block] Schedule of Supplemental Balance Sheet Disclosures [Table Text Block] Leases [Abstract] Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Weighted average discount rate Lessee, Operating Lease, Discount Rate Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Option to extend, term Lessee, Operating Lease, Renewal Term Option to terminate, term Lessee, Operating Lease, Termination Period Lessee, Operating Lease, Termination Period Lease term Lessee, Operating Lease, Term of Contract Rent expense Operating Leases, Rent Expense, Net Fair Value Disclosures [Abstract] FAIR VALUE MEASUREMENT Fair Value Disclosures [Text Block] Reconciliation Of Revenue From Segments To Consolidated [Table] Reconciliation of Revenue from Segments to Consolidated [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Product concentration risk Product Concentration Risk [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Sales revenue, net Sales Revenue, Net [Member] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Managed Services Program Arrangements Managed Services Program Arrangements [Member] Managed Services Program Arrangements [Member] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating segments Operating Segments [Member] Unallocated corporate overhead Corporate, Non-Segment [Member] Nurse and Allied Solutions Segment Reporting, Revenue Reconciling Item [Line Items] Segment Reporting, Revenue Reconciling Item [Line Items] Number of reportable segments Number of Operating Segments Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results Segment Reconciliation [Abstract] Revenue Revenue from Contract with Customer, Excluding Assessed Tax Segment operating income Operating Income (Loss) Unallocated corporate overhead Unallocated Corporate Overhead Unallocated corporate overhead. Depreciation and amortization Depreciation, Depletion and Amortization Share-based compensation Share-based Compensation Interest expense, net, and other Interest Expense Income before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Revenue from contract with customer, percent Concentration Risk, Percentage Schedule of financial assets and liabilities measured at fair value on recurring basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Reconciliations of changes in the fair value of contingent consideration liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Reconciliations of equity investments included in net income Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Litigation Case [Axis] Litigation Case [Axis] Litigation Case [Domain] Litigation Case [Domain] Wage and Hour claims Wage And Hour Claims [Member] Wage And Hour Claims [Member] Litigation Status [Axis] Litigation Status [Axis] Litigation Status [Domain] Litigation Status [Domain] Pending Litigation Pending Litigation [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Number of class actions related to wage and hour claims Loss Contingency, Pending Claims, Number Increase to loss contingency accruals Loss Contingency Accrual, Period Increase (Decrease) Earnings Per Share [Abstract] Computation of basic and diluted net income per common share Computation of Basic and Diluted Net Income Per Common Share [Abstract] Computation of basic and diluted net income per common share. Net income Net Income (Loss) Attributable to Parent Net income per common share - basic (in dollars per share) Earnings Per Share, Basic Net income per common share - diluted (in dollars per share) Earnings Per Share, Diluted Weighted average common shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Plus dilutive effect of potential common shares (in shares) Weighted Average Number Diluted Shares Outstanding Adjustment Weighted average common shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Common stock excluded from calculation of EPS (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Computation of basic and diluted net income per common share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Cash paid for amounts included in the measurement of operating lease liabilities (operating cash flows) Operating Lease, Payments Operating lease right-of-use assets obtained in exchange for lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Operating lease cost Operating Lease, Cost Short-term lease cost Short-term Lease, Cost Variable and other lease cost Variable Lease, Cost Net lease cost Lease, Cost 2019 (excluding the three months ended March 31, 2019) Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year 2020 Lessee, Operating Lease, Liability, Payments, Due Year Two 2021 Lessee, Operating Lease, Liability, Payments, Due Year Three 2022 Lessee, Operating Lease, Liability, Payments, Due Year Four 2023 Lessee, Operating Lease, Liability, Payments, Due Year Five Thereafter Lessee, Operating Lease, Liability, Payments, Due after Year Five Total lease payments Lessee, Operating Lease, Liability, Payments, Due Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Other current assets: Assets, Current [Abstract] Restricted cash and cash equivalents Income tax receivable Income Taxes Receivable, Current Other Other Assets, Miscellaneous, Current Other current assets Other Assets, Current Fixed assets: Property, Plant and Equipment, Net [Abstract] Furniture and equipment Furniture and Fixtures, Gross Software Capitalized Computer Software, Gross Leasehold improvements Leasehold Improvements, Gross Fixed assets, gross Property, Plant and Equipment, Gross Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Fixed assets, net Property, Plant and Equipment, Net Other assets: Other Assets [Abstract] Life insurance cash surrender value Cash Surrender Value of Life Insurance Other Other Assets, Miscellaneous Other assets Other Assets, Noncurrent Accounts payable and accrued expenses: Accounts Payable and Accrued Liabilities, Current [Abstract] Trade accounts payable Accounts Payable, Trade, Current Subcontractor payable Accounts Payable to Subcontractor Accounts payable to subcontractor. Accrued expenses Accrued Liabilities, Current Loss contingencies Loss Contingency, Accrual, Current Professional liability reserve Self Insurance Reserve, Current Other Other Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Accounts Payable And Accrued Expenses, Excluding Accrued Compensation And Benefits, Current Accounts Payable And Accrued Expenses, Excluding Accrued Compensation And Benefits, Current Accrued compensation and benefits: Employee-related Liabilities [Abstract] Accrued payroll Accrued Salaries, Current Accrued bonuses Accrued Bonuses Accrued travel expense Accrued Travel Expense Accrued Travel Expense Health insurance reserve Accrued Insurance, Current Workers compensation reserve Workers' Compensation Liability, Current Deferred compensation Deferred Compensation Liability, Current Other Other Employee-related Liabilities, Current Accrued compensation and benefits Employee-related Liabilities, Current Other current liabilities: Other Liabilities, Current [Abstract] Acquisition related liabilities Business Combination, Contingent Consideration, Liability, Current Other Other Sundry Liabilities, Current Other current liabilities Other Liabilities, Current Other long-term liabilities: Other Liabilities, Noncurrent [Abstract] Workers compensation reserve Workers' Compensation Liability, Noncurrent Professional liability reserve Self Insurance Reserve, Noncurrent Deferred rent Deferred Rent Credit, Noncurrent Unrecognized tax benefits Liability for Uncertainty in Income Taxes, Noncurrent Deferred revenue Contract with Customer, Liability, Noncurrent Other Other Sundry Liabilities, Noncurrent Other long-term liabilities Other Liabilities, Noncurrent COMMITMENTS AND CONTINGENCIES: LEGAL PROCEEDINGS Commitments and Contingencies Disclosure [Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Developed Technology Developed Technology Rights [Member] Trademarks Trademarks [Member] Customer Relationships Customer Relationships [Member] Staffing Databases Staffing Databases [Member] Staffing Databases [Member] Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Based on operating results for the twelve months ending December 31, 2019 Earn-Out Payment, Performance Condition One [Member] Earn-Out Payment, Performance Condition One [Member] Based on operating results for the twelve months ending December 31, 2020 Earn-Out Payment, Performance Condition Two [Member] Earn-Out Payment, Performance Condition Two [Member] Based on operating results for the twelve months ending December 31, 2018 Earn-Out Payment, Performance Condition Three [Member] Earn-Out Payment, Performance Condition Three [Member] Based on operating results for the six months ended June 30, 2019 Earn-Out Payment, Performance Condition Four [Member] Earn-Out Payment, Performance Condition Four [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Number of acquisitions Number of Businesses Acquired Initial purchase price Business Combination, Consideration Transferred Estimated fair value of contingent earn-out payment Business Combination, Contingent Consideration, Liability Tangible assets acquired, including cash received Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Tangible Assets Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Tangible Assets Cash received Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Intangible assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Goodwill Intangible assets, weighted-average useful life (in years) Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Working capital settlement received Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Working Capital Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Working Capital BASIS OF PRESENTATION Basis of Accounting [Text Block] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Recurring Fair Value, Measurements, Recurring [Member] Asset Class [Axis] Asset Class [Axis] Asset Class [Domain] Asset Class [Domain] Money market funds Money Market Funds [Member] Commercial paper Commercial Paper [Member] Acquisition contingent consideration liabilities Contingent Consideration [Member] Contingent Consideration [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Financial Instrument [Axis] Financial Instrument [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Schedule of financial assets and liabilities measured at fair value on recurring basis Assets, Fair Value Disclosure [Abstract] Financial assets and liabilities measured at fair value Fair Value, Net Asset (Liability) Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Tradenames and Trademarks Trademarks and Trade Names [Member] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Useful Life Finite-Lived Intangible Asset, Useful Life Fair Value Measurements, Recurring and Nonrecurring [Table] Contingent consideration liability for year ended December 31, 2016 Two Thousand Sixteen Earn-Out [Member] Two Thousand Sixteen Earn-Out [Member] Contingent consideration liability for year ended December 31, 2017 Two Thousand Seventeen Earn-Out [Member] Two Thousand Seventeen Earn-Out [Member] Liability Class [Axis] Liability Class [Axis] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] HSG HealthSource Global Staffing [Member] HealthSource Global Staffing [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Beginning balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Contingent consideration earn-out liability Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases Change in fair value of contingent consideration earn-out liability from acquisition Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Settlement of earn-out Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Ending balance Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock Common Stock [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Treasury Stock Treasury Stock [Member] Retained Earnings (Accumulated Deficit) Retained Earnings [Member] Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning balance (in shares) Shares, Issued Beginning balance Stockholders' Equity Attributable to Parent Repurchase of common stock into treasury (in shares) Treasury Stock, Shares, Acquired Repurchase of common stock into treasury Treasury Stock, Value, Acquired, Cost Method Equity awards vested and exercised, net of shares withheld for payroll taxes (in shares) Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Equity awards vested and exercised, net of shares withheld for payroll taxes Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Cumulative-effect adjustment from adoption of the new revenue recognition standard Cumulative Effect of New Accounting Principle in Period of Adoption Share-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Ending balance (in shares) Ending balance 2019 Operating Leases, Future Minimum Payments Receivable, Current 2020 Operating Leases, Future Minimum Payments Receivable, in Two Years 2021 Operating Leases, Future Minimum Payments Receivable, in Three Years 2022 Operating Leases, Future Minimum Payments Receivable, in Four Years 2023 Operating Leases, Future Minimum Payments Receivable, in Five Years Thereafter Operating Leases, Future Minimum Payments Receivable, Thereafter Total minimum lease payments Operating Leases, Future Minimum Payments Receivable Statement of Comprehensive Income [Abstract] Cost of revenue Cost of Goods and Services Sold Gross profit Gross Profit Operating expenses: Operating Expenses [Abstract] Selling, general and administrative Selling, General and Administrative Expense Total operating expenses Operating Expenses Income from operations Interest expense, net, and other Income tax expense Income Tax Expense (Benefit) Net income Other comprehensive loss: Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Foreign currency translation and other Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Comprehensive income Net income per common share: Basic (in dollars per share) Diluted (in dollars per share) Weighted average common shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic (shares) Diluted (shares) Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Accounts receivable, net of allowances of $11,716 and $10,560 at March 31, 2019 and December 31, 2018, respectively Accounts Receivable, Net, Current Accounts receivable, subcontractor Accounts receivable, subcontractor Accounts receivable, subcontractor Prepaid expenses Prepaid Expense, Current Other current assets Total current assets Assets, Current Restricted cash, cash equivalents and investments Fixed assets, net of accumulated depreciation of $119,489 and $114,413 at March 31, 2019 and December 31, 2018, respectively Other assets Goodwill Intangible assets, net of accumulated amortization of $121,575 and $114,924 at March 31, 2019 and December 31, 2018, respectively Intangible Assets, Net (Excluding Goodwill) Total assets Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable and accrued expenses Accounts Payable, Current Accrued compensation and benefits Current portion of operating lease liabilities Operating Lease, Liability, Current Deferred revenue Contract with Customer, Liability, Current Other current liabilities Total current liabilities Liabilities, Current Revolving credit facility Long-term Line of Credit, Noncurrent Notes payable, less unamortized fees Notes Payable, Noncurrent Deferred income taxes, net Deferred Income Tax Liabilities, Net Operating lease liabilities Operating Lease, Liability, Noncurrent Other long-term liabilities Total liabilities Liabilities Commitments and contingencies Commitments and Contingencies Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at March 31, 2019 and December 31, 2018 Preferred Stock, Value, Issued Common stock, $0.01 par value; 200,000 shares authorized; 49,122 issued and 46,578 outstanding at March 31, 2019 and 48,809 issued and 46,643 outstanding at December 31, 2018 Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Treasury stock, at cost (2,544 and 2,166 shares at March 31, 2019 and December 31, 2018, respectively) Treasury Stock, Value Retained earnings Retained Earnings (Accumulated Deficit) Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Total stockholders’ equity Total liabilities and stockholders’ equity Liabilities and Equity ACQUISITIONS Business Combination Disclosure [Text Block] SUBSEQUENT EVENTS Subsequent Events [Text Block] NET INCOME PER COMMON SHARE Earnings Per Share [Text Block] Income Tax Disclosure [Abstract] INCOME TAXES Income Tax Disclosure [Text Block] SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] LEASES Lessee, Operating Leases [Text Block] Document and Entity Information [Abstract] Document and entity information. Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding (excluding treasury shares) Entity Common Stock, Shares Outstanding Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] 5.125% Senior Notes due 2024 [Member] 5.125% Senior Notes due 2024 [Member] 5.125% Senior Notes due 2024 [Member] 5.125% Senior Notes Due 2024 Five Point One Two Five Percent Senior Notes Due Two Thousand Twenty-Four [Member] Five Point One Two Five Percent Senior Notes Due Two Thousand Twenty-Four [Member] Senior Notes Senior Notes [Member] Fair Value, Measurements, Nonrecurring Fair Value, Measurements, Nonrecurring [Member] Commercial paper Available-for-sale securities Debt Securities, Available-for-sale Equity investment balance Equity Securities, FV-NI Impairment charges Asset Impairment Charges Carrying amount of senior notes Debt Instrument, Face Amount Estimated fair value of senior notes Debt Instrument, Fair Value Disclosure Interest rate Debt Instrument, Interest Rate, Stated Percentage Maturity of Lease Liabilities Lessee, Operating Lease, Liability, Maturity [Table Text Block] Supplemental Cash Flow Disclosures Related to Leases Lease, Cost [Table Text Block] Assumptions Used for Operating Leases Lessee, Operating Lease, Assumptions Used [Table Text Block] Lessee, Operating Lease, Assumptions Used [Table Text Block] Schedule of Future Minimum Payments for Operating Leases Under ASC 840 Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Accounts receivable, allowance Allowance for Doubtful Accounts Receivable, Current Accumulated depreciation - fixed assets Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Common stock, shares issued (in shares) Common Stock, Shares, Issued Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Treasury stock (in shares) Treasury Stock, Shares Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Non-cash interest expense and other Other Noncash Expense Write-off of fees on the prior credit facilities Gain (Loss) on Extinguishment of Debt Change in fair value of contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Increase in allowances for doubtful accounts and sales credits Provision for Doubtful Accounts Provision for deferred income taxes Deferred Income Tax Expense (Benefit) Loss on disposal or sale of fixed assets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Amortization of discount on investments Investment Income, Amortization of Discount Non-cash lease expense Lessee, Operating Lease, Noncash Expense Lessee, Operating Lease, Noncash Expense Changes in assets and liabilities, net of effects from acquisitions: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Accounts receivable, subcontractor Increase Decrease in Accounts Receivables, subcontractor Increase Decrease in Accounts Receivables, subcontractor Income taxes receivable Increase (Decrease) in Income Taxes Receivable Prepaid expenses Increase (Decrease) in Prepaid Expense Other current assets Increase (Decrease) in Other Current Assets Other assets Increase (Decrease) in Other Operating Assets Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Accrued compensation and benefits Increase (Decrease) in Employee Related Liabilities Other liabilities Increase (Decrease) in Other Operating Liabilities Deferred revenue Increase (Decrease) in Contract with Customer, Liability Restricted investments balance Increase (Decrease) in Restricted Investments for Operating Activities Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchase and development of fixed assets Payments to Acquire Property, Plant, and Equipment Purchase of investments Payments to Acquire Investments Proceeds from maturity of investments Proceeds from Sale, Maturity and Collection of Investments Payments to fund deferred compensation plan Payment to Acquire Life Insurance Policy, Investing Activities Cash paid for acquisitions, net of cash received Payments to Acquire Businesses, Net of Cash Acquired Cash paid for other intangibles Payments to Acquire Intangible Assets Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from revolving credit facility Proceeds from Lines of Credit Repurchase of common stock Payments for Repurchase of Common Stock Payment of financing costs Payments of Financing Costs Earn-out payments for prior acquisitions Payments For Previous Acquisition, Earn-Out Payment Payments For Previous Acquisition, Earn-Out Payment Cash paid for shares withheld for taxes Payments Related to Tax Withholding for Share-based Compensation Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash Effect of Exchange Rate on Cash and Cash Equivalents Net increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, cash equivalents and restricted cash at the beginning of period Cash, cash equivalents and restricted cash at the end of period Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Cash paid for amounts included in the measurement of operating lease liabilities Cash paid for interest (net of $102 and $104 capitalized for the three months ended March 31, 2019 and 2018, respectively) Interest Paid, Excluding Capitalized Interest, Operating Activities Cash paid for income taxes Income Taxes Paid, Net Acquisitions: Fair value of tangible assets acquired in acquisitions, net of cash received Fair Value of Assets Acquired Goodwill Supplemental Disclosures Of Non Cash Investing And Financing Activities, Goodwill Supplemental Disclosures Of Non Cash Investing And Financing Activities, Goodwill Intangible assets Supplemental Disclosures Of Non Cash Investing And Financing Activities, Intangible Assets Supplemental Disclosures Of Non Cash Investing And Financing Activities, Intangible Assets Liabilities assumed Liabilities Assumed Earn-out liabilities Noncash Or Part Noncash Acquisition, Earn-Out Liability Noncash Or Part Noncash Acquisition, Earn-Out Liability Supplemental disclosures of non-cash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Purchase of fixed assets recorded in accounts payable and accrued expenses Purchase of fixed assets recorded in accounts payable and accrued expenses Purchase of fixed assets recorded in accounts payable and accrued expenses Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results Schedule of Segment Reporting Information, by Segment [Table Text Block] Summary of goodwill by reportable segment Schedule of Goodwill [Table Text Block] Revenue Recognition and Deferred Revenue [Abstract] Revenue Recognition Revenue from Contract with Customer [Text Block] EX-101.PRE 16 ahs-20190331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 17 amnex1022019033110qimage1.gif begin 644 amnex1022019033110qimage1.gif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end GRAPHIC 18 amnex1042019033110qimage1.gif begin 644 amnex1042019033110qimage1.gif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end GRAPHIC 19 amnlogoa01a01a01a18.jpg begin 644 amnlogoa01a01a01a18.jpg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htm IDEA: XBRL DOCUMENT v3.19.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2019
May 01, 2019
Document and Entity Information [Abstract]    
Entity Registrant Name AMN HEALTHCARE SERVICES INC  
Entity Central Index Key 0001142750  
Current Fiscal Year End Date --12-31  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Document Type 10-Q  
Document Period End Date Mar. 31, 2019  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Entity Common Stock, Shares Outstanding (excluding treasury shares)   46,619,697
XML 21 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 19,116 $ 13,856
Accounts receivable, net of allowances of $11,716 and $10,560 at March 31, 2019 and December 31, 2018, respectively 365,231 365,871
Accounts receivable, subcontractor 55,607 50,143
Prepaid expenses 17,724 12,409
Other current assets 31,209 39,887
Total current assets 488,887 482,166
Restricted cash, cash equivalents and investments 61,279 59,331
Fixed assets, net of accumulated depreciation of $119,489 and $114,413 at March 31, 2019 and December 31, 2018, respectively 93,625 90,419
Operating lease right-of-use assets 97,055  
Other assets 105,590 96,152
Goodwill 464,923 438,506
Intangible assets, net of accumulated amortization of $121,575 and $114,924 at March 31, 2019 and December 31, 2018, respectively 326,466 326,147
Total assets 1,637,825 1,492,721
Current liabilities:    
Accounts payable and accrued expenses 153,566 149,603
Accrued compensation and benefits 135,792 135,059
Current portion of operating lease liabilities 12,341  
Deferred revenue 11,459 12,365
Other current liabilities 20,112 10,243
Total current liabilities 333,270 307,270
Revolving credit facility 150,000 120,000
Notes payable, less unamortized fees 320,798 320,607
Deferred income taxes, net 20,079 27,326
Operating lease liabilities 99,946  
Other long-term liabilities 63,746 78,528
Total liabilities 987,839 853,731
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at March 31, 2019 and December 31, 2018 0 0
Common stock, $0.01 par value; 200,000 shares authorized; 49,122 issued and 46,578 outstanding at March 31, 2019 and 48,809 issued and 46,643 outstanding at December 31, 2018 491 488
Additional paid-in capital 447,632 452,730
Treasury stock, at cost (2,544 and 2,166 shares at March 31, 2019 and December 31, 2018, respectively) (118,368) (100,438)
Retained earnings 320,181 286,059
Accumulated other comprehensive income 50 151
Total stockholders’ equity 649,986 638,990
Total liabilities and stockholders’ equity $ 1,637,825 $ 1,492,721
XML 22 R3.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Accounts receivable, allowance $ 11,716 $ 10,560
Accumulated depreciation - fixed assets 119,489 114,413
Accumulated amortization $ 121,575 $ 114,924
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 200,000,000 200,000,000
Common stock, shares issued (in shares) 49,122,000 48,809,000
Common stock, shares outstanding (in shares) 46,578,000 46,643,000
Treasury stock (in shares) 2,544,000 2,166,000
XML 23 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Comprehensive Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Statement of Comprehensive Income [Abstract]    
Revenue $ 532,441 $ 522,489
Cost of revenue 355,682 354,665
Gross profit 176,759 167,824
Operating expenses:    
Selling, general and administrative 119,997 104,737
Depreciation and amortization 11,710 7,886
Total operating expenses 131,707 112,623
Income from operations 45,052 55,201
Interest expense, net, and other 5,673 5,335
Income before income taxes 39,379 49,866
Income tax expense 5,257 7,185
Net income 34,122 42,681
Other comprehensive loss:    
Foreign currency translation and other (101) (19)
Other comprehensive loss (101) (19)
Comprehensive income $ 34,021 $ 42,662
Net income per common share:    
Basic (in dollars per share) $ 0.73 $ 0.89
Diluted (in dollars per share) $ 0.71 $ 0.87
Weighted average common shares outstanding:    
Basic (shares) 46,784 47,733
Diluted (shares) 47,772 49,116
XML 24 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2017   48,411   930    
Beginning balance at Dec. 31, 2017 $ 562,527 $ 484 $ 453,351 $ (33,425) $ 142,229 $ (112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Equity awards vested and exercised, net of shares withheld for payroll taxes (in shares)   349        
Equity awards vested and exercised, net of shares withheld for payroll taxes (10,926) $ 4 (10,930)      
Share-based compensation 2,864   2,864      
Comprehensive income 42,662       42,681 (19)
Ending balance (in shares) at Mar. 31, 2018   48,760   930    
Ending balance at Mar. 31, 2018 599,216 $ 488 445,285 $ (33,425) 186,999 (131)
Beginning balance (in shares) at Dec. 31, 2018   48,809   2,166    
Beginning balance at Dec. 31, 2018 638,990 $ 488 452,730 $ (100,438) 286,059 151
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchase of common stock into treasury (in shares)       (378)    
Repurchase of common stock into treasury (17,930)     $ (17,930)    
Equity awards vested and exercised, net of shares withheld for payroll taxes (in shares)   313        
Equity awards vested and exercised, net of shares withheld for payroll taxes (10,281) $ 3 (10,284)      
Share-based compensation 5,186   5,186      
Comprehensive income 34,021       34,122 (101)
Ending balance (in shares) at Mar. 31, 2019   49,122   2,544    
Ending balance at Mar. 31, 2019 $ 649,986 $ 491 $ 447,632 $ (118,368) $ 320,181 $ 50
XML 25 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Net income $ 34,122 $ 42,681
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 11,710 7,886
Non-cash interest expense and other 543 600
Write-off of fees on the prior credit facilities 0 574
Change in fair value of contingent consideration (700) 0
Increase in allowances for doubtful accounts and sales credits 2,608 2,257
Provision for deferred income taxes (9,036) (5,113)
Share-based compensation 5,186 2,864
Loss on disposal or sale of fixed assets 4 5
Amortization of discount on investments (120) (15)
Non-cash lease expense (92)  
Changes in assets and liabilities, net of effects from acquisitions:    
Accounts receivable (1,500) 9,154
Accounts receivable, subcontractor (5,465) 1,985
Income taxes receivable 799 9,881
Prepaid expenses (5,387) (2,375)
Other current assets (1,783) 2,825
Other assets (6,202) (89)
Accounts payable and accrued expenses 2,949 (7,816)
Accrued compensation and benefits 330 (4,007)
Other liabilities 9,630 (1,498)
Deferred revenue (1,418) (52)
Restricted investments balance 36 (12)
Net cash provided by operating activities 36,214 59,735
Cash flows from investing activities:    
Purchase and development of fixed assets (7,388) (5,703)
Purchase of investments (7,362) (2,086)
Proceeds from maturity of investments 11,700 2,900
Payments to fund deferred compensation plan (3,583) (4,724)
Cash paid for acquisitions, net of cash received (29,525) 0
Cash paid for other intangibles (90) 0
Net cash used in investing activities (36,248) (9,613)
Cash flows from financing activities:    
Proceeds from revolving credit facility 30,000 0
Repurchase of common stock (17,930) 0
Payment of financing costs 0 (2,331)
Earn-out payments for prior acquisitions 0 (1,713)
Cash paid for shares withheld for taxes (10,280) (10,926)
Net cash provided by (used in) financing activities 1,790 (14,970)
Effect of exchange rate changes on cash (101) (19)
Net increase in cash, cash equivalents and restricted cash 1,655 35,133
Cash, cash equivalents and restricted cash at the beginning of period 84,324 98,894
Cash, cash equivalents and restricted cash at the end of period 85,979 134,027
Supplemental disclosures of cash flow information:    
Cash paid for amounts included in the measurement of operating lease liabilities 4,338  
Cash paid for interest (net of $102 and $104 capitalized for the three months ended March 31, 2019 and 2018, respectively) 1,524 201
Cash paid for income taxes 4,192 2,731
Acquisitions:    
Fair value of tangible assets acquired in acquisitions, net of cash received 1,041 0
Goodwill 26,494 0
Intangible assets 6,880 0
Liabilities assumed (3,390) 0
Earn-out liabilities (1,500) 0
Supplemental disclosures of non-cash investing and financing activities:    
Purchase of fixed assets recorded in accounts payable and accrued expenses $ 2,566 $ 2,860
XML 26 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Statement of Cash Flows [Abstract]    
Interest capitalized $ 102 $ 104
XML 27 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Basis of Presentation
3 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BASIS OF PRESENTATION
BASIS OF PRESENTATION
The condensed consolidated balance sheets and related condensed consolidated statements of comprehensive income and cash flows contained in this Quarterly Report on Form 10-Q (this “Quarterly Report”), which are unaudited, include the accounts of AMN Healthcare Services, Inc. and its wholly-owned subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted of all normal recurring items. The results of operations for the interim period are not necessarily indicative of the results to be expected for any other interim period or for the entire fiscal year or for any future period.
The unaudited condensed consolidated financial statements do not include all information and notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”). Please refer to the Company’s audited consolidated financial statements and the related notes for the fiscal year ended December 31, 2018, contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018, filed with the Securities and Exchange Commission on February 21, 2019 (“2018 Annual Report”).
The preparation of financial statements in conformity with U.S. GAAP requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, earn-out liabilities, and income taxes. Actual results could differ from those estimates under different assumptions or conditions.
Recently Adopted Accounting Pronouncements
In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-02, “Leases.” This standard requires organizations that lease assets to recognize the assets and liabilities created by those leases. The standard also will require disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. A modified retrospective transition approach is required, applying the standard to all leases existing at the date of initial application. In addition, the FASB has also issued several amendments to the standard, which clarify certain aspects of the guidance, including an optional transition method for adoption of this standard, which allows organizations to initially apply the new requirements at the effective date, recognize a cumulative effect adjustment to the opening balance of retained earnings, and continue to apply the legacy guidance in Accounting Standards Codification (“ASC”) 840, Leases, including its disclosure requirements, in the comparative periods presented. The new standard provides a number of optional practical expedients in transition. The Company elected the ‘package of practical expedients’, which permits organizations not to reassess under the new standard prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect to use the hindsight practical expedient to determine the lease term or evaluate impairment for existing leases.
The Company adopted ASU 2016-02 effective January 1, 2019, using the optional transition method described above. The Company recognized the cumulative effect of adopting this guidance as an adjustment as of the effective date, primarily related to the recognition of lease liabilities of $114,807 and corresponding right-of-use assets of $99,525 for existing operating leases. The Company also derecognized existing deferred rent liabilities of $15,302. These adjustments had no effect on opening retained earnings and prior periods were not retrospectively adjusted and continue to be reported in accordance with ASC 840. The new standard also provides practical expedients for an organization’s ongoing accounting. The Company elected the short-term lease recognition exemption and the practical expedient to not separate lease and non-lease components for all leases that qualify. The Company does not expect the adoption of this standard to impact its results of operations.

There was no other material impact to the Company’s condensed consolidated financial statements as a result of adopting this updated standard.
Cash, cash equivalents and restricted cash
The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions and highly liquid investments. Restricted cash and cash equivalents primarily represent cash and money market funds on deposit with financial institutions and investments represents commercial paper that serves as collateral for the Company’s outstanding letters of credit and captive insurance subsidiary claim payments. See Note (6), “New Credit Agreement” and Note (7), “Fair Value Measurement” for additional information.
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying condensed consolidated balance sheets and related notes to the amounts presented in the accompanying condensed consolidated statements of cash flows.
 
March 31, 2019
 
December 31, 2018
Cash and cash equivalents
$
19,116

 
$
13,856

Restricted cash and cash equivalents (included in other current assets)
16,522

 
26,329

Restricted cash, cash equivalents and investments
61,279

 
59,331

Total cash, cash equivalents and restricted cash and investments
96,917

 
99,516

Less restricted investments
(10,938
)
 
(15,192
)
Total cash, cash equivalents and restricted cash
$
85,979

 
$
84,324

XML 28 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Acquisitions
3 Months Ended
Mar. 31, 2019
Business Combinations [Abstract]  
ACQUISITIONS
ACQUISITIONS
As set forth below, the Company completed three acquisitions from January 1, 2018 through March 31, 2019. The Company accounted for each acquisition using the acquisition method of accounting. Accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. Since the applicable date of acquisition, the Company has revised the allocation of the purchase price to the tangible and intangible assets acquired and liabilities assumed based on analysis of information that has been made available through March 31, 2019. The allocation will continue to be updated through the measurement period, if necessary. For each acquisition, the Company did not incur any material acquisition-related costs.
Silversheet Acquisition
On January 30, 2019, the Company completed its acquisition of Silversheet, Inc. (“Silversheet”) which provides innovative software and services to reduce the complexities and challenges of the credentialing process for clinicians and healthcare organizations. The initial purchase price of $31,676 included (1) $30,176 cash consideration paid upon acquisition, funded primarily through borrowings under the Company’s $400,000 secured revolving credit facility (the “Senior Credit Facility”), provided for under a credit agreement (the “New Credit Agreement”), dated as of February 9, 2018, by and among the Company and several lenders, and (2) a contingent earn-out payment of up to $25,000 with an estimated fair value of $1,500 as of the acquisition date. The contingent earn-out payment is based on (A) up to $6,000 based on the operating results of Silversheet for the twelve months ending December 31, 2019, and (B) up to $19,000 based on the operating results of Silversheet for the twelve months ending December 31, 2020. The results of Silversheet have been included in the Company’s other workforce solutions segment since the date of acquisition. The New Credit Agreement is more fully described in Note (6), “New Credit Agreement.”
The preliminary allocation of the $31,676 purchase price consisted of (1) $1,692 of fair value of tangible assets acquired, which included $651 cash received, (2) $3,390 of liabilities assumed, (3) $6,880 of identified intangible assets, and (4) $26,494 of goodwill, none of which is deductible for tax purposes. The fair value of intangible assets primarily includes $5,300 of developed technology and $1,500 of trademarks with a weighted average useful life of approximately eight years.
MedPartners Acquisition
On April 9, 2018, the Company completed its acquisition of MedPartners HIM (“MedPartners”), which provides case management, clinical documentation improvement, medical coding and registry services to hospitals and physician medical groups nationwide. The initial purchase price of $200,711 included (1) $196,533 cash consideration paid upon acquisition, funded primarily through borrowings under the Senior Credit Facility, and (2) a contingent earn-out payment of up to $20,000 with an estimated fair value of $4,400 as of the acquisition date. The contingent earn-out payment is based on (A) up to $10,000 based on the operating results of MedPartners for the twelve months ending December 31, 2018, which resulted in no earn-out payment, and (B) up to $10,000 based on the operating results of MedPartners for the six months ending June 30, 2019. The results of MedPartners have been included in the Company’s other workforce solutions segment since the date of acquisition. During the third quarter of 2018, $222 was returned to the Company for the final working capital settlement.
The preliminary allocation of the $200,711 purchase price consisted of (1) $28,510 of fair value of tangible assets acquired, which included $8,403 cash received, (2) $11,848 of liabilities assumed, (3) $103,000 of identified intangible assets, and (4) $81,049 of goodwill, all of which is deductible for tax purposes. The intangible assets acquired have a weighted average useful life of approximately sixteen years. The following table summarizes the fair value and useful life of each intangible asset acquired:
 
 
 
Fair Value
 
Useful Life
 
 
 
 
 
(in years)
Identifiable intangible assets
 
 
 
 
 
Tradenames and Trademarks
 
$
46,000

 
20
 
Customer Relationships
 
57,000

 
12
 
 
 
$
103,000

 
 

Phillips DiPisa and Leaders For Today Acquisition
On April 6, 2018, the Company completed its acquisition of two related entities, Phillips DiPisa and Leaders For Today (“PDA and LFT”), which offer a range of leadership staffing and permanent placement solutions for the healthcare industry. The initial purchase price of $35,503 included (1) $30,268 cash consideration paid upon acquisition, funded through cash on hand, and (2) a contingent earn-out payment of up to $7,000 with an estimated fair value of $5,700 as of the acquisition date. The contingent earn-out payment is based on the operating results of PDA and LFT for the twelve months ending December 31, 2018, which resulted in the full earn-out payment made in April 2019. The results of PDA and LFT have been included in the Company’s other workforce solutions segment since the date of acquisition. During the third quarter of 2018, $465 was returned to the Company for the final working capital settlement.
The preliminary allocation of the $35,503 purchase price consisted of (1) $4,373 of fair value of tangible assets acquired, which included $351 cash received, (2) $4,764 of liabilities assumed, (3) $19,110 of identified intangible assets, and (4) $16,784 of goodwill, all of which is deductible for tax purposes. The fair value of intangible assets includes $5,400 of trademarks, $8,000 of customer relationships and $5,710 of staffing databases with a weighted average useful life of approximately twelve years.
XML 29 R10.htm IDEA: XBRL DOCUMENT v3.19.1
Revenue Recognition
3 Months Ended
Mar. 31, 2019
Revenue Recognition and Deferred Revenue [Abstract]  
Revenue Recognition
REVENUE RECOGNITION
Revenue primarily consists of fees earned from the temporary and permanent placement of healthcare professionals and executives as well as from the Company’s SaaS-based technology, including its vendor management systems and its scheduling software. Revenue is recognized when control of these services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. Revenue from temporary staffing services is recognized as the services are rendered by clinical and non-clinical healthcare professionals. Under the Company’s managed services program arrangements, the Company manages all or a part of a customer’s supplemental workforce needs utilizing its own network of healthcare professionals along with those of third-party subcontractors. Revenue and the related direct costs under MSP arrangements are recorded in accordance with the accounting guidance on reporting revenue gross as a principal versus net as an agent. When the Company uses subcontractors and acts as an agent, revenue is recorded net of the related subcontractor’s expense. Revenue from executive search, physician permanent placement, and recruitment process outsourcing services is recognized as the services are rendered. The Company’s SaaS-based revenue is recognized ratably over the applicable arrangement’s service period.
The Company’s customers are primarily billed as services are rendered. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended March 31, 2019, the amount recognized as revenue that was previously deferred was not material.
The Company has elected to apply the following practical expedients and optional exemptions related to contract costs and revenue recognition:
Recognize incremental costs of obtaining a contract with amortization periods of one year or less as expense when incurred. These costs are recorded within selling, general and administrative expenses.
Recognize revenue in the amount of consideration to which the Company has a right to invoice the customer if that amount corresponds directly with the value to the customer of the Company’s services completed to date.
Exemptions from disclosing the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, (ii) contracts for which revenue is recognized in the amount of consideration to which the Company has a right to invoice for services performed and (iii) contracts for which variable consideration is allocated entirely to a wholly unsatisfied performance obligation or to a wholly unsatisfied promise to transfer a distinct service that forms part of a single performance obligation.
See Note (5), “Segment Information” for additional information.
XML 30 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Net Income Per Common Share
3 Months Ended
Mar. 31, 2019
Earnings Per Share [Abstract]  
NET INCOME PER COMMON SHARE
NET INCOME PER COMMON SHARE
Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. The following table sets forth the computation of basic and diluted net income per common share for the three and three months ended March 31, 2019 and 2018, respectively:
 
Three Months Ended March 31,
 
2019
 
2018
Net income
$
34,122

 
$
42,681

 
 
 
 
Net income per common share - basic
$
0.73

 
$
0.89

Net income per common share - diluted
$
0.71

 
$
0.87

 
 
 
 
Weighted average common shares outstanding - basic
46,784

 
47,733

Plus dilutive effect of potential common shares
988

 
1,383

Weighted average common shares outstanding - diluted
47,772

 
49,116


Share-based awards to purchase 66 and 9 shares of common stock were not included in the above calculation of diluted net income per common share for the three months ended March 31, 2019 and 2018, respectively, because the effect of these instruments was anti-dilutive.
XML 31 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Segment Information
3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
SEGMENT INFORMATION
SEGMENT INFORMATION
The Company has three reportable segments: nurse and allied solutions, locum tenens solutions, and other workforce solutions.
The Company’s chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation, interest expense, net, and other, and unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.

The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes:
 
Three Months Ended March 31,
 
2019

2018
Revenue
 
 
 
Nurse and allied solutions
$
337,029

 
$
338,179

Locum tenens solutions
80,490

 
103,117

Other workforce solutions
114,922

 
81,193

 
$
532,441

 
$
522,489

Segment operating income
 
 
 
Nurse and allied solutions
$
47,922

 
$
51,805

Locum tenens solutions
5,701

 
9,958

Other workforce solutions
26,188

 
19,851

 
79,811

 
81,614

Unallocated corporate overhead
17,863

 
15,663

Depreciation and amortization
11,710

 
7,886

Share-based compensation
5,186

 
2,864

Interest expense, net, and other
5,673

 
5,335

Income before income taxes
$
39,379

 
$
49,866


The Company offers a comprehensive managed services program, in which the Company manages all or a portion of a client’s contingent staffing needs. This service includes both the placement of the Company’s own healthcare professionals and the utilization of other staffing agencies to fulfill the client’s staffing needs. See additional information in Note (3), “Revenue Recognition.” For the three months ended March 31, 2019 and 2018, revenue under the Company’s managed services program arrangements comprised approximately 67% and 63% for nurse and allied solutions revenue, 24% and 14% for locum tenens solutions revenue and 7% and 9% for other workforce solutions revenue, respectively.
The following table summarizes the activity related to the carrying value of goodwill by reportable segment:
 
Nurse and Allied Solutions
 
Locum Tenens Solutions
 
Other Workforce Solutions
 
Total
Balance, January 1, 2019
$
103,107

 
$
19,743

 
$
315,656

 
$
438,506

Goodwill adjustment for MedPartners acquisition

 

 
(64
)
 
(64
)
Goodwill adjustment for PDA and LFT acquisition

 

 
(13
)
 
(13
)
Goodwill from Silversheet acquisition

 

 
26,494

 
26,494

Balance, March 31, 2019
$
103,107

 
$
19,743

 
$
342,073

 
$
464,923

Accumulated impairment loss as of December 31, 2018 and March 31, 2019
$
154,444

 
$
53,940

 
$
6,555

 
$
214,939

XML 32 R13.htm IDEA: XBRL DOCUMENT v3.19.1
New Credit Agreement
3 Months Ended
Mar. 31, 2019
Debt Disclosure [Abstract]  
New Credit Agreement
NEW CREDIT AGREEMENT

On February 9, 2018, the Company entered into the New Credit Agreement with several lenders to provide for the $400,000 Senior Credit Facility to replace its then-existing credit facilities. The Senior Credit Facility includes a $50,000 sublimit for the issuance of letters of credit and a $50,000 sublimit for swingline loans. The obligations of the Company under the New Credit Agreement and the Senior Credit Facility are secured by substantially all of the assets of the Company. Borrowings under the Senior Credit Facility bear interest at floating rates, at the Company’s option, based upon either LIBOR plus a spread of 1.00% to 2.00% or a base rate plus a spread of 0.00% to 1.00%. The applicable spread is determined quarterly based upon the Company’s consolidated net leverage ratio. The Senior Credit Facility is available for working capital, capital expenditures, permitted acquisitions and general corporate purposes. The maturity date of the Senior Credit Facility is February 9, 2023.

In connection with obtaining the New Credit Agreement, the Company incurred $2,331 in fees paid to lenders and other third parties, which were capitalized and are amortized to interest expense over the term of the New Credit Facility. In addition, the Company wrote off $574 of unamortized financing fees during 2018 relating to the prior credit facilities.
XML 33 R14.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurement
3 Months Ended
Mar. 31, 2019
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENT
FAIR VALUE MEASUREMENT
 
The Company’s valuation techniques and inputs used to measure fair value and the definition of the three levels (Level 1, Level 2, and Level 3) of the fair value hierarchy are disclosed in Part II, Item 8, “Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note 3—Fair Value Measurement” of the 2018 Annual Report. The Company has not changed the valuation techniques or inputs it uses for its fair value measurement during the three months ended March 31, 2019.
Assets and Liabilities Measured on a Recurring Basis
The Company’s restricted cash equivalents that serve as collateral for the Company’s outstanding letters of credit
typically consist of money market funds that are measured at fair value based on quoted prices, which are Level 1 inputs.
The Company’s restricted cash equivalents and investments that serve as collateral for the Company’s captive insurance company primarily consist of commercial paper that is measured at observable market prices for identical securities that are traded in less active markets, which are Level 2 inputs. Of the $61,786 commercial paper issued and outstanding as of March 31, 2019, $10,938 had original maturities greater than three months, which were considered available-for-sale securities. As of December 31, 2018, the Company had $63,243 commercial paper issued and outstanding, of which $15,192 had original maturities greater than three months and were considered available-for-sale securities.
The Company’s contingent consideration liabilities are measured at fair value using a probability-weighted discounted cash flow analysis or a simulation-based methodology for the acquired companies, which are Level 3 inputs. The Company recognizes changes to the fair value of its contingent consideration liabilities in selling, general and administrative expenses in the condensed consolidated statements of comprehensive income.
The following tables present information about the above-referenced assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value:
 
Fair Value Measurements as of March 31, 2019
 
Total
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Money market funds
$
2,473

 
$
2,473

 
$

 
$

Commercial paper
61,786

 

 
61,786

 

Acquisition contingent consideration liabilities
(8,500
)
 

 

 
(8,500
)

 
Fair Value Measurements as of December 31, 2018
 
Total
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Money market funds
$
2,461

 
$
2,461

 
$

 
$

Commercial paper
63,243

 

 
63,243

 

Acquisition contingent consideration liabilities
(7,700
)
 

 

 
(7,700
)

Level 3 Information
The following tables set forth a reconciliation of changes in the fair value of contingent consideration liabilities classified as Level 3 in the fair value hierarchy:
 
Three Months Ended March 31,
 
2019
 
2018
Balance as of January 1,
$
(7,700
)

$
(2,070
)
Settlement of HSG contingent consideration liability for year ended December 31, 2016

 
70

Settlement of HSG contingent consideration liability for year ended December 31, 2017

 
2,000

Change in fair value of contingent consideration liability from Medpartners acquisition
700

 

Contingent consideration liability from Silversheet acquisition on January 30, 2019
(1,500
)
 

Balance as of March 31,
$
(8,500
)
 
$


Assets Measured on a Non-Recurring Basis
The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets, and equity investments.
The Company evaluates goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs, including the market capitalization of the Company, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determines the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.
The Company’s equity investment represents an investment in a non-controlled corporation without a readily determinable market value. The Company has elected to measure the investment at cost minus impairment, if any, plus or minus changes resulting from observable price changes. The fair value is determined by using quoted prices for identical or similar investments of the same issuer, which are Level 2 inputs. The Company recognizes changes to the fair value of its equity investment in interest expense, net, and other in the condensed consolidated statements of comprehensive income.
The balance of the equity investment classified as Level 2 in the fair value hierarchy was $15,449 as of both March 31, 2019 and December 31, 2018. There were no changes to the fair value of the equity investment recognized during the three months ended March 31, 2019.
There were no triggering events identified, no indication of impairment of the Company’s goodwill, indefinite-lived intangible assets, long-lived assets, or equity investments, and no impairment charges recorded during the three months ended March 31, 2019 and 2018.
Fair Value of Financial Instruments
The Company is required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. As of March 31, 2019, the Company’s senior notes have a carrying amount of $325,000 and an estimated fair value of $320,531. As of December 31, 2018, the senior notes had a carrying amount of $325,000 and an estimated fair value of $310,375. Quoted market prices in active markets for identical liabilities based inputs (Level 1) were used to estimate fair value. The senior notes were issued in October 2016 and have a fixed rate of 5.125%. See additional information in “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (7), Notes Payable and Credit Agreement” of our 2018 Annual Report.
The fair value of the Company’s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.
XML 34 R15.htm IDEA: XBRL DOCUMENT v3.19.1
Leases
3 Months Ended
Mar. 31, 2019
Leases [Abstract]  
LEASES
LEASES

The Company leases certain office facilities, data centers, and equipment under various operating leases. Leases with an initial term of 12 months or less (primarily related to housing arrangements for healthcare professionals on assignment) are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term. Most leases include one or more options to renew, with renewal terms that can extend the lease term up to 10 years. Certain leases also include options to terminate the leases within 3 years.

The components of lease expense were as follows:
 
 
Three Months Ended March 31,
 
 
2019
Lease Cost
 
 
Operating lease cost
 
$
4,536

Short-term lease cost
 
5,922

Variable and other lease cost
 
717

Net lease cost
 
$
11,175



The maturity of lease liabilities as of March 31, 2019 were as follows: 
 
 
Operating Leases
Years ending December 31,
 
 
2019 (excluding the three months ended March 31, 2019)
 
$
13,091

2020
 
17,698

2021
 
18,183

2022
 
18,057

2023
 
17,795

Thereafter
 
50,318

Total lease payments
 
$
135,142

Less imputed interest
 
(22,855
)
Present value of lease liabilities
 
$
112,287



Supplemental cash flow information related to leases was as follows: 
 
 
Three Months Ended March 31,
 
 
2019
Cash paid for amounts included in the measurement of operating lease liabilities (operating cash flows)
 
$
4,338

Operating lease right-of-use assets obtained in exchange for lease obligations
 
$


Weighted average remaining lease term
 
7 years

Weighted average discount rate
 
4.8
%


Future minimum lease payments under noncancelable operating leases (with initial or remaining lease terms in excess of one year) as of December 31, 2018 were as follows: 
 
 
Operating Leases
Years ending December 31,
 

2019
 
$
18,218

2020
 
18,149

2021
 
18,349

2022
 
18,144

2023
 
17,990

Thereafter
 
50,436

Total minimum lease payments
 
$
141,286



Rent expense under operating leases (with initial lease terms in excess of one year) was $21,402 for the year ended December 31, 2018.
XML 35 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes
3 Months Ended
Mar. 31, 2019
Income Tax Disclosure [Abstract]  
INCOME TAXES
INCOME TAXES
The Company is subject to taxation in the U.S. and various states and foreign jurisdictions. With few exceptions, as of March 31, 2019, the Company is no longer subject to state, local or foreign examinations by tax authorities for tax years before 2009 and the Company is no longer subject to U.S. federal income or payroll tax examinations for tax years before 2015. The IRS conducted, completed, and settled audits of the Company’s 2011-2012 and 2013 tax years related to income and employment tax issues for the Company’s treatment of certain non-taxable per diem allowances and travel benefits in November 2017 and May 2018, respectively.

The Company believes its reserve for unrecognized tax benefits and contingent tax issues is adequate with respect to all open years. Notwithstanding the foregoing, the Company could adjust its provision for income taxes and contingent tax liability based on future developments.
XML 36 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies: Legal Proceedings
3 Months Ended
Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES: LEGAL PROCEEDINGS
COMMITMENTS AND CONTINGENCIES: LEGAL PROCEEDINGS

From time to time, the Company is involved in various lawsuits, claims, investigations, and proceedings that arise in the ordinary course of business. These matters typically relate to professional liability, tax, compensation, contract, competitor disputes and employee-related matters and include individual and class action lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company’s employment and compensation practices. Additionally, some of the Company’s clients may also become subject to claims, governmental inquiries and investigations, and legal actions relating to services provided by the Company’s healthcare professionals. Depending upon the particular facts and circumstances, the Company may also be subject to indemnification obligations under its contracts with such clients relating to these matters. The Company records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. The most significant matters for which the Company has established loss contingencies are class actions related to wage and hour claims under California and Federal law. Specifically, among other claims in these lawsuits, it is alleged that employees were not afforded required breaks or compensated for all time worked, employees’ wage statements are not sufficiently clear, and certain expense reimbursements should be included in the regular rate of pay for purposes of calculating overtime rates. The Company believes that its wage and hour practices conform with law in all material respects, but litigation is always subject to inherent uncertainty. As a result, the Company entered into settlement agreements relating to claims in two wage and hour class actions during September and October 2018. The settlement agreements are subject to court approval, which is considered probable. The Company recorded increases to its accruals established in connection with these matters amounting to $12,140 during the third quarter of 2018.
With regard to outstanding loss contingencies as of March 31, 2019, which are included in accounts payable and accrued expenses in the condensed consolidated balance sheet, the Company believes that such matters will not, either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations, or cash flows.
XML 37 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details
3 Months Ended
Mar. 31, 2019
Balance Sheet Related Disclosures [Abstract]  
BALANCE SHEET DETAILS
BALANCE SHEET DETAILS

The consolidated balance sheets detail is as follows as of March 31, 2019 and December 31, 2018:
 
 
March 31, 2019
 
December 31, 2018
Other current assets:
 
 
 
 
Restricted cash and cash equivalents
 
$
16,522

 
$
26,329

Income tax receivable
 

 
799

Other
 
14,687

 
12,759

Other current assets
 
$
31,209

 
$
39,887

 
 
 
 
 
Fixed assets:
 
 
 
 
Furniture and equipment
 
$
36,313

 
$
34,211

Software
 
168,030

 
162,006

Leasehold improvements
 
8,771

 
8,615

 
 
213,114

 
204,832

Accumulated depreciation
 
(119,489
)
 
(114,413
)
Fixed assets, net
 
$
93,625

 
$
90,419

 
 
 
 
 
Other assets:
 
 
 
 
Life insurance cash surrender value
 
$
64,500

 
$
55,028

Other
 
41,090

 
41,124

Other assets
 
$
105,590

 
$
96,152

 
 
 
 
 
Accounts payable and accrued expenses:
 
 
 
 
Trade accounts payable
 
$
23,203

 
$
31,537

Subcontractor payable
 
55,575

 
50,892

Accrued expenses
 
37,831

 
30,236

Loss contingencies
 
24,578

 
24,549

Professional liability reserve
 
7,961

 
8,633

Other
 
4,418

 
3,756

Accounts payable and accrued expenses
 
$
153,566

 
$
149,603

 
 
 
 
 
Accrued compensation and benefits:
 
 
 
 
Accrued payroll
 
$
39,933

 
$
42,571

Accrued bonuses
 
13,546

 
18,021

Accrued travel expense
 
2,684

 
3,417

Health insurance reserve
 
3,582

 
3,559

Workers compensation reserve
 
8,378

 
7,817

Deferred compensation
 
65,820

 
55,720

Other
 
1,849

 
3,954

Accrued compensation and benefits
 
$
135,792

 
$
135,059

 
 
 
 
 
Other current liabilities:
 
 
 
 
Acquisition related liabilities
 
$
7,668

 
$
7,918

Other
 
12,444


2,325

Other current liabilities
 
$
20,112


$
10,243

 
 
 
 
 
Other long-term liabilities:
 
 
 
 
Workers compensation reserve
 
$
18,953

 
$
19,454

Professional liability reserve
 
38,058

 
38,324

Deferred rent
 

 
15,012

Unrecognized tax benefits
 
4,916

 
4,862

Deferred revenue
 
769

 
865

Other
 
1,050

 
11

Other long-term liabilities
 
$
63,746

 
$
78,528

XML 38 R19.htm IDEA: XBRL DOCUMENT v3.19.1
Subsequent Events
3 Months Ended
Mar. 31, 2019
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS

On April 29, 2019, the Company entered into an agreement to acquire Advanced Medical Personnel Services, Inc. (“Advanced”) for $200,000 in cash and tiered contingent consideration of up to $20,000. Advanced is a national healthcare staffing company that specializes in placing therapists and nurses across multiple settings, including hospitals, schools, clinics, skilled nursing facilities, and home health. The closing of the acquisition is contingent upon satisfaction of certain conditions and, upon consummation, Advanced will become a wholly owned subsidiary of the Company.
XML 39 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Basis of Presentation (Policies)
3 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, earn-out liabilities, and income taxes. Actual results could differ from those estimates under different assumptions or conditions.
Recently Adopted Accounting Pronouncements
Recently Adopted Accounting Pronouncements
In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-02, “Leases.” This standard requires organizations that lease assets to recognize the assets and liabilities created by those leases. The standard also will require disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. A modified retrospective transition approach is required, applying the standard to all leases existing at the date of initial application. In addition, the FASB has also issued several amendments to the standard, which clarify certain aspects of the guidance, including an optional transition method for adoption of this standard, which allows organizations to initially apply the new requirements at the effective date, recognize a cumulative effect adjustment to the opening balance of retained earnings, and continue to apply the legacy guidance in Accounting Standards Codification (“ASC”) 840, Leases, including its disclosure requirements, in the comparative periods presented. The new standard provides a number of optional practical expedients in transition. The Company elected the ‘package of practical expedients’, which permits organizations not to reassess under the new standard prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect to use the hindsight practical expedient to determine the lease term or evaluate impairment for existing leases.
The Company adopted ASU 2016-02 effective January 1, 2019, using the optional transition method described above. The Company recognized the cumulative effect of adopting this guidance as an adjustment as of the effective date, primarily related to the recognition of lease liabilities of $114,807 and corresponding right-of-use assets of $99,525 for existing operating leases. The Company also derecognized existing deferred rent liabilities of $15,302. These adjustments had no effect on opening retained earnings and prior periods were not retrospectively adjusted and continue to be reported in accordance with ASC 840. The new standard also provides practical expedients for an organization’s ongoing accounting. The Company elected the short-term lease recognition exemption and the practical expedient to not separate lease and non-lease components for all leases that qualify. The Company does not expect the adoption of this standard to impact its results of operations.

There was no other material impact to the Company’s condensed consolidated financial statements as a result of adopting this updated standard.
Cash, cash equivalents and restricted cash
The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions and highly liquid investments. Restricted cash and cash equivalents primarily represent cash and money market funds on deposit with financial institutions and investments represents commercial paper that serves as collateral for the Company’s outstanding letters of credit and captive insurance subsidiary claim payments. See Note (6), “New Credit Agreement” and Note (7), “Fair Value Measurement” for additional information.
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying condensed consolidated balance sheets and related notes to the amounts presented in the accompanying condensed consolidated statements of cash flows.
 
March 31, 2019
 
December 31, 2018
Cash and cash equivalents
$
19,116

 
$
13,856

Restricted cash and cash equivalents (included in other current assets)
16,522

 
26,329

Restricted cash, cash equivalents and investments
61,279

 
59,331

Total cash, cash equivalents and restricted cash and investments
96,917

 
99,516

Less restricted investments
(10,938
)
 
(15,192
)
Total cash, cash equivalents and restricted cash
$
85,979

 
$
84,324



Revenue Recognition
Revenue primarily consists of fees earned from the temporary and permanent placement of healthcare professionals and executives as well as from the Company’s SaaS-based technology, including its vendor management systems and its scheduling software. Revenue is recognized when control of these services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. Revenue from temporary staffing services is recognized as the services are rendered by clinical and non-clinical healthcare professionals. Under the Company’s managed services program arrangements, the Company manages all or a part of a customer’s supplemental workforce needs utilizing its own network of healthcare professionals along with those of third-party subcontractors. Revenue and the related direct costs under MSP arrangements are recorded in accordance with the accounting guidance on reporting revenue gross as a principal versus net as an agent. When the Company uses subcontractors and acts as an agent, revenue is recorded net of the related subcontractor’s expense. Revenue from executive search, physician permanent placement, and recruitment process outsourcing services is recognized as the services are rendered. The Company’s SaaS-based revenue is recognized ratably over the applicable arrangement’s service period.
The Company’s customers are primarily billed as services are rendered. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended March 31, 2019, the amount recognized as revenue that was previously deferred was not material.
The Company has elected to apply the following practical expedients and optional exemptions related to contract costs and revenue recognition:
Recognize incremental costs of obtaining a contract with amortization periods of one year or less as expense when incurred. These costs are recorded within selling, general and administrative expenses.
Recognize revenue in the amount of consideration to which the Company has a right to invoice the customer if that amount corresponds directly with the value to the customer of the Company’s services completed to date.
Exemptions from disclosing the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, (ii) contracts for which revenue is recognized in the amount of consideration to which the Company has a right to invoice for services performed and (iii) contracts for which variable consideration is allocated entirely to a wholly unsatisfied performance obligation or to a wholly unsatisfied promise to transfer a distinct service that forms part of a single performance obligation.
Net Income per Common Share
Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period.
Segment Information
The Company’s chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation, interest expense, net, and other, and unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The Company is required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. As of March 31, 2019, the Company’s senior notes have a carrying amount of $325,000 and an estimated fair value of $320,531. As of December 31, 2018, the senior notes had a carrying amount of $325,000 and an estimated fair value of $310,375. Quoted market prices in active markets for identical liabilities based inputs (Level 1) were used to estimate fair value. The senior notes were issued in October 2016 and have a fixed rate of 5.125%. See additional information in “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (7), Notes Payable and Credit Agreement” of our 2018 Annual Report.
The fair value of the Company’s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.
Assets Measured on a Non-Recurring Basis
The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets, and equity investments.
The Company evaluates goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs, including the market capitalization of the Company, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determines the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.
Assets and Liabilities Measured on a Recurring Basis
The Company’s restricted cash equivalents that serve as collateral for the Company’s outstanding letters of credit
typically consist of money market funds that are measured at fair value based on quoted prices, which are Level 1 inputs.
The Company’s restricted cash equivalents and investments that serve as collateral for the Company’s captive insurance company primarily consist of commercial paper that is measured at observable market prices for identical securities that are traded in less active markets, which are Level 2 inputs. Of the $61,786 commercial paper issued and outstanding as of March 31, 2019, $10,938 had original maturities greater than three months, which were considered available-for-sale securities. As of December 31, 2018, the Company had $63,243 commercial paper issued and outstanding, of which $15,192 had original maturities greater than three months and were considered available-for-sale securities.
XML 40 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Basis of Presentation (Tables)
3 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Restricted Cash
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying condensed consolidated balance sheets and related notes to the amounts presented in the accompanying condensed consolidated statements of cash flows.
 
March 31, 2019
 
December 31, 2018
Cash and cash equivalents
$
19,116

 
$
13,856

Restricted cash and cash equivalents (included in other current assets)
16,522

 
26,329

Restricted cash, cash equivalents and investments
61,279

 
59,331

Total cash, cash equivalents and restricted cash and investments
96,917

 
99,516

Less restricted investments
(10,938
)
 
(15,192
)
Total cash, cash equivalents and restricted cash
$
85,979

 
$
84,324

Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying condensed consolidated balance sheets and related notes to the amounts presented in the accompanying condensed consolidated statements of cash flows.
 
March 31, 2019
 
December 31, 2018
Cash and cash equivalents
$
19,116

 
$
13,856

Restricted cash and cash equivalents (included in other current assets)
16,522

 
26,329

Restricted cash, cash equivalents and investments
61,279

 
59,331

Total cash, cash equivalents and restricted cash and investments
96,917

 
99,516

Less restricted investments
(10,938
)
 
(15,192
)
Total cash, cash equivalents and restricted cash
$
85,979

 
$
84,324

XML 41 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Acquisition (Tables)
3 Months Ended
Mar. 31, 2019
Business Combinations [Abstract]  
Schedule of Intangible Assets Acquired
The following table summarizes the fair value and useful life of each intangible asset acquired:
 
 
 
Fair Value
 
Useful Life
 
 
 
 
 
(in years)
Identifiable intangible assets
 
 
 
 
 
Tradenames and Trademarks
 
$
46,000

 
20
 
Customer Relationships
 
57,000

 
12
 
 
 
$
103,000

 
 
XML 42 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Net Income Per Common Share (Tables)
3 Months Ended
Mar. 31, 2019
Earnings Per Share [Abstract]  
Computation of basic and diluted net income per common share
The following table sets forth the computation of basic and diluted net income per common share for the three and three months ended March 31, 2019 and 2018, respectively:
 
Three Months Ended March 31,
 
2019
 
2018
Net income
$
34,122

 
$
42,681

 
 
 
 
Net income per common share - basic
$
0.73

 
$
0.89

Net income per common share - diluted
$
0.71

 
$
0.87

 
 
 
 
Weighted average common shares outstanding - basic
46,784

 
47,733

Plus dilutive effect of potential common shares
988

 
1,383

Weighted average common shares outstanding - diluted
47,772

 
49,116

XML 43 R24.htm IDEA: XBRL DOCUMENT v3.19.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes:
 
Three Months Ended March 31,
 
2019

2018
Revenue
 
 
 
Nurse and allied solutions
$
337,029

 
$
338,179

Locum tenens solutions
80,490

 
103,117

Other workforce solutions
114,922

 
81,193

 
$
532,441

 
$
522,489

Segment operating income
 
 
 
Nurse and allied solutions
$
47,922

 
$
51,805

Locum tenens solutions
5,701

 
9,958

Other workforce solutions
26,188

 
19,851

 
79,811

 
81,614

Unallocated corporate overhead
17,863

 
15,663

Depreciation and amortization
11,710

 
7,886

Share-based compensation
5,186

 
2,864

Interest expense, net, and other
5,673

 
5,335

Income before income taxes
$
39,379

 
$
49,866

Summary of goodwill by reportable segment
The following table summarizes the activity related to the carrying value of goodwill by reportable segment:
 
Nurse and Allied Solutions
 
Locum Tenens Solutions
 
Other Workforce Solutions
 
Total
Balance, January 1, 2019
$
103,107

 
$
19,743

 
$
315,656

 
$
438,506

Goodwill adjustment for MedPartners acquisition

 

 
(64
)
 
(64
)
Goodwill adjustment for PDA and LFT acquisition

 

 
(13
)
 
(13
)
Goodwill from Silversheet acquisition

 

 
26,494

 
26,494

Balance, March 31, 2019
$
103,107

 
$
19,743

 
$
342,073

 
$
464,923

Accumulated impairment loss as of December 31, 2018 and March 31, 2019
$
154,444

 
$
53,940

 
$
6,555

 
$
214,939

XML 44 R25.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurement (Tables)
3 Months Ended
Mar. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of financial assets and liabilities measured at fair value on recurring basis
The following tables present information about the above-referenced assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value:
 
Fair Value Measurements as of March 31, 2019
 
Total
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Money market funds
$
2,473

 
$
2,473

 
$

 
$

Commercial paper
61,786

 

 
61,786

 

Acquisition contingent consideration liabilities
(8,500
)
 

 

 
(8,500
)

 
Fair Value Measurements as of December 31, 2018
 
Total
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Money market funds
$
2,461

 
$
2,461

 
$

 
$

Commercial paper
63,243

 

 
63,243

 

Acquisition contingent consideration liabilities
(7,700
)
 

 

 
(7,700
)
Reconciliations of changes in the fair value of contingent consideration liabilities
The following tables set forth a reconciliation of changes in the fair value of contingent consideration liabilities classified as Level 3 in the fair value hierarchy:
 
Three Months Ended March 31,
 
2019
 
2018
Balance as of January 1,
$
(7,700
)

$
(2,070
)
Settlement of HSG contingent consideration liability for year ended December 31, 2016

 
70

Settlement of HSG contingent consideration liability for year ended December 31, 2017

 
2,000

Change in fair value of contingent consideration liability from Medpartners acquisition
700

 

Contingent consideration liability from Silversheet acquisition on January 30, 2019
(1,500
)
 

Balance as of March 31,
$
(8,500
)
 
$

Reconciliations of equity investments included in net income
The balance of the equity investment classified as Level 2 in the fair value hierarchy was $15,449 as of both March 31, 2019 and December 31, 2018. There were no changes to the fair value of the equity investment recognized during the three months ended March 31, 2019.
XML 45 R26.htm IDEA: XBRL DOCUMENT v3.19.1
Leases (Tables)
3 Months Ended
Mar. 31, 2019
Leases [Abstract]  
Maturity of Lease Liabilities
The maturity of lease liabilities as of March 31, 2019 were as follows: 
 
 
Operating Leases
Years ending December 31,
 
 
2019 (excluding the three months ended March 31, 2019)
 
$
13,091

2020
 
17,698

2021
 
18,183

2022
 
18,057

2023
 
17,795

Thereafter
 
50,318

Total lease payments
 
$
135,142

Less imputed interest
 
(22,855
)
Present value of lease liabilities
 
$
112,287

Supplemental Cash Flow Disclosures Related to Leases
Supplemental cash flow information related to leases was as follows: 
 
 
Three Months Ended March 31,
 
 
2019
Cash paid for amounts included in the measurement of operating lease liabilities (operating cash flows)
 
$
4,338

Operating lease right-of-use assets obtained in exchange for lease obligations
 
$

The components of lease expense were as follows:
 
 
Three Months Ended March 31,
 
 
2019
Lease Cost
 
 
Operating lease cost
 
$
4,536

Short-term lease cost
 
5,922

Variable and other lease cost
 
717

Net lease cost
 
$
11,175

Assumptions Used for Operating Leases
Weighted average remaining lease term
 
7 years

Weighted average discount rate
 
4.8
%
Schedule of Future Minimum Payments for Operating Leases Under ASC 840
Future minimum lease payments under noncancelable operating leases (with initial or remaining lease terms in excess of one year) as of December 31, 2018 were as follows: 
 
 
Operating Leases
Years ending December 31,
 

2019
 
$
18,218

2020
 
18,149

2021
 
18,349

2022
 
18,144

2023
 
17,990

Thereafter
 
50,436

Total minimum lease payments
 
$
141,286

XML 46 R27.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details (Tables)
3 Months Ended
Mar. 31, 2019
Balance Sheet Related Disclosures [Abstract]  
Schedule of Supplemental Balance Sheet Disclosures
The consolidated balance sheets detail is as follows as of March 31, 2019 and December 31, 2018:
 
 
March 31, 2019
 
December 31, 2018
Other current assets:
 
 
 
 
Restricted cash and cash equivalents
 
$
16,522

 
$
26,329

Income tax receivable
 

 
799

Other
 
14,687

 
12,759

Other current assets
 
$
31,209

 
$
39,887

 
 
 
 
 
Fixed assets:
 
 
 
 
Furniture and equipment
 
$
36,313

 
$
34,211

Software
 
168,030

 
162,006

Leasehold improvements
 
8,771

 
8,615

 
 
213,114

 
204,832

Accumulated depreciation
 
(119,489
)
 
(114,413
)
Fixed assets, net
 
$
93,625

 
$
90,419

 
 
 
 
 
Other assets:
 
 
 
 
Life insurance cash surrender value
 
$
64,500

 
$
55,028

Other
 
41,090

 
41,124

Other assets
 
$
105,590

 
$
96,152

 
 
 
 
 
Accounts payable and accrued expenses:
 
 
 
 
Trade accounts payable
 
$
23,203

 
$
31,537

Subcontractor payable
 
55,575

 
50,892

Accrued expenses
 
37,831

 
30,236

Loss contingencies
 
24,578

 
24,549

Professional liability reserve
 
7,961

 
8,633

Other
 
4,418

 
3,756

Accounts payable and accrued expenses
 
$
153,566

 
$
149,603

 
 
 
 
 
Accrued compensation and benefits:
 
 
 
 
Accrued payroll
 
$
39,933

 
$
42,571

Accrued bonuses
 
13,546

 
18,021

Accrued travel expense
 
2,684

 
3,417

Health insurance reserve
 
3,582

 
3,559

Workers compensation reserve
 
8,378

 
7,817

Deferred compensation
 
65,820

 
55,720

Other
 
1,849

 
3,954

Accrued compensation and benefits
 
$
135,792

 
$
135,059

 
 
 
 
 
Other current liabilities:
 
 
 
 
Acquisition related liabilities
 
$
7,668

 
$
7,918

Other
 
12,444


2,325

Other current liabilities
 
$
20,112


$
10,243

 
 
 
 
 
Other long-term liabilities:
 
 
 
 
Workers compensation reserve
 
$
18,953

 
$
19,454

Professional liability reserve
 
38,058

 
38,324

Deferred rent
 

 
15,012

Unrecognized tax benefits
 
4,916

 
4,862

Deferred revenue
 
769

 
865

Other
 
1,050

 
11

Other long-term liabilities
 
$
63,746

 
$
78,528

XML 47 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Basis of Presentation Basis of Presentation - Recently Adopted Accounting Pronouncements (Details) - USD ($)
$ in Thousands
Jan. 01, 2019
Mar. 31, 2019
Dec. 31, 2018
Mar. 31, 2018
Dec. 31, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Operating lease right-of-use assets   $ 97,055      
Present value of lease liabilities   112,287      
Cash and cash equivalents   19,116 $ 13,856    
Restricted cash and cash equivalents (included in other current assets)   16,522 26,329    
Restricted cash, cash equivalents and investments   61,279 59,331    
Total cash, cash equivalents and restricted cash and investments   96,917 99,516    
Less restricted investments   (10,938) (15,192)    
Cash, cash equivalents and restricted cash at the end of period   $ 85,979 $ 84,324 $ 134,027 $ 98,894
Accounting Standards Update 2016-02          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Operating lease right-of-use assets $ 99,525        
Present value of lease liabilities (114,807)        
Derecognition of existing deferred rent liabilities $ 15,302        
XML 48 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Acquisitions (Details)
3 Months Ended
Jan. 30, 2019
USD ($)
Apr. 09, 2018
USD ($)
Apr. 06, 2018
USD ($)
Mar. 31, 2019
USD ($)
aquisition
Sep. 30, 2018
USD ($)
Dec. 31, 2018
USD ($)
Feb. 09, 2018
USD ($)
Business Acquisition [Line Items]              
Number of acquisitions | aquisition       3      
Goodwill       $ 464,923,000   $ 438,506,000  
Silversheet              
Business Acquisition [Line Items]              
Initial purchase price $ 31,676,000            
Cash consideration 30,176,000            
Tiered contingent earn-out payment 25,000,000            
Estimated fair value of contingent earn-out payment 1,500,000            
Tangible assets acquired, including cash received 1,692,000            
Cash received 651,000            
Liabilities assumed 3,390,000            
Intangible assets acquired 6,880,000            
Goodwill $ 26,494,000            
Intangible assets, weighted-average useful life (in years) 8 years            
Silversheet | Based on operating results for the twelve months ending December 31, 2019              
Business Acquisition [Line Items]              
Tiered contingent earn-out payment $ 6,000,000            
Silversheet | Based on operating results for the twelve months ending December 31, 2020              
Business Acquisition [Line Items]              
Tiered contingent earn-out payment 19,000,000            
Silversheet | Developed Technology              
Business Acquisition [Line Items]              
Intangible assets acquired 5,300,000            
Silversheet | Trademarks              
Business Acquisition [Line Items]              
Intangible assets acquired $ 1,500,000            
MedPartners              
Business Acquisition [Line Items]              
Initial purchase price   $ 200,711,000          
Cash consideration   196,533,000          
Tiered contingent earn-out payment   20,000,000          
Estimated fair value of contingent earn-out payment   4,400,000          
Tangible assets acquired, including cash received   28,510,000          
Cash received   8,403,000          
Liabilities assumed   11,848,000          
Intangible assets acquired   103,000,000          
Goodwill   $ 81,049,000          
Intangible assets, weighted-average useful life (in years)   16 years          
Working capital settlement received         $ 222,000    
MedPartners | Based on operating results for the twelve months ending December 31, 2018              
Business Acquisition [Line Items]              
Tiered contingent earn-out payment   $ 10,000,000          
MedPartners | Based on operating results for the six months ended June 30, 2019              
Business Acquisition [Line Items]              
Tiered contingent earn-out payment   10,000,000          
MedPartners | Customer Relationships              
Business Acquisition [Line Items]              
Intangible assets acquired   $ 57,000,000          
PDA and LFT              
Business Acquisition [Line Items]              
Initial purchase price     $ 35,503,000        
Cash consideration     30,268,000        
Tiered contingent earn-out payment     7,000,000        
Estimated fair value of contingent earn-out payment     5,700,000        
Tangible assets acquired, including cash received     4,373,000        
Cash received     351,000        
Liabilities assumed     4,764,000        
Intangible assets acquired     19,110,000        
Goodwill     $ 16,784,000        
Intangible assets, weighted-average useful life (in years)     12 years        
Working capital settlement received         $ 465,000    
PDA and LFT | Trademarks              
Business Acquisition [Line Items]              
Intangible assets acquired     $ 5,400,000        
PDA and LFT | Customer Relationships              
Business Acquisition [Line Items]              
Intangible assets acquired     8,000,000        
PDA and LFT | Staffing Databases              
Business Acquisition [Line Items]              
Intangible assets acquired     $ 5,710,000        
Revolving Credit Facility | Line of Credit              
Business Acquisition [Line Items]              
Maximum borrowing capacity             $ 400,000,000
XML 49 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Acquisitions - Schedule of Intangible Assets Acquired (Details) - MedPartners
$ in Thousands
Apr. 09, 2018
USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]  
Intangible assets acquired $ 103,000
Tradenames and Trademarks  
Acquired Finite-Lived Intangible Assets [Line Items]  
Intangible assets acquired $ 46,000
Useful Life 20 years
Customer Relationships  
Acquired Finite-Lived Intangible Assets [Line Items]  
Intangible assets acquired $ 57,000
Useful Life 12 years
XML 50 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Net Income Per Common Share - Narrative (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Computation of basic and diluted net income per common share    
Net income $ 34,122 $ 42,681
Net income per common share - basic (in dollars per share) $ 0.73 $ 0.89
Net income per common share - diluted (in dollars per share) $ 0.71 $ 0.87
Weighted average common shares outstanding - basic (in shares) 46,784 47,733
Plus dilutive effect of potential common shares (in shares) 988 1,383
Weighted average common shares outstanding - diluted (in shares) 47,772 49,116
Common stock excluded from calculation of EPS (in shares) 66 9
XML 51 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Segment Information - Narrative (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2019
USD ($)
segment
Mar. 31, 2018
USD ($)
Segment Reporting, Revenue Reconciling Item [Line Items]    
Number of reportable segments | segment 3  
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results    
Revenue $ 532,441 $ 522,489
Segment operating income 45,052 55,201
Depreciation and amortization 11,710 7,886
Share-based compensation 5,186 2,864
Interest expense, net, and other 5,673 5,335
Income before income taxes 39,379 49,866
Operating segments    
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results    
Revenue 532,441 522,489
Segment operating income 79,811 81,614
Operating segments | Nurse and Allied Solutions    
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results    
Revenue 337,029 338,179
Segment operating income 47,922 51,805
Operating segments | Locum Tenens Solutions    
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results    
Revenue 80,490 103,117
Segment operating income 5,701 9,958
Operating segments | Other Workforce Solutions    
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results    
Revenue 114,922 81,193
Segment operating income 26,188 19,851
Unallocated corporate overhead    
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results    
Unallocated corporate overhead $ 17,863 $ 15,663
Product concentration risk | Sales revenue, net | Managed Services Program Arrangements | Nurse and Allied Solutions    
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results    
Revenue from contract with customer, percent 67.00% 63.00%
Product concentration risk | Sales revenue, net | Managed Services Program Arrangements | Locum Tenens Solutions    
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results    
Revenue from contract with customer, percent 24.00% 14.00%
Product concentration risk | Sales revenue, net | Managed Services Program Arrangements | Other Workforce Solutions    
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results    
Revenue from contract with customer, percent 7.00% 9.00%
XML 52 R33.htm IDEA: XBRL DOCUMENT v3.19.1
Segment Information - Goodwill (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Goodwill [Roll Forward]    
Goodwill, beginning balance $ 438,506  
Goodwill, ending balance 464,923  
Accumulated impairment loss 214,939 $ 214,939
Nurse and Allied Solutions    
Goodwill [Roll Forward]    
Goodwill, beginning balance 103,107  
Goodwill, ending balance 103,107  
Accumulated impairment loss 154,444 154,444
Locum Tenens Solutions    
Goodwill [Roll Forward]    
Goodwill, beginning balance 19,743  
Goodwill, ending balance 19,743  
Accumulated impairment loss 53,940 53,940
Other Workforce Solutions    
Goodwill [Roll Forward]    
Goodwill, beginning balance 315,656  
Goodwill, ending balance 342,073  
Accumulated impairment loss 6,555 $ 6,555
MedPartners    
Goodwill [Roll Forward]    
Goodwill, adjustments (64)  
MedPartners | Other Workforce Solutions    
Goodwill [Roll Forward]    
Goodwill, adjustments (64)  
PDA and LFT    
Goodwill [Roll Forward]    
Goodwill, adjustments (13)  
PDA and LFT | Other Workforce Solutions    
Goodwill [Roll Forward]    
Goodwill, adjustments (13)  
Silversheet    
Goodwill [Roll Forward]    
Goodwill acquired 26,494  
Silversheet | Nurse and Allied Solutions    
Goodwill [Roll Forward]    
Goodwill acquired 0  
Silversheet | Locum Tenens Solutions    
Goodwill [Roll Forward]    
Goodwill acquired 0  
Silversheet | Other Workforce Solutions    
Goodwill [Roll Forward]    
Goodwill acquired $ 26,494  
XML 53 R34.htm IDEA: XBRL DOCUMENT v3.19.1
New Credit Agreement - Narrative (Details) - Line of Credit - USD ($)
3 Months Ended
Feb. 09, 2018
Mar. 31, 2019
Debt Instrument [Line Items]    
Fees paid to lenders and other third parties   $ 2,331,000
Unamortized financing fees written off   $ 574,000
Letter of Credit    
Debt Instrument [Line Items]    
Maximum borrowing capacity $ 50,000,000  
Revolving Credit Facility, Swing Line Loan    
Debt Instrument [Line Items]    
Maximum borrowing capacity 50,000,000  
Revolving Credit Facility    
Debt Instrument [Line Items]    
Maximum borrowing capacity $ 400,000,000  
Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Minimum    
Debt Instrument [Line Items]    
Basis spread on variable rate 1.00%  
Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Maximum    
Debt Instrument [Line Items]    
Basis spread on variable rate 2.00%  
Revolving Credit Facility | Base Rate | Minimum    
Debt Instrument [Line Items]    
Basis spread on variable rate 0.00%  
Revolving Credit Facility | Base Rate | Maximum    
Debt Instrument [Line Items]    
Basis spread on variable rate 1.00%  
XML 54 R35.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurement - Narrative (Details) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Oct. 31, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Impairment charges $ 0 $ 0    
Fair Value, Measurements, Nonrecurring | Significant Other Observable Inputs (Level 2)        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Equity investment balance 15,449,000   $ 15,449,000  
Commercial paper | Fair Value, Measurements, Recurring        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Commercial paper 61,786,000   63,243,000  
Commercial paper | Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Commercial paper 61,786,000   63,243,000  
Available-for-sale securities 10,938,000   15,192,000  
5.125% Senior Notes due 2024 [Member] | Senior Notes        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Carrying amount of senior notes 325,000,000   325,000,000  
Estimated fair value of senior notes $ 320,531,000   $ 310,375,000  
5.125% Senior Notes Due 2024 | Senior Notes        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Interest rate       5.125%
XML 55 R36.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurement - Financial Assets and Liabilities (Details) - Fair Value, Measurements, Recurring - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Money market funds    
Schedule of financial assets and liabilities measured at fair value on recurring basis    
Financial assets and liabilities measured at fair value $ 2,473 $ 2,461
Money market funds | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Schedule of financial assets and liabilities measured at fair value on recurring basis    
Financial assets and liabilities measured at fair value 2,473 2,461
Money market funds | Significant Other Observable Inputs (Level 2)    
Schedule of financial assets and liabilities measured at fair value on recurring basis    
Financial assets and liabilities measured at fair value 0 0
Money market funds | Significant Unobservable Inputs (Level 3)    
Schedule of financial assets and liabilities measured at fair value on recurring basis    
Financial assets and liabilities measured at fair value 0 0
Commercial paper    
Schedule of financial assets and liabilities measured at fair value on recurring basis    
Financial assets and liabilities measured at fair value 61,786 63,243
Commercial paper | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Schedule of financial assets and liabilities measured at fair value on recurring basis    
Financial assets and liabilities measured at fair value 0 0
Commercial paper | Significant Other Observable Inputs (Level 2)    
Schedule of financial assets and liabilities measured at fair value on recurring basis    
Financial assets and liabilities measured at fair value 61,786 63,243
Commercial paper | Significant Unobservable Inputs (Level 3)    
Schedule of financial assets and liabilities measured at fair value on recurring basis    
Financial assets and liabilities measured at fair value 0 0
Acquisition contingent consideration liabilities    
Schedule of financial assets and liabilities measured at fair value on recurring basis    
Financial assets and liabilities measured at fair value (8,500) (7,700)
Acquisition contingent consideration liabilities | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Schedule of financial assets and liabilities measured at fair value on recurring basis    
Financial assets and liabilities measured at fair value 0 0
Acquisition contingent consideration liabilities | Significant Other Observable Inputs (Level 2)    
Schedule of financial assets and liabilities measured at fair value on recurring basis    
Financial assets and liabilities measured at fair value 0 0
Acquisition contingent consideration liabilities | Significant Unobservable Inputs (Level 3)    
Schedule of financial assets and liabilities measured at fair value on recurring basis    
Financial assets and liabilities measured at fair value $ (8,500) $ (7,700)
XML 56 R37.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurement - Reconciliation of Changes in Contingent Consideration Liabilities (Details) - Significant Unobservable Inputs (Level 3) - Acquisition contingent consideration liabilities - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning balance $ (7,700) $ (2,070)
Ending balance (8,500) 0
MedPartners    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Change in fair value of contingent consideration earn-out liability from acquisition 700 0
Silversheet    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Contingent consideration earn-out liability (1,500) 0
Contingent consideration liability for year ended December 31, 2016 | HSG    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Settlement of earn-out 0 70
Contingent consideration liability for year ended December 31, 2017 | HSG    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Settlement of earn-out $ 0 $ 2,000
XML 57 R38.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Lessee, Lease, Description [Line Items]    
Option to extend, term 10 years  
Option to terminate, term 3 years  
Rent expense   $ 21,402
Minimum    
Lessee, Lease, Description [Line Items]    
Lease term 1 year  
XML 58 R39.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Components of Lease Expense (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2019
USD ($)
Leases [Abstract]  
Operating lease cost $ 4,536
Short-term lease cost 5,922
Variable and other lease cost 717
Net lease cost $ 11,175
XML 59 R40.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Maturity of Lease Liabilities (Details)
$ in Thousands
Mar. 31, 2019
USD ($)
Leases [Abstract]  
2019 (excluding the three months ended March 31, 2019) $ 13,091
2020 17,698
2021 18,183
2022 18,057
2023 17,795
Thereafter 50,318
Total lease payments 135,142
Less imputed interest (22,855)
Present value of lease liabilities $ 112,287
XML 60 R41.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Supplemental Cash Flow Information Regarding Leases (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2019
USD ($)
Leases [Abstract]  
Cash paid for amounts included in the measurement of operating lease liabilities (operating cash flows) $ 4,338
Operating lease right-of-use assets obtained in exchange for lease obligations $ 0
XML 61 R42.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Assumptions Used for Operating Leases (Details)
Mar. 31, 2019
Leases [Abstract]  
Weighted average remaining lease term 7 years
Weighted average discount rate 4.80%
XML 62 R43.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Minimum Lease Payments Under ASC 840 (Details)
$ in Thousands
Dec. 31, 2018
USD ($)
Leases [Abstract]  
2019 $ 18,218
2020 18,149
2021 18,349
2022 18,144
2023 17,990
Thereafter 50,436
Total minimum lease payments $ 141,286
XML 63 R44.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies: Legal Proceedings - Narrative (Details) - Wage and Hour claims - Pending Litigation
$ in Thousands
3 Months Ended
Sep. 30, 2018
USD ($)
Oct. 31, 2018
claim
Loss Contingencies [Line Items]    
Number of class actions related to wage and hour claims | claim   2
Increase to loss contingency accruals | $ $ 12,140  
XML 64 R45.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details - Narrative (Details) - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Other current assets:    
Restricted cash and cash equivalents $ 16,522 $ 26,329
Income tax receivable 0 799
Other 14,687 12,759
Other current assets 31,209 39,887
Fixed assets:    
Furniture and equipment 36,313 34,211
Software 168,030 162,006
Leasehold improvements 8,771 8,615
Fixed assets, gross 213,114 204,832
Accumulated depreciation (119,489) (114,413)
Fixed assets, net 93,625 90,419
Other assets:    
Life insurance cash surrender value 64,500 55,028
Other 41,090 41,124
Other assets 105,590 96,152
Accounts payable and accrued expenses:    
Trade accounts payable 23,203 31,537
Subcontractor payable 55,575 50,892
Accrued expenses 37,831 30,236
Loss contingencies 24,578 24,549
Professional liability reserve 7,961 8,633
Other 4,418 3,756
Accounts payable and accrued expenses 153,566 149,603
Accrued compensation and benefits:    
Accrued payroll 39,933 42,571
Accrued bonuses 13,546 18,021
Accrued travel expense 2,684 3,417
Health insurance reserve 3,582 3,559
Workers compensation reserve 8,378 7,817
Deferred compensation 65,820 55,720
Other 1,849 3,954
Accrued compensation and benefits 135,792 135,059
Other current liabilities:    
Acquisition related liabilities 7,668 7,918
Other 12,444 2,325
Other current liabilities 20,112 10,243
Other long-term liabilities:    
Workers compensation reserve 18,953 19,454
Professional liability reserve 38,058 38,324
Deferred rent 0 15,012
Unrecognized tax benefits 4,916 4,862
Deferred revenue 769 865
Other 1,050 11
Other long-term liabilities $ 63,746 $ 78,528
XML 65 R46.htm IDEA: XBRL DOCUMENT v3.19.1
Subsequent Events - Narrative (Details) - Advanced - Subsequent Event
Apr. 29, 2019
USD ($)
Subsequent Event [Line Items]  
Cash consideration $ 200,000,000
Tiered contingent earn-out payment $ 20,000,000
XML 66 R9999.htm IDEA: XBRL DOCUMENT v3.19.1
Label Element Value
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption $ 2,089,000
Retained Earnings [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption $ 2,089,000
XML 67 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} EXCEL 68 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 69 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 70 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 147 260 1 false 53 0 false 7 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.amnhealthcare.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income Sheet http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income Statements 4 false false R5.htm 1004000 - Statement - Condensed Consolidated Statements of Stockholders' Equity Sheet http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 1005000 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 1005501 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsOfCashFlowsParenthetical Condensed Consolidated Statements of Cash Flows (Parenthetical) Statements 7 false false R8.htm 2101100 - Disclosure - Basis of Presentation Sheet http://www.amnhealthcare.com/role/BasisOfPresentation Basis of Presentation Notes 8 false false R9.htm 2103100 - Disclosure - Acquisitions Sheet http://www.amnhealthcare.com/role/Acquisitions Acquisitions Notes 9 false false R10.htm 2104100 - Disclosure - Revenue Recognition Sheet http://www.amnhealthcare.com/role/RevenueRecognition Revenue Recognition Notes 10 false false R11.htm 2105100 - Disclosure - Net Income Per Common Share Sheet http://www.amnhealthcare.com/role/NetIncomePerCommonShare Net Income Per Common Share Notes 11 false false R12.htm 2117100 - Disclosure - Segment Information Sheet http://www.amnhealthcare.com/role/SegmentInformation Segment Information Notes 12 false false R13.htm 2118100 - Disclosure - New Credit Agreement Sheet http://www.amnhealthcare.com/role/NewCreditAgreement New Credit Agreement Notes 13 false false R14.htm 2119100 - Disclosure - Fair Value Measurement Sheet http://www.amnhealthcare.com/role/FairValueMeasurement Fair Value Measurement Notes 14 false false R15.htm 2120100 - Disclosure - Leases Sheet http://www.amnhealthcare.com/role/Leases Leases Notes 15 false false R16.htm 2121100 - Disclosure - Income Taxes Sheet http://www.amnhealthcare.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 2122100 - Disclosure - Commitments and Contingencies: Legal Proceedings Sheet http://www.amnhealthcare.com/role/CommitmentsAndContingenciesLegalProceedings Commitments and Contingencies: Legal Proceedings Notes 17 false false R18.htm 2123100 - Disclosure - Balance Sheet Details Sheet http://www.amnhealthcare.com/role/BalanceSheetDetails Balance Sheet Details Notes 18 false false R19.htm 2124100 - Disclosure - Subsequent Events Sheet http://www.amnhealthcare.com/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 2201201 - Disclosure - Basis of Presentation (Policies) Sheet http://www.amnhealthcare.com/role/BasisOfPresentationPolicies Basis of Presentation (Policies) Policies 20 false false R21.htm 2301302 - Disclosure - Basis of Presentation (Tables) Sheet http://www.amnhealthcare.com/role/BasisOfPresentationTables Basis of Presentation (Tables) Tables http://www.amnhealthcare.com/role/BasisOfPresentation 21 false false R22.htm 2303301 - Disclosure - Acquisition (Tables) Sheet http://www.amnhealthcare.com/role/AcquisitionTables Acquisition (Tables) Tables http://www.amnhealthcare.com/role/Acquisitions 22 false false R23.htm 2305301 - Disclosure - Net Income Per Common Share (Tables) Sheet http://www.amnhealthcare.com/role/NetIncomePerCommonShareTables Net Income Per Common Share (Tables) Tables http://www.amnhealthcare.com/role/NetIncomePerCommonShare 23 false false R24.htm 2317301 - Disclosure - Segment Information (Tables) Sheet http://www.amnhealthcare.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.amnhealthcare.com/role/SegmentInformation 24 false false R25.htm 2319301 - Disclosure - Fair Value Measurement (Tables) Sheet http://www.amnhealthcare.com/role/FairValueMeasurementTables Fair Value Measurement (Tables) Tables http://www.amnhealthcare.com/role/FairValueMeasurement 25 false false R26.htm 2320301 - Disclosure - Leases (Tables) Sheet http://www.amnhealthcare.com/role/LeasesTables Leases (Tables) Tables http://www.amnhealthcare.com/role/Leases 26 false false R27.htm 2323301 - Disclosure - Balance Sheet Details (Tables) Sheet http://www.amnhealthcare.com/role/BalanceSheetDetailsTables Balance Sheet Details (Tables) Tables http://www.amnhealthcare.com/role/BalanceSheetDetails 27 false false R28.htm 2401403 - Disclosure - Basis of Presentation Basis of Presentation - Recently Adopted Accounting Pronouncements (Details) Sheet http://www.amnhealthcare.com/role/BasisOfPresentationBasisOfPresentationRecentlyAdoptedAccountingPronouncementsDetails Basis of Presentation Basis of Presentation - Recently Adopted Accounting Pronouncements (Details) Details 28 false false R29.htm 2403402 - Disclosure - Acquisitions (Details) Sheet http://www.amnhealthcare.com/role/AcquisitionsDetails Acquisitions (Details) Details http://www.amnhealthcare.com/role/AcquisitionTables 29 false false R30.htm 2403403 - Disclosure - Acquisitions - Schedule of Intangible Assets Acquired (Details) Sheet http://www.amnhealthcare.com/role/AcquisitionsScheduleOfIntangibleAssetsAcquiredDetails Acquisitions - Schedule of Intangible Assets Acquired (Details) Details 30 false false R31.htm 2405402 - Disclosure - Net Income Per Common Share - Narrative (Details) Sheet http://www.amnhealthcare.com/role/NetIncomePerCommonShareNarrativeDetails Net Income Per Common Share - Narrative (Details) Details 31 false false R32.htm 2417402 - Disclosure - Segment Information - Narrative (Details) Sheet http://www.amnhealthcare.com/role/SegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 32 false false R33.htm 2417403 - Disclosure - Segment Information - Goodwill (Details) Sheet http://www.amnhealthcare.com/role/SegmentInformationGoodwillDetails Segment Information - Goodwill (Details) Details 33 false false R34.htm 2418401 - Disclosure - New Credit Agreement - Narrative (Details) Sheet http://www.amnhealthcare.com/role/NewCreditAgreementNarrativeDetails New Credit Agreement - Narrative (Details) Details 34 false false R35.htm 2419402 - Disclosure - Fair Value Measurement - Narrative (Details) Sheet http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails Fair Value Measurement - Narrative (Details) Details 35 false false R36.htm 2419403 - Disclosure - Fair Value Measurement - Financial Assets and Liabilities (Details) Sheet http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsAndLiabilitiesDetails Fair Value Measurement - Financial Assets and Liabilities (Details) Details 36 false false R37.htm 2419404 - Disclosure - Fair Value Measurement - Reconciliation of Changes in Contingent Consideration Liabilities (Details) Sheet http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationOfChangesInContingentConsiderationLiabilitiesDetails Fair Value Measurement - Reconciliation of Changes in Contingent Consideration Liabilities (Details) Details 37 false false R38.htm 2420402 - Disclosure - Leases - Narrative (Details) Sheet http://www.amnhealthcare.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 38 false false R39.htm 2420403 - Disclosure - Leases - Components of Lease Expense (Details) Sheet http://www.amnhealthcare.com/role/LeasesComponentsOfLeaseExpenseDetails Leases - Components of Lease Expense (Details) Details 39 false false R40.htm 2420404 - Disclosure - Leases - Maturity of Lease Liabilities (Details) Sheet http://www.amnhealthcare.com/role/LeasesMaturityOfLeaseLiabilitiesDetails Leases - Maturity of Lease Liabilities (Details) Details 40 false false R41.htm 2420405 - Disclosure - Leases - Supplemental Cash Flow Information Regarding Leases (Details) Sheet http://www.amnhealthcare.com/role/LeasesSupplementalCashFlowInformationRegardingLeasesDetails Leases - Supplemental Cash Flow Information Regarding Leases (Details) Details 41 false false R42.htm 2420406 - Disclosure - Leases - Assumptions Used for Operating Leases (Details) Sheet http://www.amnhealthcare.com/role/LeasesAssumptionsUsedForOperatingLeasesDetails Leases - Assumptions Used for Operating Leases (Details) Details 42 false false R43.htm 2420407 - Disclosure - Leases - Minimum Lease Payments Under ASC 840 (Details) Sheet http://www.amnhealthcare.com/role/LeasesMinimumLeasePaymentsUnderAsc840Details Leases - Minimum Lease Payments Under ASC 840 (Details) Details 43 false false R44.htm 2422401 - Disclosure - Commitments and Contingencies: Legal Proceedings - Narrative (Details) Sheet http://www.amnhealthcare.com/role/CommitmentsAndContingenciesLegalProceedingsNarrativeDetails Commitments and Contingencies: Legal Proceedings - Narrative (Details) Details http://www.amnhealthcare.com/role/CommitmentsAndContingenciesLegalProceedings 44 false false R45.htm 2423402 - Disclosure - Balance Sheet Details - Narrative (Details) Sheet http://www.amnhealthcare.com/role/BalanceSheetDetailsNarrativeDetails Balance Sheet Details - Narrative (Details) Details 45 false false R46.htm 2424401 - Disclosure - Subsequent Events - Narrative (Details) Sheet http://www.amnhealthcare.com/role/SubsequentEventsNarrativeDetails Subsequent Events - Narrative (Details) Details 46 false false R9999.htm Uncategorized Items - ahs-20190331.xml Sheet http://xbrl.sec.gov/role/uncategorizedFacts Uncategorized Items - ahs-20190331.xml Cover 47 false false All Reports Book All Reports ahs-20190331.xml ahs-20190331.xsd ahs-20190331_cal.xml ahs-20190331_def.xml ahs-20190331_lab.xml ahs-20190331_pre.xml http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2018-01-31 http://fasb.org/us-gaap/2018-01-31 true true ZIP 72 0001142750-19-000021-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001142750-19-000021-xbrl.zip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